2013 CRS Annual Meeting Abstracts

 

The CRS Annual Meeting & Exposition offers over 770 podium and poster presentations. Below you will find podium presentation within scientific sessions and mini symposia grouped by day followed by the poster categories. Click on a session to be brought to the presentations. From there you may access the abstracts if you are logged in and are registered to attend the annual meeting. Abstracts will also be available to current members after the meeting concludes.

Search Abstracts

Shortcuts to Podium Sessions

Monday
Food, Nutraceuticals and Personalized Diet
Mini Symposia: Hybrid Groups - Bridging the Gap Between Industry and Academia
Parenteral Sustained Release Drug Delivery
Rising Suns in Asia
RNAi and DNA Delivery
Challenges Around Brain Delivery: Sampling Site Issues and Interspecies Extrapolations
Micro- and Nanoparticle Design
Mini Symposia: Breakthrough Technologies in DDS from Asia
Smart Building and Construction Materials and Coatings
Topical/Transdermal Drug Delivery


Tuesday
Drug Delivery for Developing Countries
Imaging and Characterization Techniques for Drug Delivery: Systems and Targeted Drug Delivery
Mini Symposia: Energy: Problems Within the Industry that Controlled Delivery Can Solve
Peptide and Protein Delivery
Solubilization Technology - A Key Enabler for the Delivery of Poorly Soluble Drugs
Drug Targeting, Pharmacokinetics, and Biodistribution: Differences Between Species
Mini Symposia: Drug Combination Products
Modern Agriculture and Aquaculture
Oral CR - Pharmaceutical Formulations, Technologies and Development Strategies
Processing Technology/Manufacturability


Wednesday
Emerging Technologies
Mini Symposia: Nanoparticles and Cancer
Oral CR - Predictive Tools (in vitro / in vivo / in silico)
Personal and Home Care
Regional Delivery: Challenges in Ocular Delivery and Pulmonary Delivery

Shortcuts to Poster Sessions

Biological Structural Materials and Coatings
Challenges Around Brain Delivery: Sampling Site Issues and Interspecies Extrapolations
Drug Delivery for Developing Countries/Global Challenges
Emerging Technologies
Food, Nutraceuticals and Personalized Diet
Imaging and Characterization Techniques for Drug Delivery: Systems and Targeted Drug Delivery
Micro- and Nanoparticle Design
Modern Agriculture and Aquaculture
Oral CR - Pharmaceutical Formulations, Technologies and Development Strategies
Oral CR - Predictive Tools (in vitro / in vivo / in silico)
Parenteral Sustained Release Drug Delivery
Peptide and Protein Delivery
Personal and Home Care
Processing Technology/Manufacturability
Regional Delivery: Challenges in Ocular Delivery and Pulmonary Delivery
Rising Suns in Asia
RNAi and DNA Delivery
Solubilization Technology - A Key Enabler for the Delivery of Poorly Soluble Drugs
Topical/Transdermal Drug Delivery

PODIUM PRESENTATIONS

Food, Nutraceuticals and Personalized Diet     [RETURN TO TOP]

1  Invited Speaker: Systems Approaches to Personalized Nutrition and Ingredient Bioavailability. Presenter: Martin Kussmann, Nestle Institute of Health Sciences, Switzerland. Author(s): M. Kussmann. VIEW ABSTRACT

2  Novel protein based microparticles for intestinal delivery of bioactive compounds. Presenter: Zhigang Tian, University of Alberta, Dept. of Agricultural, Food and Nutritional Science, Canada. Author(s): Z. Tian, R. Wang, L. Chen. VIEW ABSTRACT

3  Tauroursodeoxycholic acid attenuates lipid accumulation and adipogenesis of adipose-derived stem cells. Presenter: Hansoo Park, College of Integrative Engineering, Chung-Ang University, Korea. Author(s): B. Cha, J. Kim, J. Ahn, H. Park, S. Park, S. Lee. VIEW ABSTRACT

4  Silk-based biomaterials for stabilization and sustained release of neutraceuticals. Presenter: Xiaoqin Wang, Suzhou University, Prc Peoples Rep of China. Author(s): X. Wang. VIEW ABSTRACT

5  Evaluation of cellular uptake and transport of Ginkgo biloba Extract niosomes. Presenter: Jingyuan Wen, School of Pharmacy, the University of Auckland, New Zealand. Author(s): Y. Jin, D. Li, L. Teng, W. Zhang, J. Jin, J. Wen. VIEW ABSTRACT

Mini Symposia: Hybrid Groups - Bridging the Gap Between Industry and Academia     [RETURN TO TOP]

6  Invited Speaker: Transforming Discovery into Opportunity - The Centre for Drug Research and Development (CDRD) and New Models for Commercialization. Presenter: Karimah Es Sabar, The Centre for Drug Research and Development, Canada. Author(s): K. Es Sabar. VIEW ABSTRACT

7  Invited Speaker: Connecting Academia and Pharmaceutical Industry – A Max Planck Initiative Toward Closing the Innovation Gap in Drug Discovery. Presenter: Bert Klebl, Lead Discover Center GmbH, Germany. Author(s): B. Klebl. VIEW ABSTRACT

8  Invited Speaker: Funding Translational Research in Academia. Presenter: Patrick Griffin, The Scripps Research Institute, U.S.A. Author(s): P. Griffin. VIEW ABSTRACT

Parenteral Sustained Release Drug Delivery     [RETURN TO TOP]

9  Invited Speaker: Aqueous Microencapsulation of Large Molecules in PLGAs. Presenter: Steven Schwendeman, University of Michigan, U.S.A. Author(s): S. P. Schwendeman, K. H. Desai, J. M. Mazzara. VIEW ABSTRACT

10  Enhanced Exposure of a Chemotherapeutic Drug to the Lymphatic System with the use of PEG-Modified and Nano-Sized Drug Carriers. Presenter: Gemma Ryan, Monash University, Australia. Author(s): G. M. Ryan. VIEW ABSTRACT

11  In vitro release studies on parenteral sustained release dosage forms: Crystal suspensions of poorly soluble peptides desired for intra-articular application. Presenter: Bernd Sterner, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany, Germany. Author(s): B. Sterner, M. Harms, M. Windbergs, M. Weigandt, C. Lehr. VIEW ABSTRACT

12  A drug transport model for delivery vectors incorporating chemical and microstructure properties. Presenter: Arturas Ziemys, The Methodist Hospital Research Institute, U.S.A. Author(s): M. Kojic, M. Milosevic, N. Kojic, M. Ferrari, A. Ziemys. VIEW ABSTRACT

13  Anastrozole loaded-PLGA microspheres as a novel therapy to overcome noncompliance issues on breast cancer patients. Presenter: Hongkee Kim, SKchemicals Life Science Biz, Korea. Author(s): H. Kim, K. H. Lee, S. H. Hong, H. Shin. VIEW ABSTRACT

Rising Suns in Asia     [RETURN TO TOP]

14  Invited Speaker: Nanotechnology in vivo: Redox Polymer Therapeutics. Presenter: Yukio Nagasaki, University of Tsukuba, Japan. Author(s): Y. Nagasaki, Y. Nagasaki. VIEW ABSTRACT

15  C225-conjugated polymeric micelles for targetable photodynamic therapy. Presenter: Ping-Shan Lai, National Chung Hsing University, Taiwan. Author(s): P. Lai. VIEW ABSTRACT

16  Development of pH responsive polymeric self-assembly system for curcumin delivery. Presenter: Warayuth Sajomsang, National Nanotechnology Center, Thailand. Author(s): W. Sajomsang. VIEW ABSTRACT

17  Multifunctional carrier for RNA delivery. Presenter: Shiyue Duan, Shanghai Jiao Tong University, Prc Peoples Rep of China. Author(s): S. Duan, W. Yuan, F. Wu, T. Jin. VIEW ABSTRACT

18  Enhanced Gene Expression, Transfection, and Reduced Cytotoxicity of Novel Hyaluronic Acid-PEI-Cyclodextrin Polyplexes. Presenter: Sanyog Jain, National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, India. Author(s): S. Jain, S. Kumar, A. K. Agrawal, K. Thanki, U. C. Banerjee. VIEW ABSTRACT

RNAi and DNA Delivery     [RETURN TO TOP]

19  Invited Speaker: Oncolytic adenovirus coated with stimuli-responsive block copolymer for passive tumor targeting. Presenter: Chae-Ok Yun, Hanyang University, South Korea. Author(s): C. Yun. VIEW ABSTRACT

20  Sequence-defined multifunctional carriers for targeted siRNA delivery. Presenter: Ernst Wagner, Pharmaceutical Biotechnology, Ludwig Maximilians University, Munich, Germany. Author(s): E. Wagner. VIEW ABSTRACT

21  Ischemic myocardium targeting peptide-guided gene delivery system. Presenter: Young-Wook Won, University of Utah, U.S.A. Author(s): Y. Won, A. N. McGinn, M. Lee, D. A. Bull, S. Kim. VIEW ABSTRACT

22  Noncovalenly PEGylated ternary complex for pulmonary delivery of therapeutic siRNA. Presenter: Won Ho Kong, POSTECH, Korea. Author(s): W. Kong, H. Kim, S. Hahn. VIEW ABSTRACT

23  A flexible nano carrier for siRNA delivery into tumor. Presenter: Kentaro Kogure, Kyoto Pharmaceutical University, Japan. Author(s): K. Kogure, Y. Shimatani, K. Uno, H. Chon, S. Hama. VIEW ABSTRACT

Challenges Around Brain Delivery: Sampling Site Issues and Interspecies Extrapolations     [RETURN TO TOP]

24  Invited Speaker: Challenges in measuring active concentration in the brain and its impact for nanocarrier delivery. Presenter: Margareta Hammarlund-Udenaes, Uppsala University, Sweden. Author(s): M. Hammarlund-Udenaes, I. Loryan, A. Lindqvist. VIEW ABSTRACT

25  Self-assembling nanoparticles containing zoledronic acid: a new challenge for the treatment of brain tumors. Presenter: Giuseppina Salzano, Department of Pharmacy, Università degli Studi di Napoli Federico II, Via Montesano, 49, 80131 Naples, Italy., Italy. Author(s): G. Salzano. VIEW ABSTRACT

26  Complete recovery of cognition for senescence-accelerated-prone mice by oral redox-polymer therapeutics. Presenter: Yukio Nagasaki, University of Tsukuba, Japan. Author(s): Y. Nagasaki, P. Chonpathompikunlert, T. Yoshitomi, N. Imaizumi, Y. Ozaki. VIEW ABSTRACT

27  Nanogels as a platform for targeted delivery of Cisplatin to the Brain Tumor. Presenter: Natalia Nukolova, Lomonosov Moscow State University, Russia. Author(s): N. Nukolova, V. Baklaushev, A. Kabanov, V. Chekhonin. VIEW ABSTRACT

28  Targeted Nano-NRTI Formulations for Suppression of HIV-1 Infection in the Brain. Presenter: Serguei Vinogradov, University of Nebraska Medical Center, U.S.A. Author(s): S. V. Vinogradov, S. Gorantla, T. Senanayake, E. Makarov, Y. Lu. VIEW ABSTRACT

Micro- and Nanoparticle Design     [RETURN TO TOP]

29  Invited Speaker: Precision fabrication of emulsion-templated structures for encapsulation and release using microfluidics. Presenter: David Weitz, Harvard University, U.S.A. Author(s): D. A. Weitz. VIEW ABSTRACT

323 Enhancing Tumor Cell Response to Chemotherapy by Simultaneous Delivery of siRNA and Anticancer Drug Using Nanoparticles. Presenter: Xiaoyang Xu, Harvard Medical School, U.S.A. Author(s): X. Xu. VIEW ABSTRACT

31  Activation of An Immune-Regulatory Macrophage Response and Inhibition of Lung Inflammation in A Mouse Model of COPD Using Porous Alpha B-crystallin-Loaded PLGA Microparticles. Presenter: Maryam Amidi, Utrecht University, Netherlands. Author(s): M. Amidi. VIEW ABSTRACT

32  Heat-activated Thermosensitive Liposomal Cisplatin (HTLC) Results in Effective Growth Delay of Cervical Carcinoma in Mice. Presenter: N. Dou. Author(s): Y. Dou, J. Zheng, R. Weersink, N. Chaudary, W. D. Foltz, D. A. Jaffray, C. J. Allen. VIEW ABSTRACT

33  Multistage Vector for Controlled Oral Delivery of Anti-Inflammatory Drug in Inflammatory Bowel Disease Treatment. Presenter: Fransisca Leonard, The Methodist Hospital Research Institute, U.S.A. Author(s): F. Leonard, E. Collnot, C. Lehr, M. Ferrari, B. Godin. VIEW ABSTRACT

Mini Symposia: Breakthrough Technologies in DDS from Asia     [RETURN TO TOP]

34  Invited Speaker: Structural Modified siRNAs for Systemic siRNA Delivery. Presenter: Kwangmeyung Kim, Korea Institute of Science and Technology , Korea. Author(s): K. Kim, S. Lee, S. Kim, C. Ahn, I. Kwon. VIEW ABSTRACT

35  Invited Speaker: Bioresponsive Degradable Nanocarriers for Active Intracellular Anticancer Drug Delivery. Presenter: Zhiyuan Zhong, Soochow University, Prc Peoples Rep of China. Author(s): Z. Zhong. VIEW ABSTRACT

36  Invited Speaker: Liposomal Systems for Pulmonary and Ocular Drug Delivery. Presenter: Hirofumi Takeuchi, Gifu Pharmaceutical Univ, Japan. Author(s): H. Takeuchi. VIEW ABSTRACT

Smart Building and Construction Materials and Coatings     [RETURN TO TOP]

37  Invited Speaker: Crack-mediated Release of Encapsulated Bacteria-based Agent Makes Concrete Self-healing. Presenter: Henk Jonkers, Delft University of Technology, Netherlands. Author(s): H. M. Jonkers. VIEW ABSTRACT

38  Enzyme-Based Nanocomposites: Using Nature to Ward off Emerging Threats. Presenter: Ravi Kane, Rensselaer Polytechnic Institute, U.S.A. Author(s): R. S. Kane, N. Grover, K. K. Mehta, R. C. Pangule, K. Solanki, M. Douaisi, E. E. Paskaleva, C. Dinu, J. S. Dordick. VIEW ABSTRACT

39  Pelletized Phase Change Material for Energy-Efficient Buildings. Presenter: Ramin Abhari, Syntroleum Corporation, U.S.A. Author(s): R. Abhari, N. Shukla, A. Fallahi, K. Biswas. VIEW ABSTRACT

40  Microencapsulation of Salts for Enhanced Thermochemical Storage Materials. Presenter: Nicole Papen-Botterhuis, TNO Responsive Materials & Coatings, Netherlands. Author(s): R. Cuypers, A. J. De Jong, J. Eversdijk, H. Van 't. Spijker, H. P. Oversloot, B. L. Ingenhut, R. K. Cremers, N. E. Papen-Botterhuis. VIEW ABSTRACT

41  Microcapsule Delivery Systems for Textile Applications. Presenter: Teresa Virgallito, Microtek Labs Inc, U.S.A. Author(s): T. Virgallito. VIEW ABSTRACT

Topical/Transdermal Drug Delivery     [RETURN TO TOP]

42  Invited Speaker: Nanoparticulate Delivery to the Skin by exploiting Passive Physical Principles. Presenter: Rainer Müller, Free University Berlin, Germany. Author(s): R. H. Müller, C. M. Keck. VIEW ABSTRACT

43  Permeability and Stability of Dispersion Systems in the Presence of Penetration Enhancers. Presenter: Jingyuan Wen, University of Auckland, New Zealand. Author(s): J. R. Falconer, J. Wen, S. Zargar-Shoshtari, J. J. Chen, M. Farid, G. M. El Maghraby, R. G. Alany. VIEW ABSTRACT

44  Controlled 90-Day In Vitro and In Vivo Delivery of Tenofovir and Levonorgestrel from a Dual-Segment Reservoir Intravaginal Ring. Presenter: Justin Clark, University of Utah, U.S.A. Author(s): J. T. Clark, M. R. Clark, T. J. Johnson, N. B. Shelke, J. S. Nebeker, G. F. Doncel, D. R. Friend, P. F. Kiser. VIEW ABSTRACT

45  Needle free vaccination using nanoparticles via transfollicular route -- a perspective for transcutaneous vaccination. Presenter: Ankit Mittal, Saarland University, Biopharmaceutics and Pharmaceutical Technology, Saarbruecken, Germany, Germany. Author(s): A. Mittal, A. S. Raber, U. F. Schaefer, S. Weissmann, T. Ebensen, K. Schulze, C. A. Guzmán, C. M. Lehr, S. Hansen. VIEW ABSTRACT

46  Rapid Skin Permeabilization by the Simultaneous Application of Dual-Frequency Ultrasound. Presenter: Carl Schoellhammer, Massachusetts Institute of Technology, U.S.A. Author(s): C. M. Schoellhammer, B. E. Polat, J. Mendenhall, R. Maa, B. Jones, D. P. Hart, R. Langer, D. Blankschtein. VIEW ABSTRACT

Drug Delivery for Developing Countries     [RETURN TO TOP]

47  Invited Speaker: Multipurpose Prevention Technologies for Global Health. Presenter: Kim Woodrow, Univ of Washington, U.S.A. Author(s): K. A. Woodrow. VIEW ABSTRACT

48  Vaginal Ring Configurations for the Simultaneous Delivery of Dapivirine and Levonorgestrel. Presenter: Susan Fetherston, Queen's University Belfast, United Kingdom. Author(s): S. M. Fetherston, P. Boyd, I. Major, B. Devlin, J. Holt, K. Malcolm. VIEW ABSTRACT

49  An improved claudin-targeting mucosal vaccine using a double alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin. Presenter: Mayo Yamashita, Graduate School of Pharmaceutical Science, Osaka University, Japan. Author(s): H. Suzuki, J. Kunisawa, A. Watari, M. Yamashita, K. Yagi, M. Kondoh. VIEW ABSTRACT

50  Skin is Special: Exploiting It With Practical Microneedle Devices For Improved Vaccines, And Diagnosis of Disease. Presenter: Mark Kendall, Australian Institute for Bioengineering and Nanotechnology, Australia. Author(s): M. A. Kendall. VIEW ABSTRACT

51  Development and Characterization of Emulsomes for Macrophage Targeted Multidrug Therapy against Tuberculosis. Presenter: Yashwant Pathak, University of South Florida, U.S.A. Author(s): S. Gupta, Y. Pathak. VIEW ABSTRACT

Imaging and Characterization Techniques for Drug Delivery: Systems and Targeted Drug Delivery     [RETURN TO TOP]

52  Invited Speaker: Noninvasive in vitro and in vivo Monitoring of Drug Delivery Processes by Electron Spin Resonance, Benchtop-NMR and Multispectral Optical Imaging. Presenter: Karsten Mäder, Martin-Luther-University Halle-Wittenberg, Germany. Author(s): K. Mäder. VIEW ABSTRACT

53  Direct Multi-nuclear Magnetic Resonance Imaging Studies of Controlled Drug Release. Presenter: Charlie Chen, University of Cambridge, United Kingdom. Author(s): C. Chen, L. F. Gladden, M. D. Mantle. VIEW ABSTRACT

54  CT/Optical Liposomes for High Accuracy Tumor Resection Using Image-Guided Surgery. Presenter: Jinzi Zheng, Princess Margaret Hospital , Canada. Author(s): J. Zheng, R. De Souza, M. Li, M. Dunne, C. Allen, D. A. Jaffray. VIEW ABSTRACT

55  Tumor-Microenvironment-On-Chip: Simulation of Complex Transport around Tumor. Presenter: Kinam Park, Department of Pharmaceutics, Purdue University, U.S.A. Author(s): B. Kwak, K. Park, B. Han. VIEW ABSTRACT

56  New Applications of UV Imaging in Stability Testing: Release of Drug from Coated Particles in Pediatric Semi-Solid Dosage Forms. Presenter: Daniel Bar-Shalom, University of Copenhagen, Denmark. Author(s): D. Bar-Shalom, S. Seric, P. Bjørnsholt, A. J. Chapman, D. M. Goodall. VIEW ABSTRACT

Mini Symposia: Energy: Problems Within the Industry that Controlled Delivery Can Solve     [RETURN TO TOP]

57  Invited Speaker: Novel Composite Microencapsulated Phase Change Tablet. Presenter: Jo Darkwa, Centre for Sustainable Energy Technologies (CSET), University of Nottingham Ningbo China, Prc Peoples Rep of China. Author(s): J. Darkwa. VIEW ABSTRACT

58  Invited Speaker: High Temperature Phase Change Materials. Presenter: James Oxley, Southwest Research Institute, U.S.A. Author(s): J. D. Oxley. VIEW ABSTRACT

59  Invited Speaker: Controlled Release of Tracer Compounds for Inflow Monitoring in Oil Wells. Presenter: Anne Dyrli, RESMAN AS, Norway. Author(s): A. D. Dyrli, L. Kilaas, R. Skjetne. VIEW ABSTRACT

Peptide and Protein Delivery     [RETURN TO TOP]

60  Invited Speaker: Modular nanomaterials for instructing therapeutic immune responses against cancer and autoimmune disease. Presenter: Tarek Fahmy, Yale University, U.S.A. Author(s): T. Fahmy, J. Park, D. Kim, A. Seifert, M. McHugh, M. Look. VIEW ABSTRACT

61  Arginine-rich cell-penetrating peptides -- The role of heparan sulfate in uptake. Presenter: Rike Wallbrecher, Department of Biochemistry, Radboud University Nijmegen Medical Centre, Netherlands. Author(s): R. Wallbrecher, W. P. Verdurmen, P. H. Bovee-Geurts, F. Bröcker, A. Reinhardt, P. H. Seeberger, R. Brock. VIEW ABSTRACT

62  Artificial Receptor-Mediated Endocytosis for Efficient Protein Delivery into Cells. Presenter: Takeshi Mori, Kyushu Univ., Japan. Author(s): T. Mori, K. Tobinaga, C. Lee, M. Takeo, M. Matsuda, T. Niidome, Y. Katayama. VIEW ABSTRACT

63  Development and Phase 1 Clinical Results for BA058-coated Microneedles for the Treatment of Osteoporosis. Presenter: Daniel Dohmeier, 3m Drug Delivery, U.S.A. Author(s): K. Hansen, D. Dohmeier, T. Fenn, J. Moseman, D. Wirtanen, J. Christensen, S. Schaefer, G. Hattersley. VIEW ABSTRACT

64  Transport of PEGylated liposomes to follicle induced by pre-stimulation of empty liposomes: Potentiating specific antibody responses against antigen encapsulated in the liposomes. Presenter: Taro Shimizu, The University of Tokushima, Japan. Author(s): T. Shimizu, T. Ishida, H. Kiwada. VIEW ABSTRACT

Solubilization Technology - A Key Enabler for the Delivery of Poorly Soluble Drugs     [RETURN TO TOP]

65  Invited Speaker: Solubilization Technology - A Key Enabler for the Delivery of Poorly Soluble Drugs. Presenter: Ravi Shanker, Pfizer Inc, U.S.A. Author(s): R. M. Shanker. VIEW ABSTRACT

66  Evolution of nanostructure during digestion of medium chain formulation lipids -- dependence on lipid mass and bile salt to lipid ratio. Presenter: Ben Boyd, Monash Institute of Pharmaceutical Sciences, Australia. Author(s): S. Phan, C. A. Prestidge, A. Hawley, X. Mulet, L. Waddington, B. J. Boyd. VIEW ABSTRACT

67  Enhanced Bioavailability of Poorly Soluble Drugs by Co-spray Drying with Mesoporous Materials. Presenter: Shoucang Shen, Institute of Chemical and Engineering Sciences, Singapore. Author(s): S. Shen, W. Ng, L. Chia, R. Tan. VIEW ABSTRACT

68  Drug-polymer filled micro-containers for oral delivery loaded using supercritical CO2 aided-impregnation. Presenter: Paolo Marizza, Department of Micro- and Nanotechnology (DTU), Denmark. Author(s): P. Marizza, S. Sylvest. Keller, A. Müllertz, T. Rades, A. Boisen. VIEW ABSTRACT

69  Effect of Supercritical Carbon Dioxide on Hot Melt Extruded Cellulose Polymers. Presenter: Michael Repka, Department of Pharmaceutics, School of Pharmacy, The University of Mississippi, University, MS-38677, USA, U.S.A. Author(s): M. A. Repka, E. A. Ashour, S. Shah, S. Majumdar, R. Bosworth, M. Keshtmand, V. Bi, T. Durig. VIEW ABSTRACT

Drug Targeting, Pharmacokinetics, and Biodistribution: Differences Between Species     [RETURN TO TOP]

70  Invited Speaker: Drug targeting, Pharmacokinetics and Biodistribution -- Differences between species. Presenter: James Klostergaard, Univ of Texas, U.S.A. Author(s): J. Klostergaard. VIEW ABSTRACT

71  PBPK Modeling of the Nanoparticle Biodistribution: Interspecies Extrapolation and Tumor Targeting. Presenter: Joshua Reineke, Wayne State University, U.S.A. Author(s): M. Li, J. Reineke. VIEW ABSTRACT

72  Pharmacokinetics and bioavailability of a controlled release monoclonal antibody formulation. Presenter: Daniel Schweizer, Novartis Pharma AG, Klybeckstrasse 141, 4057 Basel, Switzerland. Author(s): D. Schweizer, T. Serno, I. Vostiar, K. Schönhammer, M. Jahn, A. Göpferich. VIEW ABSTRACT

73  A Novel Design of Hyaluronic Acid-based Nanogels against CD44-expressing Tumors. Presenter: Xin Wei, University of Nebraska Medical Center, U.S.A. Author(s): X. Wei, T. H. Senanayake, S. V. Vinogradov. VIEW ABSTRACT

74  Hyaluronic Acid – Gold Nanoparticle / Interferon α Complex for Targeted Treatment of Hepatitis C Virus Infection. Presenter: Sei Kwang Hahn, POSTECH, South Korea. Author(s): S. Hahn, M. Lee, J. Yang. VIEW ABSTRACT

Mini Symposia: Drug Combination Products     [RETURN TO TOP]

75  Invited Speaker: The Genetic Landscape of a Cell. Presenter: Charlie Boone, University of Toronto, Canada. Author(s): C. Boone. VIEW ABSTRACT

76  Invited Speaker: Engineering Nano-scale Carriers to Coordinate the In Vivo Delivery of Anticancer Drug Combinations. Presenter: Lawrence Mayer, Celator Pharmaceuticals, U.S.A. Author(s): L. D. Mayer, B. Liboiron, D. Cabral-Lilly, T. Harasym, P. Tardi. VIEW ABSTRACT

77  Invited Speaker: Biomimetic Long-Circulating Nanoparticles for Combinatorial Drug Delivery. Presenter: Liangfang Zhang, University of California, U.S.A. Author(s): L. Zhang, C. Hu, R. Fang. VIEW ABSTRACT

Modern Agriculture and Aquaculture     [RETURN TO TOP]

78  Invited Speaker: Aquatic Animal Health Applications of Controlled-Release Technologies. Presenter: David Powell, ProFishent Inc, U.S.A. Author(s): D. B. Powell, R. C. Palm. VIEW ABSTRACT

934 Historical Perspective on Coating Technology in Agriculture/Aquaculture.  Presenter: Charles Frey, Coating Place Inc., U.S.A. Author(s): C. Frey, H. Hall. VIEW ABSTRACT

80  Modeling concentration-time relationships of benzylpenicillin in milk after intramuscular injection of penethamate in dairy cows. Presenter: Rohit Jain, School of Pharmacy, University of Otago, NEW ZEALAND. Author(s): R. Jain, O. Bork, I. G. Tucker. VIEW ABSTRACT

81  Novel controlled release intramammary delivery system for treating bovine mastitis during lactation period. Presenter: Olaf Bork, School of Pharmacy, University of Otago, New Zealand. Author(s): O. Bork, K. Petrovski, F. Alawi, I. Tucker. VIEW ABSTRACT

82  Water activity, pre-wetting and survival of Pseudomonas sp. ADP immobilized onto zeolite. Presenter: Craig Bunt, AgResearch, New Zealand. Author(s): S. A. Stelting, A. Sunna, C. R. Bunt. VIEW ABSTRACT

Oral CR - Pharmaceutical Formulations, Technologies and Development Strategies     [RETURN TO TOP]

83  Invited Speaker: Mechanistic insights of the effects of process and formulation variables on the performance of hydrophilic matrix tablets using magnetic resonance imaging. Presenter: Peter Timmins, Bristol-Myers Squibb, United Kingdom. Author(s): P. Timmins, S. Hanley, J. Brown. VIEW ABSTRACT

84  Development of M Cell Targeting Peptide-Coupled Porous PLGA Microparticles for Efficient Mucosal Immune Responses by Oral Vaccine Delivery. Presenter: Chong-Su Cho, Department of Agricultural Biotechnology, Seoul National University, South Korea. Author(s): T. Jiang, C. Cho. VIEW ABSTRACT

85  Controlled Release of Dry Polymer Coated Microparticles. Presenter: Maxx Capece, New Jersey Institute of Technology, U.S.A. Author(s): M. W. Capece, R. Dave. VIEW ABSTRACT

86  Controlled Release of Poorly Soluble Drugs via Hot Melt Extrusion. Presenter: Zhuoyang Lian, Ashland Specialty Ingredients, U.S.A. Author(s): Z. Lian, A. Bell, D. Tewari, C. Seiler, A. Djemai, T. Durig. VIEW ABSTRACT

87  New Insights into the Effects of Polymer Molecular Weight on Release Mechanisms through Polymer Blend Coatings. Presenter: Helene Andersson, SIK - The Swedish Institute for Food and Biotechnology, Sweden. Author(s): H. Andersson, M. Marucci, J. Hjärtstam, M. Stading, C. von Corswant, A. Larsson. VIEW ABSTRACT

Processing Technology/Manufacturability     [RETURN TO TOP]

88  Invited Speaker: Integrating Delivery Device Capability into Pharmaceutical Product Development and Manufacturing. Presenter: Beth Hill, Johnson & Johnson, U.S.A. Author(s): B. Hill. VIEW ABSTRACT

89  The NanoAssembl™ Platform: Microfluidics-based Manufacture of Limit Size Lipid Nanoparticles for Drug and Nucleic Acid Delivery. Presenter: Colin Walsh, University of British Columbia, Canada. Author(s): C. L. Walsh. VIEW ABSTRACT

90  Preparation and evaluation of a novel liposomal cyclosporin A using the supercritical fluid method. Presenter: Pankaj Karn, Incheon, South Korea. Author(s): P. R. Karn, W. Cho, S. Hyun, J. Ahn, B. Sun, H. Kim, S. Hwang. VIEW ABSTRACT

91  Controlled Release from Core-Sheath Microfibers Fabricated Using a Novel High-Throughput Electrospinning System. Presenter: Toby Freyman, Arsenal Medical, U.S.A. Author(s): A. Deleault, Q. Pham, X. Yan, R. Mulligan, J. Marini, T. Freyman. VIEW ABSTRACT

92  Influence of tableting on the conformational and thermal stability of a model protein drug. Presenter: Marten Klukkert, University of Hamburg, Germany. Author(s): M. Klukkert, A. Sakmann, T. Rades, C. S. Leopold. VIEW ABSTRACT

Emerging Technologies     [RETURN TO TOP]

93  Invited Speaker: DNA-based Hydrogels for Drug Development and Drug Delivery. Presenter: Dan Luo, Cornell University, U.S.A. Author(s): D. Luo. VIEW ABSTRACT

94  Stem Cell Derived Nano Vesicles- A New Delivery Platform for Cancer Targeted Therapy. Presenter: Naama Toledano Furman, The Technion, Israel. Author(s): N. E. Toledano Furman. VIEW ABSTRACT

95  Cationic amphiphilic macromolecules (CAMs)-lipid complexes for intracellular siRNA delivery. Presenter: Kathryn Uhrich, Rutgers, the State University of New Jersey, U.S.A. Author(s): K. E. Uhrich, L. Gu, L. Nusblat, C. M. Roth. VIEW ABSTRACT

96  On-demand Drug Release Triggered by Two-Photon-Absorption. Presenter: Norbert Hampp, University of Marburg, Germany. Author(s): N. A. Hampp, H. Kim, L. Hesse. VIEW ABSTRACT

97  Pollen Grains as 'Trojan Horses'™ for Oral Vaccination. Presenter: Harvinder Gill, Texas Tech University, U.S.A. Author(s): S. Atwe, Y. Ma, H. S. Gill. VIEW ABSTRACT

Mini Symposia: Nanoparticles and Cancer     [RETURN TO TOP]

98  Invited Speaker: Development of Hybrid Silica Nanoparticle Platforms: Design, evaluation and translation from lab to clinic. Presenter: Michelle Bradbury, Memorial Sloan Kettering Cancer Center, U.S.A. Author(s): M. Bradbury, O. Penate-Medina, M. Benezra, E. Phillips, P. Zanzonico, D. Hambardzumyan, D. Veach, K. Pillarsetty, P. Smith-Jones, E. Holland, S. Larson, U. Wiesner. VIEW ABSTRACT

99  Invited Speaker: Porphyrin-based Nanocarriers for Drug Delivery, Photo-therapy and Multimodal Imaging. Presenter: Yuanpei Li, University of California, Davis, U.S.A. Author(s): Y. Li, T. Lin, C. Pan, K. S. Lam. VIEW ABSTRACT

100  Invited Speaker: Polymeric Nanoparticles for Intracellular Nucleic Acid Delivery to Glioblastoma. Presenter: Jordan Green, Johns Hopkins Univ, U.S.A. Author(s): S. Y. Tzeng, K. L. Kozielski, H. Guerrero-Cazares, A. Quinones-Hinojosa, J. J. Green. VIEW ABSTRACT

Oral CR - Predictive Tools (in vitro / in vivo / in silico)     [RETURN TO TOP]

101  Invited Speaker: Modern approaches to estimating in vivo drug release and robustness of oral CR formulations. Presenter: Sandra Klein, University of Greifswald, Germany. Author(s): S. Klein. VIEW ABSTRACT

102  Application of Computational Tools in the Design of Controlled Drug Delivery Systems. Presenter: Xiao Yu Wu, University of Toronto, Canada. Author(s): X. Wu. VIEW ABSTRACT

103  Drug Imaging in Novel Geometric Three-layered Tablet Using Various Physical Properties and Raman Spectroscopy. Presenter: Duhyun Choi, College of Pharmacy, Pusan National University, Korea. Author(s): D. Choi, K. Kim, D. Lim, S. Jeong. VIEW ABSTRACT

104  Exploit In Vivo Modeling & Simulation (IVMS) for Developing New Sustained Released Formulation. Presenter: Dongzhou Liu, GlaxoSmithKline, U.S.A. Author(s): D. J. Liu. VIEW ABSTRACT

105  Novel orally swallowable IntelliCap™ device guarantee success in MR development by quantitative determination of regional drug absorption in man. Presenter: Dieter Becker, Novartis Pharma AG, Switzerland. Author(s): D. Becker, J. Zhang, T. Heimbach, H. Zou, J. Shimizu, C. Wanke. VIEW ABSTRACT

Personal and Home Care     [RETURN TO TOP]

106  Invited Speaker: Optimizing the Performance of Microcapsules in Fabric and Home Care Applications. Presenter: Jiten Dihora, Procter & Gamble Co., U.S.A. Author(s): J. Dihora. VIEW ABSTRACT

667 In-vitro Method for Quantification of Fragrance Capsules Leakage in Personal Care Products. Presenter: Claudio Ortiz, Colgate Palmolive, U.S.A. Author(s): C. Ortiz, M. Holmgren. VIEW ABSTRACT

108  Liposomes as a topical carrier system for delivery of chlorogenic acid and Lychnophora salicifolia hydroethanolic extract: preparation, characterization and in vivo penetration evaluation. Presenter: Ana Luiza Forte, Faculty of Pharmaceutical Sciences of Ribeirao Preto - University of Sao Paulo, Brazil. Author(s): A. S. Forte, R. M. Martins, S. Siqueira, D. R. Gouvea, N. P. Lopes, M. V. Fonseca. VIEW ABSTRACT

671 Smart Microcapsules containing Enzymes for Laundry Applications. Presenter: Parshuram Shukla, National Chemical Laboratory, India. Author(s): P. Shukla, M. Jackson, A. Jadhav. VIEW ABSTRACT

110  Release of Small Molecules Utilizing Enhanced Polymer Films. Presenter: Edith Mathiowitz, Brown University, U.S.A. Author(s): C. Baker, D. Suzin, E. Mathiowitz. VIEW ABSTRACT

Regional Delivery: Challenges in Ocular Delivery and Pulmonary Delivery     [RETURN TO TOP]

111  Invited Speaker: Suprachoroidal Administration of Triamcinolone Acetonide Using a Microneedle for the Treatment of Posterior Ocular Inflammation. Presenter: Samirkumar Patel, Clearside Biomedical , U.S.A. Author(s): S. R. Patel, B. C. Gilger, E. A. Piedrafita, J. H. Salmon, R. Carvalho, R. Verhoeven. VIEW ABSTRACT

112  Systemic Availability and in vivo Stability of PEGylated Poly-Lysine Dendrimers Following Pulmonary Delivery is Highly Size Dependent. Presenter: Gemma Ryan, Monash University, Australia. Author(s): G. M. Ryan. VIEW ABSTRACT

113  Multi-functional cationic dendrimers for connexin43 antisense oligodeoxynucleotide delivery in the treatment of wet age-related macular degeneration. Presenter: Ilva Rupenthal, Department of Ophthalmology, The University of Auckland, New Zealand. Author(s): I. D. Rupenthal, A. Stikkelman, I. Toth, C. R. Green. VIEW ABSTRACT

114  Evaluation of a Novel Lipid Based Nanoparticulate System for OcularDrug Delivery. Presenter: Ali Seyfoddin, School pf Pharmacy, The University of Auckland, New Zealand. Author(s): A. Seyfoddin, R. Al-Kassas. VIEW ABSTRACT

115  Efficacy Testing of Montelukast Loaded Large Porous Particles in Allergen-Induced Rat Asthma Model. Presenter: Brijeshkumar Patel, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA, U.S.A. Author(s): B. Patel, F. Ahsan. VIEW ABSTRACT

POSTER PRESENTATIONS

Biological Structural Materials and Coatings     [RETURN TO TOP]

117  A Model for the Controlled Release of Nano-encapsulated Tissue Plasminogen Activator Using Shear-Activation. Presenter: Maziyar Jalaal, Department of Mechanical Engineering, University of British Columbia, Canada. Author(s): M. Jalaal, K. Letchford, B. Stoeber. VIEW ABSTRACT

119  Dextran acetate-based porous scaffold for biomaterial application. Presenter: André Van der Vlies, Osaka University, Japan. Author(s): A. J. Van der Vlies, W. Han, H. Uyama, U. Hasegawa. VIEW ABSTRACT

121  Nano-scale Surface Coating of Thermoresponsive Block Copolymers for Thermally Regulating Cell Adhesion/Detachment Behavior. Presenter: Masamichi Nakayama, Tokyo Women's Medical University, Japan. Author(s): M. Nakayama, Y. Kimura, N. Yamada, H. Kanazawa, T. Okano. VIEW ABSTRACT

122  Precise Structural Analysis of Polymeric Micelles and Their Relation to Biological Performance. Presenter: Kazuo Sakurai, The University of Kitakyushu, Japan. Author(s): K. Sakurai, U. Sanada, S. Mochizuki, K. Shiraishi, M. Yokoyama. VIEW ABSTRACT

123  Smart Hyperthermia Nanofibers with On-Off Drug Release. Presenter: Mitsuhiro Ebara, National Institute for Materials Science (NIMS), Japan. Author(s): M. Ebara, Y. Kim, T. Aoyagi. VIEW ABSTRACT

125  Water Permeability of Composite Materials for Future Implant Materials. Presenter: Sofie Gårdebjer, Chalmers University of Technology, Sweden. Author(s): S. T. Gårdebjer, C. Börstell, A. Larsson. VIEW ABSTRACT

Challenges Around Brain Delivery: Sampling Site Issues and Interspecies Extrapolations     [RETURN TO TOP]

127  Enhanced Chemotherapy for Brain Glioma by Transferrin-modified Magnetic Mesoporous PLGA Nanoparticles with Core-and-Shell Loading of Doxorubicin and Paclitaxel. Presenter: Chi-Hwa Wang, National University of Singapore, Singapore. Author(s): Y. Cui, C. Wang, D. Wang, P. K. Chow. VIEW ABSTRACT

129  Neuroprotective Effect of PEGylated Liposomes Encapsulating FK506 on Cerebral Ischemia-reperfusion Injury. Presenter: Yurika Agato, Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Japan. Author(s): Y. Agato, T. Ishii, D. Oyama, N. Yasuda, T. Fukuta, A. Sato, K. Shimizu, T. Asai, T. Minamino, N. Oku. VIEW ABSTRACT

130  p-Hydroxybenzoic Acid (p-HA) Modified Polymeric Micelles for Brain-targeting. Presenter: Weiyue Lu, Fudan University, Prc Peoples Rep of China. Author(s): W. Lu. VIEW ABSTRACT

131  Targeted nucleic acid delivery to neuronal cells using Tet1-modified HPMA-oligolysine copolymers. Presenter: David Chu, University of Washington, U.S.A. Author(s): D. S. Chu, J. G. Schellinger, M. J. Bocek, R. N. Johnson, S. H. Pun. VIEW ABSTRACT

Drug Delivery for Developing Countries/Global Challenges     [RETURN TO TOP]

133  A novel peptide ligand directed targeted drug delivery to Myeloid-derived suppressor cells (MDSCs) in tumor bearing mouse. Presenter: Xiaofei Si, School of Pharmacy, Shanghai Jiao Tong University, Prc Peoples Rep of China. Author(s): X. Si, X. Chen. VIEW ABSTRACT

134  A novel transcutaneous vaccine formulation using a self-dissolving microneedle patch. Presenter: Sachiko Hirobe, Osaka University, Japan. Author(s): S. Hirobe, K. Matsuo, Y. Quan, F. Kamiyama, N. Okada, S. Nakagawa. VIEW ABSTRACT

135  Biophysical characterization of hydrogel-core, lipid-shell nanolipogels for HIV-1 chemoprophylaxis. Presenter: Renuka Ramanathan, University of Washington, U.S.A. Author(s): R. Ramanathan, R. Mahadevan, T. Chaowanachan, M. G. Iadanza, T. Gonen, K. A. Woodrow. VIEW ABSTRACT

136  Claudin-1-specific monoclonal antibodies and their inhibition of hepatitis C virus infection. Presenter: Shotaro Nagase, Graduate School of Pharmaceutical Sciences, Osaka University, Japan. Author(s): S. Nagase, M. Yamashita, M. IIda, A. Watari, K. Yagi, M. Fukasawa, M. Kondoh. VIEW ABSTRACT

137  Cytotoxicity and cell uptake of Anionic Docetaxel Self Micro Emulsifying Drug Delivery System on A-549 (human alveolar carcinoma) cell line. Presenter: Rohit Joshi, Institute of Chemical Technology, Mumbai, India. Author(s): R. R. Joshi, D. M. Benival. VIEW ABSTRACT

139  Developing a novel, Glycol-Chitin based thermo-sensitive Gel for the vaginal delivery of Progesterone: Synthesis and Sol-Gel Transition evaluation. Presenter: Margit Janát-Amsbury, University of Utah, U.S.A. Author(s): A. A. Abduljabar, S. Cho, K. M. Huh, M. M. Janát-Amsbury. VIEW ABSTRACT

140  Development of implants for sustained release of rotigotine to achieve CDS for the treatment of PD. Presenter: Wanhui Liu, Yantai University, Luye Pharm, Prc Peoples Rep of China. Author(s): A. Wang, W. Liu, K. Sun. VIEW ABSTRACT

141  Drug formulations intended to stop the spreading of Sexually Transmitted Diseases (STDs). Presenter: Christel Bergström, Uppsala University, Sweden. Author(s): C. Pedersen, A. Slepenkin, E. Peterson, C. Bergström. VIEW ABSTRACT

142  Ellagic Acid loaded pH Sensitive nanoparticles for the treatment of inflammatory bowel disease. Presenter: Dalapathi Gugulothu, Institute of Chemical Technology, India. Author(s): D. B. Gugulothu. VIEW ABSTRACT

143  Enhancement by cyclodextrin of cell surface modification with PEGylated lipid. Presenter: Yoshimasa Takafuji, Graduate School of Pharmaceutical Sciences of Kyoto University, Japan. Author(s): Y. Takafuji, Y. Higuchi, S. Kawakami, F. Yamashita, M. Hashida. VIEW ABSTRACT

144  ESA –SMEDDS: An Innovative Approach for Bioenhanced Curcumin. Presenter: Prashant Mande, Institute of Chemical Technology, India. Author(s): P. P. Mande. VIEW ABSTRACT

145  Evaluation of the Enhanced Oral Bioavailability for Spray-Dried Megestrol Acetate Nanoparticles. Presenter: Yonghai Nan, Utah & Inha DDS and Advanced therapuetic research center, Prc Peoples Rep of China. Author(s): Y. Nan. VIEW ABSTRACT

146  Fabrication and Evaluation of Novel Risperidone Implanys as a Long Term Antipsychotic Therapy. Presenter: Farid Dorkoosh, Tehran University of Medical Sciences, Iran. Author(s): F. A. Dorkoosh, E. Saadat. VIEW ABSTRACT

147  Formulation of Inactivated Polio Vaccine for Thermal Stability. Presenter: Jeong Woo Lee, Georgia Institute of Technology, U.S.A. Author(s): J. Lee, M. R. Prausnitz. VIEW ABSTRACT

149  Intravitreal Zero-order Release Levofloxacin Implant in an Experimental Model of Endophthalmitis. Presenter: Hong Zhang, Centre for Eye Research Australia, Australia. Author(s): H. Zhang, F. Wang, L. Adams, D. Yang, A. Donohue, R. Prankerd, R. Robins-Browne, R. Tait. VIEW ABSTRACT

150  Long term stability of acrylic derivatised dextran-concanavalin A gels as part of an implantable closed loop insulin delivery device. Presenter: Tarsem Sahota, DE MONTFORT UNIVERSITY, United Kingdom. Author(s): T. S. Sahota, M. Taylor. VIEW ABSTRACT

151  Manufacturing scale-up potential of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery. Presenter: Emily Krogstad, University of Washington, U.S.A. Author(s): E. A. Krogstad, K. A. Woodrow. VIEW ABSTRACT

152  Mass transfer and modeling release of Olanzapine from Glycerol monooleate. Presenter: Farid Dorkoosh, Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Author(s): G. Bagheri, E. Vasheghani-Farahani, H. Attar, M. Arjmand, F. Abedin Dorkoosh. VIEW ABSTRACT

153  NanoAnnomaal: A herbal Nanoparticulate system for antimalarial chemotherapy. Presenter: Sampada Sawant, SNDT Women's University, India. Author(s): S. S. Sawant, K. K. Singh. VIEW ABSTRACT

154  Oral Mucosal (Sub-Lingual) Delivery of Vaccines using Zydis Orally Disintegrating Tablets. Presenter: Scott Lamb, Catalent Pharma Solutions, United Kingdom. Author(s): R. T. McLaughlin, L. Grother, S. Lamb. VIEW ABSTRACT

155  Peptide ligand mediated drug delivery to TAMs. Presenter: Lieyi Wu, Shanghai Jiao Tong University, Prc Peoples Rep of China. Author(s): L. Wu. VIEW ABSTRACT

157  Synthesis and Evaluation of a Novel Polymeric Micelle Based on Hyaluronic Acid and Phospholipids. Presenter: Farid Dorkoosh, Tehran University of Medical Sciences, Iran. Author(s): E. Saadat, F. A. Dorkoosh. VIEW ABSTRACT

Emerging Technologies     [RETURN TO TOP]

159  A functionalized hybrid material for sustained drug release. Presenter: Peter Thomsen, BioModics Aps, Denmark. Author(s): P. Thomsen, M. Wojcik, M. Alm. VIEW ABSTRACT

160  A novel system for removing etiologic factors in the blood: Drug-Navigated Clearance System (DNCS). Presenter: Tetsuji Yamaoka, National Cerebral and Cardiovascular Center Research Institute, Japan. Author(s): T. Yamaoka. VIEW ABSTRACT

161  Acceptability and Usability of Hollow Microneedle Drug Delivery Devices for the Treatment of Rheumatoid Arthritis. Presenter: Daniel Dohmeier, 3M Drug Delivery, U.S.A. Author(s): A. Bohlke, S. Burton, L. Marshall, S. Schaefer, K. Hansen, D. Dohmeier. VIEW ABSTRACT

164  Characterizing and evaluating preclinical suitability of a syngeneic mouse ovarian cancer model. Presenter: Margit Janát-Amsbury, University of Utah, U.S.A. Author(s): M. M. Janát-Amsbury, S. Cho, E. A. Jarboe, A. Kennedy, C. Peterson. VIEW ABSTRACT

165  Co-delivery of MDM2 Antagonist Nutlin with Proteasome Inhibitor Curcumin in Immuno-Nanoparticle for Targeted Gliobastoma Therapy. Presenter: Manasi Das, Institute of life Sciences, India. Author(s): M. Das, S. K. Sahoo. VIEW ABSTRACT

166  Comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies to target a model immunomodulator to the lymphatic system. Presenter: Sifei Han, Monash Institute of Pharmaceutical Sciences, Monash University, Australia. Author(s): S. Han, T. Quach, L. Hu, A. Wahab, W. N. Charman, V. J. Stella, N. L. Trevaskis, J. S. Simpson, C. J. Porter. VIEW ABSTRACT

171  Ethyl Cellulose Composite Membranes with Photosensitive Microspheres for Controlled Diffusion. Presenter: Song Li, King Abdullah University of Science and Technology, Saudi Arabia. Author(s): S. Li, N. M. Khashab. VIEW ABSTRACT

172  First successful report of a humanized Endometrial Cancer mouse model following characteristics of patient tumor growth, pathology, and metastatic progression available for preclinical drug evaluation. Presenter: Margit Janát-Amsbury, University of Utah, U.S.A. Author(s): M. M. Janát-Amsbury, C. H. Yang, E. A. Jarboe, C. Peterson. VIEW ABSTRACT

174  Functional Polymer-coated Exosomes: Nanogel Hybrid Assembly for Drug Delivery System. Presenter: Kazunari Akiyoshi, Kyoto University, JST ERATO, Japan. Author(s): K. Akiyoshi, J. Yasuoka, S. Sawada, N. Harada, N. Seo, H. Shiku. VIEW ABSTRACT

177  Hard capsules filled with liquid crystalline phase matrix for sustained oral drug delivery. Presenter: Xin Pan, School of Pharmaceutical Science, Sun Yat-Sen University, Prc Peoples Rep of China. Author(s): Y. Huang, Y. Xiao, C. Zhu, X. Pan, P. Liu, H. Huang, C. Wu. VIEW ABSTRACT

178  Hydrogen Peroxide Mediated Transmucosal Drug Delivery. Presenter: David Johnson, parc, U.S.A. Author(s): D. Johnson, F. Linn, S. Uhland. VIEW ABSTRACT

179  Investigation Into the Effect of Different Physiochemical Parameters of Drugs on Release From poly(2-Hydroxyethyl methacrylate) Using Multiple Regression Analysis. Presenter: Rory Bell, Queen's University Belfast, United Kingdom. Author(s): R. A. Bell, C. P. McCoy, D. S. Jones. VIEW ABSTRACT

180  Light-Controlled Release of Reactive Oxygen Species from Anti-Infective, Covalently-Bound Porphyrin Biomaterial Conjugates. Presenter: Daniel Corbett, Queen's University Belfast, United Kingdom. Author(s): D. J. Corbett, C. P. McCoy, A. T. De Baroid, S. P. Gorman, D. S. Jones. VIEW ABSTRACT

181  Lysosomal mediated apoptosis of Imatinib resistant leukemia cells by an herbal reactive oxygen species (ROS) nanoscavenger. Presenter: Sarbari Acharya, Institute of life Sciences, India. Author(s): S. Acharya, S. K. Sahoo. VIEW ABSTRACT

182  Nanofibrous hydrogels crosslinked with catecholized polymers. Presenter: Young Ju Son, Dapartment of Biomedical Materials Engineering, Kangwon National University, South Korea. Author(s): Y. Son, H. Yoo. VIEW ABSTRACT

183  Nanostructures at Oppositely Charged Surfactant-Polymer Interfaces as Tailored Release Nanomaterials. Presenter: Kristian Tangso, Monash Institute of Pharmaceutical Sciences, Monash University, Australia. Author(s): K. J. Tangso, B. J. Boyd, P. Spicer, S. Lindberg, P. Hartley, R. Knott. VIEW ABSTRACT

184  Novel Methodology for Quantifying Distribution between Free and Bound API in Biorelevant Media: Application to Naproxen in Albumin-containing Solutions. Presenter: Alexander Chapman, Paraytec Ltd, United Kingdom. Author(s): A. Chapman. VIEW ABSTRACT

185  Photoacoustic Drug Delivery: An Emerging Technology for Intracellular Delivery. Presenter: Aritra Sengupta, Georgia Institute of Technology, U.S.A. Author(s): A. Sengupta, S. C. Kelly, M. D. Gray, M. R. Prausnitz, N. N. Thadhani. VIEW ABSTRACT

186  Plasmonic Liposomes for Synergistic Photodynamic and Photothermal Therapy. Presenter: Ji-Ho Park, KAIST, Korea. Author(s): J. Oh, H. Yoon, J. Park. VIEW ABSTRACT

187  Probuphine®: A Sub-dermal Buprenorphine Implant for Treating Opioid Dependence. Presenter: Rajesh Patel, Titan Pharmaceuticals, Inc., U.S.A. Author(s): R. A. Patel, H. Patel, S. Sreedharan. VIEW ABSTRACT

188  Rapamycin Drug Eluting Stent by Crystallization onto Stent Struts. Presenter: Shady Farah, Institute of Drug Research, School of Pharmacy-Faculty of Medicine, Center for Nanoscience and Nanotechnology and The Alex Grass Center for Drug Design and Synthesis, The Hebrew University of Jerusalem, Israel. Author(s): S. M. Farah, W. Khan, A. J. Domb. VIEW ABSTRACT

189  Short Chain Elastin-Like Polypeptide-Incorporated Thermosensitive Liposome: In Vitro Evaluation and In Vivo Study Combined with High Intensity Focused Ultrasound (HIFU). Presenter: Hyun Kim, Samsung Advanced Institute of Technology, South Korea. Author(s): H. R. Kim, S. M. Park, S. Park, K. Choi, Y. S. Kim, E. S. Park. VIEW ABSTRACT

190  Single-Step Grafting of Aminooxy-Peptides to Hyaluronan: A Simple Approach to Multifunctional Therapeutics for Experimental Autoimmune Encephalomyelitis. Presenter: Joshua Sestak, University of Kansas, U.S.A. Author(s): J. O. Sestak, C. Berkland. VIEW ABSTRACT

193  Super cationic nanofibrous mesh for surfaces modification. Presenter: Hye Sung Kim, Kangwon National University, South Korea. Author(s): H. Kim, J. Kang, H. Yoo. VIEW ABSTRACT

194  Three-Dimensional Model of Breast Tumor Stroma for Drug Testing. Presenter: Hamsa Jaganathan, The Methodist Hospital Research Institute, U.S.A. Author(s): H. Jaganathan, G. Souza, B. Dave, B. Godin. VIEW ABSTRACT

Food, Nutraceuticals and Personalized Diet     [RETURN TO TOP]

195  Separation and quantification of cystine and cysteine in simulated aqueous humor using capillary electrophoresis. Presenter: Ali Al-Kinani, School of Pharmacy and Chemistry, Kingston University London, United Kingdom. Author(s): A. A. Al-Kinani, G. Calabrese, D. P. Naughton, B. K. Pierscionek, J. Swinden, A. Vangala, R. G. Alany. VIEW ABSTRACT

Imaging and Characterization Techniques for Drug Delivery: Systems and Targeted Drug Delivery     [RETURN TO TOP]

196  6-MethoxyethylaminoNumonafide (MEAN) Eluting Microspheres for Catheter-Directed Delivery to Liver Tumors. Presenter: Dong-Hyun Kim, Department of Radiology, Northwestern University Feinberg School of Medicine, U.S.A. Author(s): D. Kim, S. Huang, R. M. Green, R. A. Omary, A. C. Larson. VIEW ABSTRACT

199  Apoptosis-Targeted Delivery of T Cells to Tumor after Chemotherapy. Presenter: Byung-Heon Lee, Kyungpook National University, Korea. Author(s): B. Lee, N. Bonaparte, I. Kim. VIEW ABSTRACT

200  Apoptosis-targeted low molecular weight heparin derivatives for cancer therapy. Presenter: Jong-Ho Kim, Department of Pharmaceutical Science, Kyung Hee University, South Korea. Author(s): J. Kim, S. Bae, Y. Byun, I. Kim, R. Park. VIEW ABSTRACT

201  Bifunctional Solid Lipid Nanoparticle System as a Potential Tool for Tumor Detection Using Optical and MR Imaging. Presenter: Xiao Yu Wu, Departmen of Pharmaceutical Sciences, University of Toronto, Canada. Author(s): P. Prasad, A. Abbasi, X. Wu. VIEW ABSTRACT

202  Biomimetic Nanoarchitectures of Peptide Dendrimers for Drug/Gene Delivery. Presenter: Zhongwei Gu, National Engineering Research Center for Biomaterials, Sichuan University, Prc Peoples Rep of China. Author(s): Z. Gu, K. Luo, X. Xu, B. He. VIEW ABSTRACT

203  Bioreducible Nanoparticles for Intracellular Hydrogen Peroxide Generation. Presenter: Fwu-Long Mi, Department of Biochemistry, School of Medicine, Taipei Medical University, Taipei, Taiwan, Taiwan. Author(s): F. Mi, Y. Su, S. Yu, D. Tang, Y. Ho, A. Chao. VIEW ABSTRACT

204  Bladder cancer targeting nanomicelle. Presenter: Tzuyin Lin, UCDavis, U.S.A. Author(s): T. Lin. VIEW ABSTRACT

206  Chitosan oligosaccharide-arachidic acid-based nanoprobes for magnetic resonance imaging of cancer. Presenter: Hyun-Jong Cho, Kangwon National University, Korea. Author(s): H. Cho, U. Termsarasab, D. Kim. VIEW ABSTRACT

207  Comparing the Acoustic Release of Doxorubicin from Targeted and non-Targeted Polymeric Micelles. Presenter: Ghaleb Husseini, American University of Sharjah, Uae. Author(s): G. A. Husseini, L. Kherbeck, W. G. Pitt, J. A. Hubbell. VIEW ABSTRACT

209  DDS Evaluation Using Intravital Real-Time Laser Scanning Confocal Microscopy. Presenter: Yu Matsumoto, The University of Tokyo, Japan. Author(s): Y. Matsumoto, T. Nomoto, K. Toh, N. Nishiyama, T. Yamasoba, K. Kataoka. VIEW ABSTRACT

210  Design of Novel Nanosized Theragnostic Niosomes for Diagnosis and Therapy of Parkinson's Disease. Presenter: A. Yekta özer, Hacettepe University Faculty of Pharmacy Department of Radiopharmacy, Turkey. Author(s): M. Silindir, S. Erdogan, A. özer. VIEW ABSTRACT

212  Development of Targeted [64Cu]CuS Nanoparticles for PET/CT Imaging and Photothermal Ablation Therapy. Presenter: Lili Cui, university of Houston, U.S.A. Author(s): L. Cui, M. Zhou, C. Xiong, C. Li, D. Chow. VIEW ABSTRACT

213  Development of Three-Dimensional Lung Multicellular Spheroids for the Evaluation of Anti-Cancer Therapeutics. Presenter: Samantha Meenach, University of Kentucky, U.S.A. Author(s): S. A. Meenach, A. N. Tsoras, R. C. McGarry, H. M. Mansour, J. Z. Hilt, K. W. Anderson. VIEW ABSTRACT

214  Differentiation of drug release from geopolymer formulations by a new bench-top method. Presenter: Bing Cai, Uppsala University, Sweden. Author(s): B. Cai, H. Engqvist, S. Bredenberg. VIEW ABSTRACT

215  Dual Temperature- and pH-Responsive Fluorescence Molecular Probe for Cellular Imaging utilizing a Functional Polymer. Presenter: Minami Matsuura, Keio University, Japan. Author(s): M. Matsuura, T. Funatsu, Y. Maekawa, Y. Hiruta, T. Okano, H. Kanazawa. VIEW ABSTRACT

216  Dual-targeting paclitaxel-loaded nanoparticles for the treatment of glioma in mice. Presenter: Zhiqing Pang, Department of Pharmaceutics, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, Prc Peoples Rep of China. Author(s): Z. Pang, B. Zhang, Y. Hu. VIEW ABSTRACT

217  Dynamic contrast enhanced computed tomography imaging of perfusion predicts for the heterogeneous spatial distribution of liposomes. Presenter: Shawn Stapleton, University of Toronto, Canada. Author(s): S. Stapleton, M. Pintilie, C. Allen, D. A. Jaffray. VIEW ABSTRACT

218  Effect of Polymers on API Precipitation Determined by Polarized Light Microscopy. Presenter: Anette Müllertz, Department of Pharmacy, University of Copenhagen, Denmark. Author(s): L. G. Jensen, J. X. Wu, T. Rades, J. Rantanen, B. Abrahamsson, A. Müllertz. VIEW ABSTRACT

219  EPR effect in metastatic and autochthonous tumor and antimetastatic effect of SMA-pirarubicin (THP). Presenter: Hiroshi Maeda, Sojo University, Japan. Author(s): H. Maeda, H. Nakamura, K. Tsukigawa, L. Liao, J. Fang. VIEW ABSTRACT

220  Facile Preparation of Calcium Phosphate Nanoparticles for Noninvasive Cancer Diagnosis. Presenter: Peng Mi, The University of Tokyo, Japan. Author(s): P. Mi, D. Kokuryo, H. Cabral, M. Kumagai, I. Aoki, N. Nishiyama, K. Kataoka. VIEW ABSTRACT

222  Fluorescence Real-time Imaging of Cell Dynamics in Tissue of a Living Mouse using Tissue Fixing Suction Device. Presenter: Yuriko Higuchi, Graduate School of Pharmaceutical Sciences, Kyoto University, Japan. Author(s): Y. Higuchi, Y. Sugihara, Y. Kozu, K. Shimizu, S. Konishi, M. Hashida. VIEW ABSTRACT

223  Glutathione–Responsive Polymeric Micelles Composed of In-Situ Formed Gemini Surfactants for Controlled Drug Release. Presenter: Hyun-Chul Kim, Daegu Gyeongbuk Institute of Science & Technology(DGIST), South Korea. Author(s): H. Kim. VIEW ABSTRACT

226  Improvement of cellular uptake efficiency with small amount of iron oxide according to the number of surface-immobilized folic acid. Presenter: Young Ju Son, Dapartment of Biomedical Materials Engineering, Kangwon National University, South Korea. Author(s): Y. Son, Y. Kim, H. Yoo. VIEW ABSTRACT

227  In Vitro Drug Release and In Vivo Tumor Delivery of Near-Infrared Emissive Biodegradable Polymersomes Containing Poly(ethylene glycol) and Randomized Poly(trimethylene carbonate-co-caprolactone). Presenter: Christina Hofmann, Duke University, U.S.A. Author(s): C. L. Hofmann, W. Qi, C. D. Landon, M. J. Therien, M. W. Dewhirst, G. M. Palmer. VIEW ABSTRACT

228  In vivo Evaluation of Annexin A2-Targeted Combinatorial Nanoparticles to cause Sustained Reduction of Plasminogen Activation in Highly Metastatic Breast Cancer. Presenter: Anindita Mukerjee, University of North Texas Helath Science Center, U.S.A. Author(s): A. Mukerjee, A. P. Ranjan, J. K. Vishwanatha. VIEW ABSTRACT

230  In vivo Visualization of Fluorescent siRNA Delivery by Microneedles. Presenter: Tycho Speaker, TransDerm, Inc., U.S.A. Author(s): T. J. Speaker, R. P. Hickerson, M. Flores, R. L. Kaspar. VIEW ABSTRACT

231  Inhibitory effect on choroidal neovascularization using cyclic RGD tethered heparin-Pluronic nanogels carrying avastin. Presenter: Ki Dong Park, Ajou University, South Korea. Author(s): J. Choi, J. Bae, K. Lee, K. Park. VIEW ABSTRACT

232  Intravital Monitoring of Intact siRNA Using Fluorescence Resonance Energy Transfer. Presenter: Kazuko Toh, The University of Tokyo, Japan. Author(s): K. Toh, T. Nomoto, Y. Matsumoto, S. Watanabe, S. Fukushima, H. Chaya, R. J. Christie, K. Miyata, N. Nishiyama, K. Kataoka. VIEW ABSTRACT

233  Investigation of pH and temperature profiles in the GI tract of fasted human subjects by Intellicap® system. Presenter: Werner Weitschies, University of Greifswald, Germany. Author(s): M. Grimm, M. Koziolek, V. Iordanov, C. Wanke, W. Weitschies. VIEW ABSTRACT

234  Monitoring Controlled Release of Doxorubicin from Porous Microparticles using in vitro Models and Time Lapse Microscopy. Presenter: Sabeel Shamsudeen, Swansea University, TMHRI, U.S.A. Author(s): S. Shamsudeen, J. Tonkin, I. Meraz, R. E. Serda, P. Rees, H. D. Summers. VIEW ABSTRACT

235  Multicellular Tumor Spheroids for Performance Evaluation of Nanomedicines In Vitro. Presenter: Sina Eetezadi, University of Toronto, Canada. Author(s): S. Eetezadi, A. S. Mikhail, C. Allen. VIEW ABSTRACT

236  Multifunctional Mesoporous Nanoconstructs for Contrast Enhanced Imaging. Presenter: Paolo Decuzzi, The Methodist Hospital Research Institute, U.S.A. Author(s): J. S. Ananta, A. Gizzatov, X. Liu, L. J. Wilson, P. Decuzzi. VIEW ABSTRACT

237  Nanobioconjugates for Differential Imaging of Solid and Metastatic Brain Cancer. Presenter: Rameshwar Patil, Cedars-Sinai Medical Center, U.S.A. Author(s): E. Holler, R. Patil, P. Gangalum, S. Wagner, J. Portilla-Arias, S. Inoue, H. Ding, A. Rekechenetskiy, B. Konda, J. Markman, A. Chesnokova, K. L. Black, J. Y. Ljubimova. VIEW ABSTRACT

238  Nanostructures and drug distribution within Nanostructured LipidCarriers (NLC). Presenter: Cornelia Keck, University of Applied Sciences Kaiserslautern, Germany. Author(s): C. M. Keck, A. Boreham, T. Schlieter, R. H. Müller, U. Alexiev. VIEW ABSTRACT

239  Nanotheranostic approach by magnetic nanoparticles labeled stem cells for cancer therapy. Presenter: Sanjeeb Sahoo, Institute of life Sciences, India. Author(s): S. K. Sahoo, A. Singh, R. Verma. VIEW ABSTRACT

240  Novel Nanocarrier Drug Delivery System for Imaging and Treatment of Cancer. Presenter: Apurva Patel, Florida A&M University, U.S.A. Author(s): A. R. Patel, M. B. Chougule, E. Lim, K. P. Francis, S. Safe, M. S. Sachdeva. VIEW ABSTRACT

241  Paclitaxel Loaded Magnetic Nanoparticle Labeled Mesenchymal Stem Cells as Drug Delivery Vehicle in Cancer Therapy. Presenter: Abhalaxmi Singh, Institute of life Sciences, India. Author(s): A. Singh, S. K. Sahoo. VIEW ABSTRACT

243  pH-Responsive Nanogel-Coated Polymersomes for Targetable Delivery of Anticancer Agent and Magnetic Nanoparticles. Presenter: Hsin-Cheng Chiu, National Tsing Hua University, Taiwan. Author(s): H. Chiu, W. Chiang, Z. Shih, W. Huang. VIEW ABSTRACT

245  Potential Use of Folate-appended Methyl-β-cyclodextrin as a Novel Antitumor Drug Carrier. Presenter: Taishi Higashi, Graduate School of Pharmaceutical Sciences, Kumamoto University, Japan. Author(s): T. Higashi, R. Onodera, K. Motoyama, A. Okamatsu, H. Arima. VIEW ABSTRACT

246  Preparation and Evaluation of Solid-Self Emulsifying Drug Delivery System for Enhancing Bioavailability and Lymphatic Delivery of Cyclosporin A. Presenter: Hea-Young Cho, College of Pharmacy, CHA University, Korea. Author(s): H. Cho, Y. Oh, Y. Lee. VIEW ABSTRACT

247  Preparation, Characterization and In Situ Absorption Studies of Lercanidipine Loaded Eudragit Nanoparticles. Presenter: Nayanabhirama Udupa, Professor and Principal, India. Author(s): N. Udupa, P. B. Deshpande, A. Gurram, R. Averineni, P. B. Musmade, S. Reddy. VIEW ABSTRACT

248  PSMA-Targeted Aptamosomes for Improving Intracellular siRNA and Drug Co-delivery. Presenter: Keun-Sik Kim, KONYANG UNIVERSITY, South Korea. Author(s): K. Kim, G. Lee, J. S. Park, Y. Park, D. Kim. VIEW ABSTRACT

249  Raman mapping to identify dry and wet states of pharmaceutical components in a hydroxypropyl methylcellulose (HPMC) hydrophilic matrix tablet. Presenter: Yewande Oni, University of Nottingham, United Kingdom. Author(s): Y. I. Oni, A. Inchley, J. C. Burley, C. D. Melia. VIEW ABSTRACT

251  Research on the Real-time Dynamics of Releasing Process in vivo of Drug Delivery System. Presenter: Zhongjian Fang, Shanghai Jiao Tong University, Prc Peoples Rep of China. Author(s): Z. Fang. VIEW ABSTRACT

253  Size and Count Analysis of Drug and Gene Delivery Nanoparticles in Complex Biological Media. Presenter: Duncan Griffiths, NanoSight USA, U.S.A. Author(s): S. Capracotta, D. Griffiths, P. Vincent, W. Bernt, P. Hole. VIEW ABSTRACT

254  Superparamagnetic Hollow Hybrid Nanogels as a Theranostic Platform with pH-Regulated MR Imaging Contrast and Drug Release. Presenter: Wen-Hsuan Chiang, National Tsing Hua University, Taiwan. Author(s): W. Chiang, V. Ho, H. Chiu. VIEW ABSTRACT

255  Targetable and Inhalable Nanoerythrosomes Containing Fasudil, a Rho-kinase Inhibitor, for the Treatment of Pulmonary Arterial Hypertension. Presenter: Brijeshkumar Patel, Texas Tech University Health Sciences Center, Amarillo, TX 79106, U.S.A. Author(s): N. Gupta, B. Patel, F. Ahsan. VIEW ABSTRACT

256  Targeted Multifunctional Lipopolymeric Hybrid Nanosystems for Metastatic Breast Cancer Imaging and Therapy. Presenter: Anindita Mukerjee, University of North Texas Health Science Center, U.S.A. Author(s): A. P. Ranjan, A. Mukerjee, J. K. Vishwanatha. VIEW ABSTRACT

257  Ultrasound-Induced Cell Permeability in Endothelial Cells for Targeted Delivery. Presenter: Pavlos Anastasiadis, Molecular Biology and Bioengineering, University of Hawaii at Manoa, U.S.A. Author(s): P. Anastasiadis, M. L. Matter, J. S. Allen. VIEW ABSTRACT

258  Uptake and Degradation of Protein Nanoparticles in Cerebellar Granular Cells. Presenter: Miriam Dadparvar, Institute of Pharmaceutical Technology, Goethe University Frankfurt, Germany. Author(s): M. Dadparvar. VIEW ABSTRACT

Micro- and Nanoparticle Design     [RETURN TO TOP]

260  83-14 monoclonal antibody-grafted solid lipid nanoparticles for targeting delivery of saquinavir across the blood–brain barrier. Presenter: Yung-Chih Kuo, Department of Chemical Engineering, National Chung Cheng University, Taiwan. Author(s): Y. Kuo. VIEW ABSTRACT

261  A cisplatin-incorporated liposome that targets the epidermal growth factor receptor enhances radiotherapeutic efficacy without nephrotoxicity. Presenter: Eun Jin Ju, Asan Medical Center, South Korea. Author(s): E. Ju, J. Jung, S. Kuroda, H. Chung, J. Choi, J. Park, S. Park, K. Lee, J. Park, S. Shin, H. Park, E. Ko, S. Song, S. Jeong, E. Choi. VIEW ABSTRACT

262  A mitochondrial targeted paclitaxel loaded self-assembled nanocarrier reduces the multidrug resistance of breast cancer. Presenter: Zhiwen Zhang, Shanghai Institute of Materia Medica, CAS, Prc Peoples Rep of China. Author(s): Z. Zhang, J. Xiao, Y. Li. VIEW ABSTRACT

263  A novel controlled release PLGA microspheres for the antisense oligonucleotide. Presenter: Lesheng Teng, Jilin University, Prc Peoples Rep of China. Author(s): J. Xie, R. J. Lee, L. Teng. VIEW ABSTRACT

264  A phase 1 study of the polymeric nanoparticle containing docetaxel to patients with advanced solid tumors. Presenter: Jin Park, Asan medical center, South Korea. Author(s): J. Park, H. Chung, J. Choi, J. Park, S. Park, K. Lee, E. Ju, H. Park, S. Shin, E. Ko, J. Jung, S. Jeong, S. Song, E. Choi. VIEW ABSTRACT

265  A targeted liposomal delivery system to liver endothelial cell based on a new peptide motif present in the Apo B-100 sequence. Presenter: Afsana Akhter, Laboratory of Innovative Nanomedicine, Faculty of Pharmaceutical Sciences, Hokkaido University, Japan. Author(s): A. Akhter, Y. Hayashi, N. Ohga, K. Hida, H. Harashima. VIEW ABSTRACT

266  A unique combination of tissue engineering and cell encapsulation for the entrapment of insulin-producing stem and liver cells. Presenter: Marcelle Machluf, Biotechnology and Food Engineering, Israel. Author(s): D. Chaimov, M. Machluf. VIEW ABSTRACT

267  Accelerated blood clearance phenomenon upon PEGylated protein. Presenter: Yu Mima, The University of Tokushima, Japan. Author(s): Y. Mima, Y. Hashimoto, T. Shimizu, T. Ishida, H. Kiwada. VIEW ABSTRACT

268  Active Targeting of Perfluorocarbon Nanoemulsions for 19F MRI. Presenter: Christoph Grapentin, Dept. of Pharmaceutical Technology and Biopharmacy, University of Freiburg, Germany. Author(s): C. Grapentin, R. Schubert, F. Mayenfels, S. Temme, U. Flögel, J. Schrader, C. Jacoby. VIEW ABSTRACT

269  Amphiphilic Poly(amino acid) Nanoparticles as Vaccine Carriers and Adjuvants. Presenter: Takami Akagi, Graduate School of Engineering, Osaka University, Japan. Author(s): T. Akagi, F. Shima, T. Uto, T. Tatsumi, M. Baba, M. Akashi. VIEW ABSTRACT

270  An injectable nanodelivery system for prolonged, controlled release of the local anesthetic lidocaine. Presenter: Ennio Tasciotti, The Methodist Hospital Research Institute, U.S.A. Author(s): I. K. Yazdi, J. Van Eps, S. Z. Khaled, J. Fernandez-Moure, N. Taghipour, J. Martinez, S. G. Haddix, E. Tasciotti. VIEW ABSTRACT

271  Analysis of Protein Adsorption Patterns on Ultra-Small Dendritic Polyglycerol Sulfate. Presenter: Sven Staufenbiel, Freie Universitaet Berlin, Department of Pharmaceutics, Biopharmaceutics & NutriCosmetics, Germany. Author(s): S. Staufenbiel, D. Groeger, R. Haag, R. H. Mueller. VIEW ABSTRACT

272  Antigen-Expressing Immunostimulatory Liposomes, as novel genetically programmable vaccines. Presenter: Maryam Amidi, Utrecht University, Netherlands. Author(s): M. Amidi. VIEW ABSTRACT

273  Antioxidant poly(vanillyl alcohol-oxalate) nanoparticles as novel therapeutics for acetaminophen-induced acute liver failure. Presenter: Dongwon Lee, sgpark8841@gmail.com, South Korea. Author(s): E. Ko, S. Park, J. Kim, J. Noh, G. Khang, D. Lee. VIEW ABSTRACT

274  Artificial neural networks and modeling of release of Olanzapine from Glycerol monooleate matrices. Presenter: Farid Dorkoosh, Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Author(s): G. Bagheri, E. Vasheghani-Farahani, R. Bagheri, M. Arjmand, H. Attar, F. Abedin Dorkoosh. VIEW ABSTRACT

275  Backbone Degradable HPMA Copolymer Paclitaxel and Gemcitabine Conjugates for the Combination Therapy of Ovarian Cancer. Presenter: Rui Zhang, University of Utah, U.S.A. Author(s): R. Zhang, J. Yang, M. Sima, J. Kopecek. VIEW ABSTRACT

276  Biodegradable Aluminium Phthalocyanine Amphiphilic Nanoparticles for Anticancer Photodynamic Therapy. Presenter: Noha Nafee, Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt, Egypt. Author(s): H. Asem, N. A. Nafee, A. Abd. El-Fattah, L. K. El-Khordagui, S. Kandil. VIEW ABSTRACT

278  Biomimetic Coating Modulates the Biodistribution and Release Kinetic of Nanoporous Particles. Presenter: Michael Evangelopoulos, The Methodist Hospital Research Institute, U.S.A. Author(s): M. Evangelopoulos, A. Parodi, N. Quattrocchi, E. Tasciotti. VIEW ABSTRACT

279  Bioreducible Robust Polymersomes for Anticancer Drug Delivery. Presenter: Thavasyappan Thambi, Sunkyunkwan University, Korea. Author(s): T. Thambi, W. Um, D. Lee, J. Park. VIEW ABSTRACT

280  Bixin Liposomes as Antineoplasic drugs carrier. Presenter: Rafael Teruiti Takamoto, University of Sao Paulo, Brazil. Author(s): R. O. Takamoto, M. S. Matuo, T. A. Pinto, I. S. Kikuchi. VIEW ABSTRACT

281  Caffeine Nanocrystals: A New Concept for Improved Skin Delivery. Presenter: Sven Staufenbiel, Freie Universität Berlin, Department of Pharmaceutics, Biopharmaceutics & NutriCosmetics, Germany. Author(s): X. Zhai, S. Staufenbiel, C. M. Keck, R. H. Mueller. VIEW ABSTRACT

282  CD44 receptor targeting with Hyaluronic acid-conjugated PLGA nanoparticles loaded with SN 38. Presenter: Srinath Palakurthi, Texas A&M Health Science Center, U.S.A. Author(s): S. Palakurthi, K. Vangara. VIEW ABSTRACT

283  Characterization of Temperature-Responsive Liposome with Tunable Surface Property. Presenter: Hideko Kanazawa, Keio University, Japan. Author(s): H. Kanazawa, Y. Matsukami, Y. Kimura, H. Horiuchi, E. Ayano, T. Okano. VIEW ABSTRACT

284  Chitosan nanoparticles: correlation of in situ metrology with interactions at biological interfaces. Presenter: Lee Yong Lim, Pharmacy, School of Medicine and Pharmacology, The University of Western Australia, Australia. Author(s): L. Lim. VIEW ABSTRACT

287  Co-modification of Cholesterol-anchored Cleavable PEG and Octaarginines (R8) on Liposomes to Enhance Tumor Targeting and Anti-tumor Effect. Presenter: Qin He, Key Laboratory of Drug Targeting and Drug Delivery Systems, Prc Peoples Rep of China. Author(s): J. Tang, H. Fu, Q. Kuang, L. Zhang, Q. He. VIEW ABSTRACT

288  Comparative therapeutic performances of drug loaded magnetic dendritic nanoparticles towards various cancer cell lines. Presenter: Saumya Nigam, IITB-MONASH RESEARCH ACADEMY, India. Author(s): S. Nigam, Q. Chen, D. Bahadur. VIEW ABSTRACT

289  Competitive cellular adhesion of pseudobacterial lipid nanocarriers and bacteria on β1 integrin receptors. Presenter: Hagar Labouta, Helmholtz Center for Infection Research, Helmholtz Institute for Pharmaceutical Research Saarland, Department of Drug Delivery, Saarbrücken, Germany. Author(s): H. I. Labouta, A. Kochut, P. Dersch, C. Lehr. VIEW ABSTRACT

290  Construction of Hyaluronic Acid-Coated Cisplatin-Loaded Hydrogel Nanoparticles for Targeted Chemotherapy. Presenter: Teppei Shirakura, Biophysics and Chemistry, The University of Michigan, U.S.A. Author(s): T. Shirakura, C. Smith, Y. Koo. Lee, R. Kopelman. VIEW ABSTRACT

291  Controlled Release of Doxorubicin Using pH and Temperature Sensitive Core-shell Nanogels Containing Amphiphilic Acid Monomer. Presenter: Aracely Serrano-Medina, Universidad Autónoma de Baja California, Mexico. Author(s): A. Serrano-Medina, V. E. Gomez-Resendiz, A. Licea-Claverie, J. M. Cornejo-Bravo. VIEW ABSTRACT

292  Curcumin-derivative RL71 micelles for the treatment of breast cancer. Presenter: Khaled Greish, University of Otago, New Zealand. Author(s): S. Taurin, H. Nehoff, J. Diong, L. Larsen, R. J. Rosengren, K. Greish. VIEW ABSTRACT

293  Cyclic RGD Peptide Amphiphiles as Potential Drug Carriers for Cancer Targeting. Presenter: Poonam Saraf, University of the Pacific, U.S.A. Author(s): P. Saraf, M. Alhamadsheh, X. Li, B. Jasti. VIEW ABSTRACT

294  Delivery of Photoactive Ruthenium-based Prodrugs with Cross-linked Nanoassemblies for Photodynamic Therapy. Presenter: Matthew Dickerson, University of Kentucky, U.S.A. Author(s): M. Dickerson, Y. Bae, E. Glazer. VIEW ABSTRACT

295  Design and optimization of PLGA microspheres of donepezil hydrochloride for improved Alzheimer's therapy. Presenter: Ditixa Desai, C.U. SHAH COLLEGE OF PHARMACY, SNDT WOMEN'S UNIVERSITY, MUMBAI-400 049, India. Author(s): D. T. Desai, K. Singh. VIEW ABSTRACT

298  Development and characterization of dexamethasone-loaded microsphere formulations prepared with PLGA blends. Presenter: Diane Burgess, University of Connecticut, U.S.A. Author(s): Y. Wang, B. Gu, D. Burgess. VIEW ABSTRACT

299  Development of a combinational drug-loaded nanoparticle for improving of paclitaxel uptake into multidrug resistant breast cancer cells . Presenter: Jong-Suep Baek, Chungnam National University, South Korea. Author(s): J. Baek, M. Park, C. Lee, E. Lee, C. Cho. VIEW ABSTRACT

300  Development of a novel liposomal formulation for paclitaxel. Presenter: Josimar Eloy, University of São Paulo, Brazil. Author(s): J. O. Eloy, J. M. Marchetti. VIEW ABSTRACT

302  Development of Calcium Phosphate Nanoparticles for Oral Delivery of Therapeutic agents. Presenter: William Wild, King's College London, UK, United Kingdom. Author(s): W. Wild, S. Abdul Ghani, M. Wright, A. Warley, M. Thanou. VIEW ABSTRACT

303  Development of Dequalinium Coated Poly ( D,L-lactide-co-glycolide) Nanoparticles for Paclitaxel Delivery. Presenter: Venkata Yellepeddi, ROSEMAN UNIVERSITY OF HEALTH SCIENCES, U.S.A. Author(s): V. K. Yellepeddi, R. Nielson, S. R. Chennamaneni, J. Radhakrishnan. VIEW ABSTRACT

304  Development of Mesoporous Silica Nanoparticle (MSN)-loaded PICsomes for Delivery of Low Molecular-weight Drugs. Presenter: Akinori Goto, Kyorin Pharmaceutical CO., LTD., Japan. Author(s): A. Goto, H. C. Yen, P. S. Lai, Y. Anraku, A. Kishimura, K. Kataoka. VIEW ABSTRACT

305  Development of novel nanovesicles consisting of an antitumor agent tocopheryl succinate for cancer combination therapy. Presenter: Susumu Hama, Department of Biophysical Chemistry, Kyoto Pharmaceutical University, Japan. Author(s): S. Hama, S. Utsumi, Y. Fukuda, K. Nakayama, Y. Okamura, H. Tsuchiya, K. Fukuzawa, H. Harashima, K. Kogure. VIEW ABSTRACT

306  Development of platinum nanoparticles, liver-targeting reactive oxygen species scavenger, for prevention of hepatic ischemia/reperfusion injury. Presenter: Hidemasa Katsumi, Department of Biopharmaceutics, Kyoto Pharmaceutical University, Japan. Author(s): H. Katsumi, K. Fukui, K. Sato, T. Sakane, A. Yamamoto. VIEW ABSTRACT

308  Development of Ursolic Acid Nanocrystals with Improved in-vitro Anticancer Activity. Presenter: Ying Zheng, Institute of Chinese Medical Science, University of Macau, Prc Peoples Rep of China. Author(s): J. Song, Y. Wang, Y. Song, R. Yan, Y. Wang, Y. Zheng. VIEW ABSTRACT

309  Discovery of peptidic agents targeting human lung cancer by in vivo phage display. Presenter: Kyoung Jin Lee, Asan medical center, South Korea. Author(s): K. Lee, H. Park, E. Ju, H. Chung, J. Choi, J. Park, S. Park, J. Park, S. Shin, E. Ko, J. Jung, S. Song, S. Jeong, E. Choi. VIEW ABSTRACT

310  Double selective antitumor action of pirarubicin-conjugated N-(2-hydroxypropyl) methacrylamide copolymer. Presenter: Hideaki Nakamura, Sojo University, Japan. Author(s): H. Nakamura, T. Etrych, P. Chytil, K. Tsukigawa, J. Fang, K. Ulbrich, H. Maeda. VIEW ABSTRACT

311  Drug-specific protein polymer nanoparticles: in vivo reduction of toxicity and suppression of tumor growth. Presenter: Pu Shi, University of Southern California, U.S.A. Author(s): P. Shi, S. Aluri, Y. Lin, H. Cui, J. Dhandhukia, A. MacKay. VIEW ABSTRACT

312  Dual action pro-apoptotic drug loaded immuno-nanoparticles with enhanced chemotherapeutic effect. Presenter: Christopher Scott, Queens University Belfast, United Kingdom. Author(s): D. Schmid, D. Small, F. Fay, M. K. Greene, D. Longley, C. J. Scott. VIEW ABSTRACT

313  Dual MMP-7-Proximity-Activated and Folate-Targeted Nanoparticles for siRNA Delivery. Presenter: Todd Giorgio, Vanderbilt University, U.S.A. Author(s): H. Li, M. Miteva, M. Cheng, C. E. Nelson, C. L. Duvall, T. D. Giorgio. VIEW ABSTRACT

314  Dual Responsive, Stabilized Nanoparticles for Efficient in vivo Plasmid Delivery. Presenter: Hua Wei, Department of Bioengineering and Molecular Engineering and Sciences Institute, University of Washington, Seattle, WA 98195, U.S.A. Author(s): H. Wei, L. Volpatti, D. Sellers, D. O. Maris, I. W. Andrews, L. W. Chan, P. J. Horner, S. H. Pun. VIEW ABSTRACT

315  Effect of a Nanoparticle-Based Multivalent Targeted Proapoptotic Peptide on Obesity. Presenter: M. N. Hossen, Laboratory of Innovative Nanomedicine, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo, Hokkaido 060-0812, Japan, Japan. Author(s): M. N. Hossen, K. Kajimoto, H. Akita, M. Hyodo, H. Harashima. VIEW ABSTRACT

317  Effect of terminal group of PEG on induction of ABC phenomenon to PEGylated liposome. Presenter: Risako Fujita, The University of Tokushima, Japan. Author(s): R. Fujita, Y. Hashimoto, T. Shimizu, T. Ishida, H. Kiwada. VIEW ABSTRACT

318  Effects of Dendrimer Phthalocyanine Incorporated Polyion Complex Micelle-Mediated Photodynamic Treatments on P-glycoprotein Activities. Presenter: Wei-Jhe Syu, Department of Chemistry College of Science National Chung Hsing University, Taiwan. Author(s): W. Syu. VIEW ABSTRACT

321  Enhancement of Active Targeting and Cellular Uptake of Liposomes by Bio-nanocapsule Modification. Presenter: Masaharu Somiya, Graduate School of Bioagricultural Sciences, Nagoya University, Japan. Author(s): M. Somiya, S. Kuroda. VIEW ABSTRACT

322  Enhancing Cellular Uptake of Poly(ethyl-cyanoacrylate) Nanoparticles Through Arginine Association. Presenter: Jasper Ze Siong Chiu, School of Pharmacy, University of Otago, New Zealand. Author(s): J. Chiu, I. G. Tucker, A. McDowell, B. J. McLeod. VIEW ABSTRACT

324  Estimation of Boron-containing Rare Earth Oxides as Drugs for Boron Neutron Capture Therapy. Presenter: Hiroko Yukawa, Osaka City University, Japan. Author(s): H. Yukawa, R. Kawasaki, M. Sakuramoto, K. Katagiri, K. Tomita, S. Masunaga, K. Ono, Y. Sakurai, M. Kirihata, H. Azuma. VIEW ABSTRACT

325  Eudragit® nanoparticles for photodynamic therapy: Optimization of formulation design and manufacture. Presenter: Matthias Wacker, Goethe University, Institute of Pharmaceutical Technology, Germany. Author(s): S. Beyer, V. Vogel, P. Schlupp, B. Baumstümmler, A. E. Türeli, G. Wieland, A. Wiehe, S. Gräfe, V. Albrecht, F. Runkel, M. Wacker. VIEW ABSTRACT

326  Evaluationof Polystyrene Microsphere Uptake Utilizing invitro and in vivo Methods. Presenter: Edith Mathiowitz, Brown University, U.S.A. Author(s): S. Furtado, S. Bakhru, F. Laulicht, B. Laulicht, V. Leandre, H. Yang, B. Pavlov, A. Morello, J. Reineke, D. Cho, M. Godfrin, A. Tripathi, E. Mathiowitz. VIEW ABSTRACT

327  Fabrication andcharacterization of Eudragit S100-coated pectin/alginate microcapsulescontaining cisplatin-hyaluronan nanoparticles for colon targeted delivery. Presenter: Shiao-Wen Tsai, Chang Gung University , Taiwan. Author(s): S. Tsai. VIEW ABSTRACT

329  Folic Acid-Conjugated Liposomal Vincristine for Multidrug Resistant Cancer Therapy. Presenter: Weiyue Lu, Fudan University, Prc Peoples Rep of China. Author(s): C. Wang, L. Feng, X. Yang, F. Wang, W. Lu. VIEW ABSTRACT

330  Formulation and Characterization of Inhalable Magnetic Nanocomposite Microparticles (MnMs) for Targeted Pulmonary Delivery. Presenter: Nathanael Stocke, University of Kentucky, U.S.A. Author(s): N. A. Stocke, S. A. Meenach, H. M. Mansour, J. Z. Hilt. VIEW ABSTRACT

331  Formulation and Characterization of Polypyrrole Particles for Electrically Triggered Drug Release. Presenter: Darren Svirskis, Shool of Pharmacy, University of Auckland, New Zealand. Author(s): M. Sharma, E. Farzan, Z. Aqrawe, K. Xu, D. Ting, B. Tomkins, A. Abdulqadir, S. Garg, Z. Wu, D. Svirskis. VIEW ABSTRACT

333  Fullerenol C60 for developing nanomedicine Part 1 -Assessment of anti-inflammatory effect of fullerenol C60-. Presenter: Michihiko Aoyama, Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Japan. Author(s): M. Aoyama, Y. Yoshioka, K. Yamashita, M. Taira, T. Nagano, S. Tsunoda, H. Nakayama, Y. Fujio, H. Aoshima, K. Kokubo, T. Oshima, K. Higashisaka, Y. Tsutsumi. VIEW ABSTRACT

334  Fullerenol C60 for developing nanomedicine Part 2. Assessment of therapeutic effect of fullerenol C60 for inflammatory bowel disease. Presenter: Takashi Nagano, Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, Japan. Author(s): T. Nagano, Y. Yoshioka, K. Yamashita, M. Taira, M. Aoyama, S. Tsunoda, H. Nakayama, Y. Fujio, H. Aoshima, K. Kokubo, T. Oshima, K. Higashisaka, Y. Tsutsumi. VIEW ABSTRACT

335  Functional Nanoparticles for Oral Delivery of Anti-Angiogenic Protein. Presenter: Yi-Cheng Ho, Department of Biotechnology, Vanung University, Taiwan. Author(s): Y. Ho, D. Tang, S. Yu, F. Mi, Y. Su, A. Chao. VIEW ABSTRACT

336  Gas Bubbles Stabilized by Multifunctional Nanoparticles for Ultrasound-Mediated Drug-Delivery. Presenter: Ruth Schmid, SINTEF Materials and Chemistry, Norway. Author(s): R. Schmid, Y. Mørch, P. Stenstad, R. Hansen, S. Berg, Y. H. Hansen, M. Afadzi, S. Eggen, H. Blom, C. Davies. VIEW ABSTRACT

338  Graft and diblock copolymer micelles delivery the hydrophobic protoporphyrin IX for photodynamic cancer therapy. Presenter: Chun-Chiang Huang, National Taiwan University of Science and Technology, Taiwan. Author(s): C. Huang, H. Tsai. VIEW ABSTRACT

339  Hazard Assessment of Engineered Nanocarriers using in vitro and in vivo Studies. Presenter: Carl Webster, University of East Anglia, United Kingdom. Author(s): C. A. Webster. VIEW ABSTRACT

340  Hyaluronic Acid/Doxorubicin/Gold Nanorods-Anchored Macrophage for Combined Drug Delivery and Photothermal Therapy. Presenter: Yu-Fen Huang, National Tsing Hua University, Taiwan. Author(s): Y. Huang. VIEW ABSTRACT

341  Hybrid Polymeric Micelles Based on Polypeptides with pH Sensitivity of Secondary Structure for Targeting Delivery of Doxorubicin. Presenter: Qiming Wang, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Prc Peoples Rep of China. Author(s): Q. Wang, W. Chen, H. Wei, M. Jin, W. Huang, Z. Gao. VIEW ABSTRACT

342  Impact of the Nanoparticle Protein Corona on Assessing In Vitro Cellular Uptake of Silver Nanoparticles into Human Epidermal Keratinocytes. Presenter: Nancy Monteiro-Riviere, Kansas State University, U.S.A. Author(s): N. A. Monteiro-Riviere, M. E. Samberg, S. J. Oldenburg, J. E. Riviere. VIEW ABSTRACT

343  Importance of an interface between PEG and hydrophobic blocks, mechanistic study of PEG-related IgM response. Presenter: Koichi Shiraishi, The Jikei University School of Medicine, Japan. Author(s): K. Shiraishi, K. Kawano, Y. Maitani, T. Aoshi, K. J. Ishii, M. Yokoyama. VIEW ABSTRACT

344  Improving the Loading Efficiency and Anticancer Activity of Anthraquinone Derivative by Using Liposomal Formulations. Presenter: Chiao-Hsi Chiang, School of Pharmacy, National Defense Medical Center, Taiwan. Author(s): C. Chiang, W. Cheng, Y. Lo, C. Chen. VIEW ABSTRACT

346  In vitro interaction between novel bixin liposomes and human hepatoma cell lines. Presenter: Irene Kikuchi, University of Sao Paulo, Brazil. Author(s): M. S. Matuo, R. O. Takamoto, G. Dragunas, T. A. Pinto, I. S. Kikuchi. VIEW ABSTRACT

348  In Vivo Efficacy of Rosiglitazone-Loaded Hybrid Nanoparticles for the Treatment of Cardiovascular Diseases. Presenter: Santosh Aryal, The Methodist Hospital Research Institute, U.S.A. Author(s): S. Aryal, D. D. Mascolo, M. Ramirez, J. Wang, Y. Ren, C. J. Lyon, W. A. Hsueh, P. Decuzzi. VIEW ABSTRACT

350  Intratracheal administered polymeric micelles translocate through the air-blood barrier into the blood and pass through the blood-brain barrier to the brain. Presenter: Xiao Hu, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Prc Peoples Rep of China. Author(s): X. Hu, L. H. Quan, C. Y. Liu, X. M. Liu, Y. H. Liao. VIEW ABSTRACT

351  Involvement of functional groups on the surface of carboxyl group-terminated PAMAM dendrimers bearing arbutin in inhibition of SGLT1-mediated D-glucose uptake. Presenter: Shinji Sakuma, Setsunan University, Japan. Author(s): S. Sakuma, S. Kanamitsu, Y. Teraoka, Y. Masaoka, M. Kataoka, S. Yamashita, Y. Shirasaka, I. Tamai, M. Murakami, Y. Nakatsuji, T. Kida, M. Akashi. VIEW ABSTRACT

352  Measuring drug release from micro- and nanoformulations by derivative spectrophotometry in combination with a fiber optic system. Presenter: Johannes Kraemer, PHAST GmbH, Germany. Author(s): A. Guillot, C. Draheim, E. M. Collnot, M. Limberger, C. M. Lehr, J. Kraemer. VIEW ABSTRACT

353  Metrology of a NanoCurcumin Delivery System in Biologically Relevant Media. Presenter: Lee Yong Lim, Pharmacy, School of Medicine and Pharmacology, University of Western Australia, Australia. Author(s): S. Shamsi, Y. Chen, L. Lim. VIEW ABSTRACT

354  Microcapsules with Composite Membrane Containing Hydroxypropyl Cellulose for Thermally-Modulated Pulsatile Drug-Release. Presenter: Hideki Ichikawa, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Japan. Author(s): H. Ichikawa, S. Tsue, K. Sugisawa, Y. Fukumori. VIEW ABSTRACT

356  Microparticles built by layer by layer assembly for the encapsulation and sustained release of resveratrol. Presenter: Antonio Ribeiro, Centre for Pharmaceutical Sciences, Portugal. Author(s): A. J. Ribeiro, A. C. Santos, F. J. Veiga. VIEW ABSTRACT

357  Molecular modeling of PAMAM dendrimers modified with peptides and polymers. Presenter: Hwankyu Lee, Dankook University, South Korea. Author(s): H. Lee. VIEW ABSTRACT

359  Multi-Functional Nanoparticles for CD44 and Folate Receptors Targeting. Presenter: Shu-Huei Yu, Department of Materials Science and Engineering, Vanung University, Taiwan. Author(s): S. Yu, F. Mi, D. Tang, Y. Ho, Y. Su, A. Chao. VIEW ABSTRACT

360  Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells. Presenter: Isil Altintas, MSc., Netherlands. Author(s): I. Altintas, R. Heukers, R. van der Meel, M. Lacombe, M. Amidi, P. M. van Bergen en Henegouwen, W. E. Hennink, R. M. Schiffelers, R. J. Kok. VIEW ABSTRACT

361  Nanocapsules prepared by vesicle templating using RAFT polymerization. Presenter: Alex van Herk, Institute of Chemical and Engineering Sciences, Singapore. Author(s): A. M. van Herk. VIEW ABSTRACT

363  Nanoporous silicon particles for thrombolytic therapy. Presenter: Guoting Qin, The Methodist Hospital Research Institute, U.S.A. Author(s): G. Qin. VIEW ABSTRACT

364  Nanoscale, Non-Drug HIV Entry Inhibitors Using a CXCR4 Selective Synthetic Peptide, DV3: Binding Affinity and Evaluation of Drug Delivery Potential. Presenter: Zoltan Szekely, Ernest Mario School of Pharmacy, Rutgers University, U.S.A. Author(s): P. J. Sinko, Z. Szekely, M. S. Palombo, X. Zhang. VIEW ABSTRACT

366  N-modification of chitosan for improved membrane permeability: Synthesis, physicochemical characterization and submicron particle formulation. Presenter: Ali Al-Kinani, School of Pharmacy and Chemistry, Kingston University London, United Kingdom. Author(s): A. A. Al-Kinani, Z. K. Abbas, A. Vangala, D. P. Naughton, B. K. Pierscionek, R. G. Alany, G. Calabrese. VIEW ABSTRACT

367  Novel drug vehicle with MR/US imaging functionality. Presenter: Tse Ying Liu, Institute of Biomedical Engineering, National Yang-Ming University, Taiwan. Author(s): T. Liu. VIEW ABSTRACT

368  Novel Enzyme Responsive Cross-linked Polymeric Micelles for Chemotherapy. Presenter: Woei Ping Cheng, University of Hertfordshire, United Kingdom. Author(s): W. Cheng, J. Stair, J. Stanley, A. Khan. VIEW ABSTRACT

369  Novel Method to Load High Amount of Drugs and Macromolecules into Polyion Complex Vesicles (PICsomes). Presenter: Akihiro Kishimura, Graduate School of Engineering, The University of Tokyo, Japan. Author(s): A. Kishimura, Y. Anraku, A. Goto, D. Sueyoshi, L. Xiao, N. Nishiyama, K. Kataoka. VIEW ABSTRACT

371  Novel TPGS based paclitaxel prodrug to overcome multidrug resistance of cancer cells. Presenter: Songwei Tan, Tongji School of Pharmacy, Huazhong University of Science and Technology, Prc Peoples Rep of China. Author(s): S. Tan, Y. Bao, B. Cheng, D. Li, Z. Zhang. VIEW ABSTRACT

372  Optimizing drug delivery platforms by matching physico-chemical and pharmacokinetic properties of drugs and drug vectors. Presenter: Arturas Ziemys, The Methodist Hospital Research Institute, U.S.A. Author(s): P. Norvaisas, A. Ziemys. VIEW ABSTRACT

374  Paclitaxel and carboplatin co-loaded nanovesicles prepared with novel multifunctional amphiphilic phosphonated calix[4]arene. Presenter: Lee Yong Lim, Pharmacy, School of Medicine and Pharmacology, The University of Western Australia, Prc Peoples Rep of China. Author(s): J. Mo, P. Eggers, C. Raston, L. Lim. VIEW ABSTRACT

375  Particles with Optimal Release Profile. Presenter: Filis Kazazi Hyseni, Utrecht University, Netherlands. Author(s): F. Kazazi Hyseni, R. Kok, M. Landin, A. Lathuile, G. J. Veldhuis, S. Rahimian, W. E. Hennink, C. F. Van Nostrum. VIEW ABSTRACT

376  PEGylated liposomes injected sequentially distribute in different region of solid tumor. Presenter: Miho Nishio, The University of Tokushima, Japan. Author(s): M. Nishio, H. Nakamura, T. Ishida, H. Kiwada. VIEW ABSTRACT

377  Peptide conjugated liposomes for the targeted and localized delivery of fasudil for the treatment of pulmonary arterial hypertension. Presenter: Kamrun Nahar, Texas Tech University Health Sciences Center, U.S.A. Author(s): K. Nahar, F. Ahsan. VIEW ABSTRACT

378  Peptidic PEGylated solid lipid nanoparticles for oral delivery of salmon calcitonin (sCT) and the influence of mucus. Presenter: Yuan Huang, Key Laboratory of Drug Targeting and Drug Delivery System, Ministry of Education, West China School of Pharmacy, Sichuan University, Prc Peoples Rep of China. Author(s): Y. Huang, T. Fan, C. Chen, X. Zhu, Z. Zhang. VIEW ABSTRACT

379  Performance testing of microparticulate solid dispersions prepared using electrospraying. Presenter: Adam Bohr, University of Copenhagen, Denmark. Author(s): A. Bohr, J. Kristensen, M. Edirisinghe, M. Yang. VIEW ABSTRACT

380  Phage-Derived Peptides Facilitate Caco-2 Cell Translocation of Nanoparticles: Initial Studies and Implications on Oral Delivery. Presenter: Patrick Sinko, Rutgers, The State University of New Jersey, U.S.A. Author(s): P. J. Sinko, R. K. Prud'homme, Z. Szekley, X. Zhang, M. Palombo. VIEW ABSTRACT

383  Polymethacrylic acid-based nanoparticles for the peroral delivery of flurbiprofen – physicochemical properties and evaluation in cell culture models. Presenter: Susanne Beyer, Institute of Pharmaceutical Technology / Goethe University Frankfurt (Main), Germany. Author(s): S. Beyer. VIEW ABSTRACT

384  Potential Use of Folate-appended β-Cyclodextrins as Tumor Targeting Carriers for Antitumor Drugs. Presenter: Hidetoshi Arima, Kumamoto University, Japan. Author(s): H. Arima, A. Okamatsu, K. Motoyama, R. Onodera, T. Higashi, T. Koshigoe, Y. Shimada, K. Hattori, T. Takeuchi. VIEW ABSTRACT

385  Preparation and characterization of cationically modified bee venom-loaded PLGA nanoparticles. Presenter: Min-Ho Park, College of Pharmacy, Chungnam National University, South Korea. Author(s): M. Park, J. Baek, C. Lee, E. Lee, C. Cho. VIEW ABSTRACT

386  Preparation and evaluation of chondroitin sulfate-chitosan nanoparticles for doxorubicin delivery. Presenter: Sung-Ling Tang, Department of Pharmacy Practice, Tri-Service General Hospital, Taiwan. Author(s): S. Tang, C. Hu, C. Chiang, T. Wang, W. Cheng, P. Hong, M. Yeh. VIEW ABSTRACT

387  Preparation of a drug delivery system based on magnetic nanoparticles conjugated with polyethylene imine. Presenter: Farid Dorkoosh, Associate professor, Iran. Author(s): F. A. Dorkoosh, M. Khoobi, H. Akbari. Javar, N. Babanejad. VIEW ABSTRACT

388  Preparation of hydrophobic carrier for medical agents using cross-linked polysaccharide. Presenter: Kazuya Maeda, Graduate School of Engineering, University of Kitakyushu, Japan. Author(s): K. Maeda, S. Mochizuki, Y. Sanada, K. Sakurai. VIEW ABSTRACT

389  Preparation of nano-particulated docetaxel using NUFS (nanoparticulation using fat and supercritical fluid) technique and its preclinical evaluation. Presenter: Eun Jung Ko, asan medical center, South Korea. Author(s): E. Ko, H. Chung, K. Kim, J. Choi, J. Park, S. Park, E. Ju, K. Lee, J. Park, S. Shin, H. Park, J. Jung, S. Song, S. Jeong, E. Choi. VIEW ABSTRACT

390  Preparation of Zwitterionic Polypeptides and Biomedical Application. Presenter: Huayu Tian, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Prc Peoples Rep of China. Author(s): H. Tian. VIEW ABSTRACT

391  Prodrug-Loaded Mesoporous Silica Nanoparticles for Stimuli-Responsive Chemotherapy. Presenter: Eduardo Ruiz-Hernández, Utrecht University, Spain. Author(s): E. Ruiz-Hernández, G. Melen, M. Ramírez, J. W. Scheeren, G. Storm, W. E. Hennink, M. Vallet-Regí. VIEW ABSTRACT

392  Protein-polymer conjugates as therapeutics. Presenter: Hiteshri Makwana, University of Nottingham, UK, United Kingdom. Author(s): H. B. Makwana. VIEW ABSTRACT

393  Raloxifene micelles for the treatment of prostate cancer. Presenter: Sebastien Taurin, University of Otago, New Zealand. Author(s): S. Taurin, T. van Aswegen, H. Nehoff, R. J. Rosengren, K. Greish. VIEW ABSTRACT

394  Rationally Designed Discoidal PLGA/PEG Nanoconstructs for Cancer Theranostics. Presenter: Jaehong Key, The Methodist Hospital Research Institute, U.S.A. Author(s): J. Key, S. Ayral, F. Gentile, J. S. Ananta, M. Zhong, P. Decuzzi. VIEW ABSTRACT

395  Recent Developments and Preclinical Evaluation of HPMA Copolymer-Drug Conjugates as Anticancer Therapeutics. Presenter: Jiyuan Yang, University of Utah, U.S.A. Author(s): J. J. Yang, J. H. Kopecek. VIEW ABSTRACT

396  Robust Cross-linked Hyaluronic Acid Nanoparticles for Efficient Intracellular Drug Delivery. Presenter: Hwa Seung Han, Sungkyunkwan University, Korea. Author(s): H. Han, G. Saravanakumar, W. Um, D. Lee, J. Park. VIEW ABSTRACT

397  Serum anti-PEG IgM concentration is a determinant factor on hepatic accumulation of PEGylated liposome in the accelerated blood clearance phenomenon. Presenter: Yosuke Hashimoto, The University of Tokushima, Japan. Author(s): Y. Hashimoto, T. Shimizu, T. Ishida, H. Kiwada. VIEW ABSTRACT

398  Shape Matters: Effect of Polymeric Nanocarriers Shape on Epithelial and Endothelial Cell Lines. Presenter: Rachit Agarwal, Biomedical Engineering, University of Texas at Austin, U.S.A. Author(s): R. Agarwal, V. Singh, P. Jurney, L. Shi, S. Sreenivasan, K. Roy. VIEW ABSTRACT

399  Shell-Detachable Polypeptide Nanogel with Reduction-Responsive Core as Intelligent Carrier for Improved Chemotherapy Efficacy. Presenter: Jianxun Ding, Changchun Institute of Applied Chemistry, Prc Peoples Rep of China. Author(s): J. Ding, X. Zhuang, X. Chen. VIEW ABSTRACT

400  Sialic acid-functionalized nanoparticles as a novel anti-inflammatory drug delivery platform. Presenter: Michelle Greene, Queen's University Belfast, United Kingdom. Author(s): M. K. Greene, F. Fay, S. Spence, D. Schmid, E. Hams, S. P. Saunders, A. Kissenpfennig, P. G. Fallon, D. F. McAuley, C. J. Scott. VIEW ABSTRACT

401  Size- and Surface Chemistry-Dependent Exocytosis of Gold Nanoparticles in Macrophages. Presenter: Nuri Oh, KAIST, Korea. Author(s): N. Oh, J. Park. VIEW ABSTRACT

402  Size controlled of core-corona type nanospheres using thermoresponsive macromonomers with various chain lengths. Presenter: Takuya Matsuyama, Tokyo University of Science, Japan. Author(s): T. Matsuyama, T. Asoh, A. Kikuchi. VIEW ABSTRACT

404 Sodium Carboxymethyl Cellulose Loaded with Vildagliptin for Diabetic Delivery: In Vitro and In Vivo Evaluation of Nanoparticles. Presenter: Ibrahim Alhaider, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia. Author(s): S. Harsha, B. Al-Dhubiab, M. Attimarad, A. Nair. VIEW ABSTRACT

405  Solid lipid nanoparticles as a drug delivery system for cancer stem cell therapy. Presenter: Sanjun Shi, West China School of Pharmacy, Sichuan University, Prc Peoples Rep of China. Author(s): S. Shi, Z. Zhang, T. Gong, X. Sun. VIEW ABSTRACT

407  Stealth Biodegradable Nanoparticles Fabricated by Dispersion Polymerization. Presenter: Emmanuel Akala, College of Pharmacy, Howard University, U.S.A. Author(s): E. O. Akala, O. O. Ogunwuyi. VIEW ABSTRACT

408  Stromal depletion and control of metastases with a polymeric conjugate of docetaxel. Presenter: Shyh-Dar Li, Ontario Institute for Cancer Research, Canada. Author(s): M. J. Ernsting, M. Murakami, E. Undzys, N. Holwell, S. Li. VIEW ABSTRACT

409  Successful formulation of solid lipid nanoparticles (SLN) using polyhydroxy surfactants. Presenter: Cornelia Keck, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Freie Universität Berlin; Applied Pharmacy Division, University of Applied Sciences Kaiserslautern, Campus Pirmasens, Germany. Author(s): A. B. Kovacevic, R. H. Müller, S. D. Savic, G. M. Vuleta, C. M. Keck. VIEW ABSTRACT

410  Surface Engineering of Gold Nanoparticles with Poly(aminoethers) for Theranostics Applications. Presenter: Kaushal Rege, Chemical Engineering, Arizona State University, Tempe, AZ 85287-6106, U.S.A. Author(s): J. Ramos, K. Rege. VIEW ABSTRACT

411  Synergistic Enhancement of Breast Cancer Cell Cytotoxicity via Co-Delivery of Doxorubicin and VEGF siRNA Loaded Peptide-Conjugated Nanoparticles. Presenter: Wen Jen Lin, Graduate Institute of Pharmaceutical Sciences, National Taiwan University, Taiwan. Author(s): W. Lin. VIEW ABSTRACT

412  Synergistic Stimulation of Immune Cells by Combination of Adjuvant and Nanoparticles Composed of Amphiphilic Poly(γ-glutamic acid). Presenter: Fumiaki Shima, Graduate School of Engineering, Osaka University, Japan. Author(s): F. Shima, T. Uto, T. Akagi, M. Akashi. VIEW ABSTRACT

413  Synthesis and Characterization of pH and Thermal Sensitive Copolymers of N-isopropylacrylamide and Carboxyalkyl Methacrylates. Presenter: Jose Cornejo-Bravo, Universidad Autonoma de Baja California, Mexico. Author(s): D. A. Castro-Vidal, A. Serrano Medina, J. M. Cornejo-Bravo. VIEW ABSTRACT

415  Targeting of e-selectin expressing human endothelial cells using liposomes with a Sialyl Lewis X ligand. Presenter: Johan Unga, Graduate School of Pharmaceutical Sciences, Kyoto University, Japan. Author(s): J. Unga, S. Kawakami, A. Ueki, H. Ando, M. Kiso, M. Hashida. VIEW ABSTRACT

417  The Effect of Polymer End-group Capping on Protein Release and Degradation of Poly(D,L-lactic-co-glycolic) Based Particles. Presenter: Neda Samadi, UTRECHT UNIVERSITY, Netherlands. Author(s): N. Samadi. VIEW ABSTRACT

418  The glucose-lowering potential of exenatide orally delivered via a goblet cell- targeting nanoparticles. Presenter: Xiang Li, Jilin University, Prc Peoples Rep of China. Author(s): Y. Li, X. Li. VIEW ABSTRACT

419  The influence of drug loading on caveolin mediated intracellular internalization of Doxorubicin Nanomicelles. Presenter: Hayley Nehoff, University of Otago, New Zealand. Author(s): H. Nehoff, S. Taurin, K. Greish. VIEW ABSTRACT

420  The nanoparticulation of α-galactosylceramide by octaarginine-modified liposome enhances α-galactosylceramide mediated antitumor effects in an experimental lung metastasis model. Presenter: Takashi Nakamura, Faculty of Pharmaceutical Sciences, Hokkaido University, Japan. Author(s): T. Nakamura, D. Yamazaki, J. Yamauchi, H. Harashima. VIEW ABSTRACT

421  Therapeutic Hydrogen Sulfide Delivery System based on Polymeric Micelles. Presenter: Urara Hasegawa, Osaka University, Japan. Author(s): A. J. van der Vlies, U. Hasegawa. VIEW ABSTRACT

422  Thermosensitive Liposomes for the Localized Delivery of Gemcitabine and Oxaliplatin. Presenter: Jonathan May, Ontario Institute for Cancer Research, Canada. Author(s): J. P. May, M. J. Ernsting, E. Undzys, S. Li. VIEW ABSTRACT

424  Transport of L-DOPA loaded PLGA Nanoparticles across Blood-Brain Barrier. Presenter: Jingyuan Wen, University of Auckland, New Zealand. Author(s): Y. Zhou, R. G. Alany, V. Chuang, J. Wen. VIEW ABSTRACT

425  Triamcinalone and Raloxifene Loaded PCL Microspheres for Treatment of Rheumatoid Arthritis. Presenter: Dilek Keskin, Middle East Technical University, Turkey. Author(s): Y. Ocal, B. Kurum, S. Karahan, A. Tezcaner, S. Ozen, D. Keskin. VIEW ABSTRACT

426  Triggered Release of CPT-11 in Multidrug Resistant Cancer Cells by Biofunctionalized Lipid Bilayer Supported Mesoporous Silica Nanoparticles. Presenter: Xinxin Zhang, Xinxin Zhang, Prc Peoples Rep of China. Author(s): X. Zhang, Y. Gan, F. Li, S. Guo, C. Zhu. VIEW ABSTRACT

427  Tumor-Selective Anticancer Drug Delivery System Mediated by Dendritic Poly(L-Lysine)s. Presenter: Takuro Niidome, Graduate School of Science and Technology, Kumamoto University, Japan. Author(s): T. Niidome, K. Takahashi, K. Naoyama, H. Yamauchi, T. Mori, Y. Katayama. VIEW ABSTRACT

428  Tunable Degradation and Release Profiles from Multistage Nanovectors. Presenter: Michael Evangelopoulos, The Methodist Hospital Research Institute, U.S.A. Author(s): J. O. Martinez, C. Chiappini, A. Ziemys, A. Faust, M. Evangelopoulos, M. Kojic, X. Liu, M. Ferrari, E. Tasciotti. VIEW ABSTRACT

429  Uncovering tumor-host molecular and cellular interactions involved in tumor dormancy using polymer therapeutics. Presenter: Ronit Satchi-Fainaro, Tel Aviv University, Israel. Author(s): G. Tiram, E. Segal, P. Ofek, N. Shomron, H. Pan, P. Kopecková, J. Kopecek, T. Udagawa, R. Satchi-Fainaro. VIEW ABSTRACT

430  Uptake of new somatostatin analogue loaded recombinant human serum albumin nanoparticles in pancreatic carcinoma cells. Presenter: Ina Rosenberger, Institute of Pharmaceutical Technology, Goethe University Frankfurt, Germany. Author(s): I. Rosenberger, C. Schmithals, M. Oron-Herman, T. Shekhter, E. Gazid, A. Orenstein, A. Piiper, J. Kreuter. VIEW ABSTRACT

Modern Agriculture and Aquaculture     [RETURN TO TOP]

431  Zein coated sodium nitrite for brushtail possum control. Presenter: Craig Bunt, Lincoln University, New Zealand. Author(s): L. Shapiro, D. MacMorran, C. Eason, C. R. Bunt. VIEW ABSTRACT

Oral CR - Pharmaceutical Formulations, Technologies and Development Strategies     [RETURN TO TOP]

432  A Comparison of Spherical Core Materials Used for Controlled Release Drug Layering Processes. Presenter: Shawn Engels, Freund-Vector Corporation, U.S.A. Author(s): S. Engels, B. Jensen, S. Freers, C. Shipley, B. Porter. VIEW ABSTRACT

433  A novel biphasic drug delivery system containing taste masked diclofenac sodium. Presenter: Scott Lamb, Catalent Pharma Solutions, U.S.A. Author(s): O. Schinzinger, U. Hanenberg, S. Juenkering, H. Barlianto, M. Fritschi, K. Nielsen, S. Lamb. VIEW ABSTRACT

434  A novel granulation technique to obtain zero order release from solid dosage forms. Presenter: Abhijit Gokhale, Patheon Pharmaceutical, U.S.A. Author(s): A. Gokhale, T. Williams, J. Vaughn. VIEW ABSTRACT

435  Absorption profiles of an oral paclitaxel formulation, DHP107 with variable dosing intervals in mice. Presenter: Yura Jang, Korea Institute of Science and Technology, Korea. Author(s): Y. Jang, Y. Jo, H. Lee, H. Chung. VIEW ABSTRACT

436  Anti-tumor activity and tumor distribution of paclitaxel following an oral administration of DHP109 in mice. Presenter: Yura Jang, Korea Institute of Science and Techonology, Korea. Author(s): Y. Jang, I. Lee, H. Chung, H. Chung. VIEW ABSTRACT

437  Application of Super Fine Powder, Special Low Viscosity Grade of Hydroxypropyl Cellulose(HPC-SSL-SFP) to 'Tablet Hardness Enhancer' for Hydrophilic Matrix Formulation. Presenter: Kenji Sugisawa, Nippon Soda Co., Ltd., Japan. Author(s): K. Sugisawa, S. Tsue, T. Shimotori. VIEW ABSTRACT

438  Aqueous ethyl cellulose coating with alcohol resistant properties: Formulation and process considerations. Presenter: Rina Chokshi, FMC BioPolymer, U.S.A. Author(s): R. Chokshi, B. Leclercq, M. Sestrick, J. Lee, M. Butt. VIEW ABSTRACT

439  Barrier Membrane Coating of Hydrophilic Matrices: A Simplified Strategy to Attain Zero Order Drug Release. Presenter: Ali Rajabi-Siahboomi, Colorcon Inc, U.S.A. Author(s): R. Y. Mehta, S. Missaghi, S. Tiwari, T. P. Farrell, A. Rajabi-Siahboomi. VIEW ABSTRACT

441  Characterizations of Tablets Manufactured by One-Step Dry Coating (OSDrC®) OptiDose™ Technology. Presenter: Scott Lamb, Cata, U.S.A. Author(s): C. P. Hollis, M. Bicknell, H. Cocolas, K. Nielsen, S. Lamb. VIEW ABSTRACT

443  Consideration of Critical Material Attributes in Hypromellose-Based Hydrophilic Matrices Comprising Drugs of Various Solubility . Presenter: Ali Rajabi-Siahboomi, Colorcon Inc, U.S.A. Author(s): H. Deng, L. Martin, B. Prusak, S. Missaghi, T. P. Farrell, A. Rajabi-Siahboomi. VIEW ABSTRACT

446  Co-Processed Excipients: A Strategy for Reducing Risk in Early Dosage Form Development. Presenter: Adam Lambert, CoreRx Inc., U.S.A. Author(s): A. Lambert, T. Daviau, M. Greene, B. McMillan. VIEW ABSTRACT

447  Design of experiments approach for the development of coated pellets for MUPS tablets. Presenter: Anna Novikova, University of Hamburg, Germany. Author(s): A. Novikova, C. S. Leopold. VIEW ABSTRACT

450  Development of a Swellable Matrix Tablet for a Novel CNS Drug Candidate. Presenter: Marcus Brewster, Johnson & Johnson, Belgium. Author(s): D. Verstraete, F. Vanhoutte, G. Verreck, G. Jans, R. De Maesschalck, V. Sinha, A. Van Peer, E. Mannaert, J. Herman, D. Peeters, M. Brewster. VIEW ABSTRACT

451  Development of Extended-release Capsules loaded with Albumin-based Microspheres. Presenter: Duc Do, Chicago State University, U.S.A. Author(s): B. A. Orawiec, G. G. Enriquez, S. A. Rizvi, M. Newaz, D. P. Do. VIEW ABSTRACT

452  Development of Thioguanine Extended Release Tablets. Presenter: Yunmei Song, university of south Australia , Australia. Author(s): Y. Song, F. Peddie. VIEW ABSTRACT

453  Ectopic protein bodies, a novel strategy for oral delivery of recombinant proteins. Presenter: Anna Hofbauer, University of Natural Resources and Life Sciences, Austria. Author(s): A. Hofbauer. VIEW ABSTRACT

454  Effect of Different Types of Chitosan on Its Mucoadhesive Properties. Presenter: Sevda Senel, Hacettepe University, Turkey. Author(s): G. Soylu, M. Cansiz, M. Andersson, S. Senel. VIEW ABSTRACT

456  Effect of Polyethylene Oxide Molecular Weight and Osmogen Content on Performance of Push-Pull Osmotic Pump Tablets. Presenter: Ali Rajabi-Siahboomi, Colorcon Inc, U.S.A. Author(s): H. Deng, S. Vass, P. Patel, S. Missaghi, T. P. Farrell, A. Rajabi-Siahboomi. VIEW ABSTRACT

457  Enhanced Drug Delivery across the Intestinal Epithelium using Planar Bioadhesive Microdevices. Presenter: Hariharasudhan Chirra Dinakar, University of California at San Francisco, U.S.A. Author(s): H. Chirra Dinakar, N. Ciaccio, L. Shao, A. Ma, T. A. Desai. VIEW ABSTRACT

458  Enteric coating of microcontainers for oral delivery of poorly water soluble drugs. Presenter: Stephan Keller, Department of Micro- and Nanotechnology, Technical University of Denmark, Denmark. Author(s): S. S. Keller, L. H. Nielsen, A. Müllertz, A. Boisen. VIEW ABSTRACT

459  Ethanol-Resistant Polymeric Film Coatings for Controlled Drug Delivery. Presenter: Rina Chokshi, FMC BioPolymer, U.S.A. Author(s): R. Chokshi, Y. Cuppok, S. Muschert, B. Leclercq, J. Siepmann, F. Siepmann. VIEW ABSTRACT

461  Evaluation of Super Fine Powder, Special Low Viscosity Grade of Hydroxypropyl Cellulose(HPC-SSL-SFP) for Orally Disintegrating Tablet Application. Presenter: Kenji Sugisawa, Nippon Soda Co., Ltd., Japan. Author(s): K. Sugisawa, S. Tsue, T. Shimotori. VIEW ABSTRACT

462  Evaluation of Ultra High Viscosity Hydroxypropyl Cellulose for Hydrophilic Matrix, Sustained Release Formulation. Presenter: Kenji Sugisawa, Nippon Soda Co., Ltd., Japan. Author(s): K. Sugisawa, S. Tsue, T. Shimotori, T. Umezawa. VIEW ABSTRACT

463  Experimental Design to optimize a Novel Geometric Multi-layered Matrix Tablet Formulation with various Mechanical properties and Drug Release Profiles. Presenter: Duhyung Choi, College of Pharmacy, Pusan National University, Korea. Author(s): D. Choi, N. Kim, J. Lim, S. Jeong. VIEW ABSTRACT

465  Extrusion spheronization technique for controlled release of pharmaceutical drugs. Presenter: Abhijit Gokhale, Patheon Pharmaceuticals, U.S.A. Author(s): A. Gokhale, T. Williams, J. Vaughn. VIEW ABSTRACT

466  Formulation development of poorly stable and poorly permeable drugs. Presenter: Abhijit Gokhale, Patheon Pharmaceuticals, U.S.A. Author(s): A. Gokhale, T. Williams, J. Vaughn. VIEW ABSTRACT

468  Gastroresistant Coating of HPC Capsules Prepared by Injection-Molding. Presenter: Elena Macchi, Sezione di Tecnologia e Leg. Farmaceutiche "Maria Edvige Sangalli", Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Italy. Author(s): E. Macchi, L. Zema, A. Gazzaniga, L. A. Felton. VIEW ABSTRACT

469  High Dose Metformin HCl Controlled-release Tablets Made via Hot-melt Extrusion. Presenter: Divya Tewari, Ashland Specialty Ingredients, U.S.A. Author(s): Y. Zong, C. Hood, D. Tewari, T. Durig. VIEW ABSTRACT

470  Hyaluronic Acid, a new Recombinant Controlled Release Excipient for Oral Solid Dosage Forms. Presenter: Ole Dall, Novozymes Biopharma DK A/S, Denmark. Author(s): O. M. Dall, K. Schwach-Abdellaoui, M. L. Jensen. VIEW ABSTRACT

471  In Situ Gelling Methylcellulose/Pectin Formulation for Oral Sustained Release Delivery. Presenter: Kunihiko Itoh, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Japan. Author(s): K. Itoh, T. Shimoyama, M. Kobayashi, S. Miyazaki, D. Antony, D. Attwood. VIEW ABSTRACT

472  In vitro Evaluation of a Multiple-Unit Formulation for Oral Colonic Release of Insulin. Presenter: Elena Macchi, Sezione di Tecnologia e Legislazione Farmaceutiche “M.E. Sangalli”, Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Italy. Author(s): M. Del. Curto, A. Maroni, E. Macchi, G. Loreti, L. Palugan, M. Cerea, A. Gazzaniga. VIEW ABSTRACT

473  In vitro Permeation Studies of Esomeprazole through Gastric Pig Mucosa. Presenter: Alessandra Rossi, Department of Pharmacy, University of Parma, Italy. Author(s): C. Benetti, P. Colombo, C. Conti, S. Mercuri, A. Rossi. VIEW ABSTRACT

474  Investigating the Impact of Polymer Blends on Drug Release from Polymer Matrices. Presenter: Yvonne Perrie, Aston University, United Kingdom. Author(s): J. Pollard, A. R. Rajabi-Siaboomi, A. R. Mohammed, Y. Perrie. VIEW ABSTRACT

475  Investigation of the dissolution behavior of Eudragit® RL/L-55 blends using a response surface methodology. Presenter: Robert Wulff, University of Hamburg, Germany. Author(s): R. Wulff, C. S. Leopold. VIEW ABSTRACT

477  Mesostructured Porous Silicon for the Controlled Delivery of Poorly Soluble Drugs. Presenter: Timothy Barnes, University of South Australia, Australia. Author(s): T. J. Barnes, F. Wang, C. A. Prestidge. VIEW ABSTRACT

478  Modified Release Strategies for Ionizable Drugs Using Ion Exchange Resins. Presenter: TRUE Rogers, The Dow Chemical Company, U.S.A. Author(s): A. S. Gehris, M. Deetz, L. Hughes, J. R. Fisher, C. B. Cherkis, T. Rogers. VIEW ABSTRACT

481  Non Swellable Gastroretentive Matrices: Formulation and Response Surface Optimization. Presenter: Aly Abdelbary, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt, Egypt. Author(s): A. A. Abdelbary, I. Elsayed. VIEW ABSTRACT

482  Novel Co-processed Excipient for Directly Compressed Controlled Release Formulations. Presenter: Jospeh Zeleznik, MEGGLE USA, Inc., U.S.A. Author(s): J. Zeleznik, F. Penz, C. Nowak. VIEW ABSTRACT

484  Oral Sustained Release Formulations Based on Coating a Nano-on-Bead Concept with a pH Sensitive Polymer. Presenter: Marcus Brewster, Johnson & Johnson, Belgium. Author(s): F. Willemse, G. Verreck, F. Vanhoutte, N. Mertens, J. Mensch, M. Brewster. VIEW ABSTRACT

485  pH responsive raft gel forming tablet of risedronate for reducing risk of gastroesophageal irritation of bisphosphonate. Presenter: Moon-Young Choi, Dong-A Pharmaceutical Co. Ltd., South Korea. Author(s): S. Jang, J. Lee, D. Yoo, J. Kim, C. Park, M. Son, M. Choi. VIEW ABSTRACT

486  Preliminary In Vivo Evaluation of a Gastroresistant Capsular Device Prepared by Injection Molding. Presenter: Elena Macchi, Sezione di Tecnologia e Legislazione Farmaceutiche 'M.E. Sangalli', Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Italy. Author(s): L. Zema, G. Loreti, A. Melocchi, E. Macchi, M. D. Del. Curto, A. Foppoli, A. Gazzaniga. VIEW ABSTRACT

487  Preparation and In Vitro Evaluation of Multifunctional Oral Drug Delivery System. Presenter: Chen-Yu Kao, National Taiwan University of Science and Technology, Taiwan. Author(s): C. Kao, C. Lo, S. Lee. VIEW ABSTRACT

488  Preparation and in vitro release of isoperidone gastroretentive tablets. Presenter: Hongnan Xia, Jilin University, Prc Peoples Rep of China. Author(s): H. Xia, D. Wang, Y. Yu, F. Sun, Y. Li. VIEW ABSTRACT

489  Preparation, characterization and in vitro release studies of Enoxaparin in nanoparticle form and enterically coated tablets containing surfactants as permeation enhancers. Presenter: Morvarid Goharzadeh, Faculty of Pharmacy, Azad University of Pharmaceutical Science, Tehran, Iran , Iran. Author(s): M. Goharzadeh, M. Avadi, A. M. M. Sadeghi. VIEW ABSTRACT

492  Production Scale of Semipermeable Coating for Push-Pull Osmotic Pump Tablets. Presenter: Ali Rajabi-Siahboomi, Colorcon Inc, U.S.A. Author(s): L. Martin, H. Deng, T. P. Farrell, A. Rajabi-Siahboomi. VIEW ABSTRACT

493  Reinforced alginate beads for anticancer drugs delivery. Presenter: Chun-Ho Kim, Korea Institute of Radiological and Medical Sciences, Korea. Author(s): M. Kim, S. Park, B. Gu, C. Kim. VIEW ABSTRACT

494  Relaxation vs diffusion on the diclofenac sodium release from matrix tablets containing hydroxypropylmethyl cellulose and/or chitosan. Presenter: Manuel Londa Vueba, University of Coimbra, Portugal. Author(s): M. Vueba, L. Batista de Carvalho, M. Pina. VIEW ABSTRACT

495  Shifting the Enteric Property of Eudragit L 30D-55 to Taste-masking by Adding Eudraigt RL 30D. Presenter: Chuanbin Wu, School of Pharmaceutical Science, Sun Yat-Sen University, Prc Peoples Rep of China. Author(s): C. Zhu, Y. Liu, Y. Huang, X. Pan, H. Huang, G. Li, M. Huang, C. Wu. VIEW ABSTRACT

498  Taste Masking Hydrocodone by Controlling Release in Simulated Saliva Using Ion Exchange Excipients. Presenter: True Rogers, The Dow Chemical Company, U.S.A. Author(s): A. S. Gehris, J. R. Fisher, M. Deetz, J. Hurry, D. Nugent, T. Rogers. VIEW ABSTRACT

499  The Behavior of Mixed Polymer HPMC/PEO Hydrophilic Matrices in Ionic Environments. Presenter: Anran Hu, University of Nottingham, United Kingdom. Author(s): A. Hu, C. Melia, A. Rajabi-Siahboomi. VIEW ABSTRACT

500  The Effect of Bilosomes and Vesicle Size on the Oral Biodistribution of a H3N2 Subunit Antigen. Presenter: Yvonne Perrie, Aston University, United Kingdom. Author(s): J. S. Wilkhu, D. E. Anderson, Y. Perrie. VIEW ABSTRACT

501  The Utility of Modified-Release, Osmotic Tablet Technology in the Early Stages of Pharmaceutical Development. Presenter: W. Brett Caldwell, Bend Research, U.S.A. Author(s): W. Caldwell, R. J. Wald, C. D. Craig, C. L. Hostetler, D. G. Koehler-King, M. Milewski, S. R. Pygall, J. C. Mann, C. Seiler. VIEW ABSTRACT

502  Transit and pH in Fasted Beagle Dogs with the IntelliCap System. Presenter: Jeff Shimizu, Medimetrics Personalized Drug Delivery, Inc., U.S.A. Author(s): H. Zou, J. Shimizu, C. Wanke, V. Iordanov. VIEW ABSTRACT

503  Understanding the Response of Xanthan Gum Hydrophilic Matrices to a Dissolved Salt Environment. Presenter: Yewande Oni, University of Nottingham, United Kingdom. Author(s): Y. I. Oni, L. Jasmani, W. Thielemans, A. Inchley, J. C. Burley, C. D. Melia. VIEW ABSTRACT

504  Use of ion exchange resin for taste masking cetirizine HCl 10mg formulated in the Zydis® dosage form. Presenter: Scott Lamb, Catalent Pharma Solutions, United Kingdom. Author(s): L. P. Grother, L. K. Dennis, K. Hau, R. T. McLaughlin, S. Lamb. VIEW ABSTRACT

505   Use of Response Surface Methodology for the Optimization of Nevirapine Sustained Release Tablets. Presenter: Roderick Walker, Rhodes University, Rep of South Africa. Author(s): R. B. Walker, C. Mwila. VIEW ABSTRACT

506  Zero-Order Release of Hydrocodone from a Hydrophilic Matrix Tablet Containing NaproxenSodium. Presenter: Christian Wertz, Upsher-Smith Laboratories, Inc., U.S.A. Author(s): C. F. Wertz, J. S. Jensen, M. A. Gehrke, R. L. Zanon, S. M. Berge, K. L. Evenstad. VIEW ABSTRACT

Oral CR - Predictive Tools (in vitro / in vivo / in silico)     [RETURN TO TOP]

507  A Comprehensive Study of Solid Lipid Microparticles (SLMs) Behavior in Biorelevant Dissolution Media. Presenter: Beatrice Albertini, Department of Pharmacy and BioTecnology, Italy. Author(s): B. Albertini, M. Di. Sabatino, N. Passerini. VIEW ABSTRACT

508  A Novel Mucus-Containing in Vitro Model for Assessment of Intestinal Drug Absorption. Presenter: Marie Boegh, University of Copenhagen, Faculty of Health and Medical Sciences, Department of Pharmacy, Denmark. Author(s): M. Boegh. VIEW ABSTRACT

509  Drug-polymer interactions significantly affect drug partition in cationic polyacrylate membranes and drug release kinetics. Presenter: Kuan Chen, Faculty of Pharmacy, University of Toronto, Canada. Author(s): K. Chen, M. Chu, S. Kwan, D. Shan, X. Wu. VIEW ABSTRACT

510  Dynamic system for simulation of physiological pH gradients for hydrogen carbonate buffers (pHysio-grad). Presenter: Werner Weitschies, Department of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Strasse 3, 17487 Greifswald, Germany, Germany. Author(s): G. Garbacz, B. Kolodziej, M. Koziolek, S. Klein, W. Weitschies. VIEW ABSTRACT

511  Evaluation of palatability for 10 commercial famotidine orally disintegrating tablets by combination of disintegration apparatus for orally disintegrating tablet and taste sensor. Presenter: Miyako Yoshida, Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences,Mukogawa Women’s University, Japan. Author(s): M. Yoshida, M. Hazekawa, T. Haraguchi, T. Uchida. VIEW ABSTRACT

513  MembranePlusTM: A tool to Study in vitro/in vivo Transport, Metabolism and Protein Binding. Presenter: Ke Szeto, Simulations Plus, Inc., U.S.A. Author(s): K. X. Szeto, V. Lukacova, M. B. Bolger, W. S. Woltosz. VIEW ABSTRACT

514  Optimization of parameters for scaled-down dissolution method for controlled release pellets. Presenter: Katja Kristan, Lek Pharmaceuticals, d.d., Slovenia. Author(s): M. Petrusevska, M. Horvat, L. Peternel, K. Kristan. VIEW ABSTRACT

515  Optimization of simulated gastric media based on rheological characterization of human gastric fluid. Presenter: Anette Müllertz, University of Copenhagen and Bioneer:FARMA, Denmark. Author(s): P. B. Pedersen, P. Vilmann, D. Bar-Shalom, S. Baldursdottir, A. Müllertz. VIEW ABSTRACT

516  pHysio-stat® - an automated system for monitoring and regulating the pH value of model biorelevant media based on bicarbonate buffers. Presenter: Werner Weitschies, Department of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Strasse 3, 17487 Greifswald, Germany, Germany. Author(s): G. Garbacz, B. Kolodziej, M. Koziolek, S. Klein, W. Weitschies. VIEW ABSTRACT

518  Rapid and Non-Destructive Dissolution Measurement of Controlled Release Pellets by NIR Spectroscopy. Presenter: Matej Horvat, Lek Pharmaceuticals, d.d., Slovenia. Author(s): S. Markovic, M. Horvat. VIEW ABSTRACT

519  Simulation of midazolam pharmacokinetics after buccal administration. Presenter: Ke Szeto, Simulations Plus, Inc., U.S.A. Author(s): H. Zhou, K. X. Szeto, V. Lukacova, M. B. Bolger, W. S. Woltosz. VIEW ABSTRACT

Parenteral Sustained Release Drug Delivery     [RETURN TO TOP]

521  A hydrogel containing crosslinkable trilayered polymeric micelles, newly-developed macromolecular assemblies, for a sustained release of hydrophilic compounds. Presenter: Yusuke Uchida, Tokyo University of Agriculture and Technology, Japan. Author(s): Y. Uchida, Y. Murakami. VIEW ABSTRACT

522  A Novel Drug Delivery System Based on Raloxifene Nanoparticles Composed of Biodegradable Carboxylated Polyurethane. Presenter: Farid Dorkoosh, Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran, Iran. Author(s): F. A. Dorkoosh, N. Babanejad, M. Alavi Nikjeh. VIEW ABSTRACT

523  A Sheet-Shaped Poly (ethylene glycol)-Modified Chitosan Hydrogel Containing Crosslinkable Polymeric Micelles for Wound Dressing and Drug Release. Presenter: Chikara Yoshida, Tokyo University of Agriculture and Technology, Japan. Author(s): C. Yoshida, Y. Murakami. VIEW ABSTRACT

525  Andrographolide-Loaded Temperature-Responsive Hydrogels for Myocardioprotection in H9c2 Cells Hypoxia/Reoxygenation Injury Model. Presenter: Hsia-Wei Liu, Fu Jen Catholic University, Taiwan. Author(s): H. Liu, S. Wu. VIEW ABSTRACT

526  Characterization of liposomal systems designed for the remote loading of ropivacaine. Presenter: Camila Silva, UNICAMP, Brazil. Author(s): C. M. Silva, M. Franz-Montan, C. M. Cereda, E. de Paula. VIEW ABSTRACT

528  Combination Therapy for Treating Angiogenesis by Targeting Downstream Signaling Pathways (HIF-1α & mTOR). Presenter: Bhuvana Dodapaneni, Oregon State University, U.S.A. Author(s): B. S. Dodapaneni, A. W. Alani. VIEW ABSTRACT

529  Comparative PK-PD Study On A Long Acting PLGA-based Microsphere of A Novel Antipsychotic and Oral Administration of Free Drug. Presenter: Lexi Wang, Jilin University, Prc Peoples Rep of China. Author(s): L. Wang. VIEW ABSTRACT

530  Core-shell Nanofibers-coated Drug-eluting Stents for Suppression of Restenosis. Presenter: Sujin Yoon, Kangwon National University, South Korea. Author(s): S. Yoon, H. Yoo. VIEW ABSTRACT

532  Development and Preclinical PK/PD Evaluations of Diethylstilbestrol Nanosuspensions in Rats. Presenter: Tanay Samant, University of Houston, U.S.A. Author(s): T. Samant, S. Tu, J. C. Shah, D. Chow. VIEW ABSTRACT

533  Development of an oily sustained release depot formulation in a prefilled syringe. Presenter: Mahesh Chaubal, Baxter Healthcare, U.S.A. Author(s): M. V. Chaubal, S. Lee, D. Shah, L. Nair. VIEW ABSTRACT

534  Development of Annual Implant for the Controlled Release of Anastrozole using Polyurethane as a Rate Limiting Membrane. Presenter: S. Thoroughman, Endo Healthcare Solutions, U.S.A. Author(s): A. Schwarz, S. Thoroughman, T. Kim, S. Decker. VIEW ABSTRACT

535  Development of injectable microspheres for controlled release: Rationalization of the release behavior by structure elucidation. Presenter: Joke Meeus, Drug Disposition and Delivery, University of Leuven, Belgium. Author(s): J. Meeus, D. J. Scurr, K. Amssoms, M. C. Davies, C. J. Roberts, G. Van den Mooter. VIEW ABSTRACT

536  Dual Drug-loaded Block Ionomer Complex Micelles for Enhanced Combination Chemotherapy. Presenter: Jong Oh Kim, Yeungnam University, South Korea. Author(s): T. Ramasamy, J. Kim, H. Choi, C. Yong, J. Kim. VIEW ABSTRACT

538  Fabrication and in vitro release research on a novel antibacterial coating containing halogenated furanone compound loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium. Presenter: Jiang Wu, Department of prosthodontics, School of Stomatology, Fourth Military Medical University, Prc Peoples Rep of China. Author(s): J. Wu, Y. Cheng, B. Gao. VIEW ABSTRACT

539  Foreign Body Response to Subcutaneous Implants: Pre-clinical Study in Gottingen Minipigs. Presenter: Michail Kastellorizios, University of Connecticut, Department of Pharmaceutical Sciences, U.S.A. Author(s): M. Kastellorizios, F. Papadimitrakopoulos, D. J. Burgess. VIEW ABSTRACT

540  Formulation and in vitro Characterization of Nanoparticles for Prenatal Cardiovascular Therapy. Presenter: Norah Albekairi, University of Texas Medical Branch, U.S.A. Author(s): N. Albekairi, E. Rytting. VIEW ABSTRACT

541  Hydrogels as adjuvants for PRRS modified live virus vaccine. Presenter: Jishu Shi, Kansas State University, U.S.A. Author(s): X. Li, A. Galliher-Beckley, J. Nietfeld, H. Huang, X. Sun, K. Faaberg, J. Shi. VIEW ABSTRACT

543  Implantable Nanochannel Delivery System for the Constant and Sustained Release of Intact Liposomes. Presenter: Silvia Ferrati, The Methodist Hospital Research Institute, U.S.A. Author(s): S. Ferrati, C. Celia, S. Bansal, A. van de Ven, B. Ruozi, E. Zabre, D. Paolino, M. Fresta, M. Ferrari, A. Grattoni. VIEW ABSTRACT

544  Implantable NanoGland for the Constant and Sustained Delivery of Therapeutics. Presenter: Alessandro Grattoni, Methodist Hospital Research Institute, U.S.A. Author(s): S. Ferrati, D. Fine, E. De Rosa, E. Zabre, S. Hosali, R. Goodall, M. Ferrari, A. Grattoni. VIEW ABSTRACT

545  Improved stability and tumor targeting of 5-fluorouracil by conjugation with hyaluronan. Presenter: Zongning Yin, Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Prc Peoples Rep of China. Author(s): Z. Dong, W. Zheng, Z. Xu, Z. Yin. VIEW ABSTRACT

546  In Situ Hydrogel for Peritoneal Delivery of Paclitaxel in Ovarian Cancer. Presenter: Yu-Wen Lo, Industrial Technology Research Institute, Taiwan. Author(s): Y. Lo, M. Lin, C. Huang, S. Chou, C. Tu, C. Liu, Wei, M. Lu. VIEW ABSTRACT

547  In vitro Haemocompatabiltiy of Solid Lipid Nanoparticle Delivery Systems of Diclofenac. Presenter: Zimei Wu, School of Pharmacy, University of Auckland, New Zealand. Author(s): Z. Wu, W. Zhang, A. McGregor, R. Alany. VIEW ABSTRACT

548  Increased in vitro and in vivo release of dexamethasone formulated with a cross-linked hyaluronic acid hydrogel. Presenter: Morten Maltesen, Novozymes Biopharma DK A/S, Denmark. Author(s): M. J. Maltesen, J. Lichtenberg, J. Fogh, O. M. Dall. VIEW ABSTRACT

549  Injectable Thermosensitive Poly(Ethylene Glycol)/Polypeptide Block Copolymer Hydrogels for Localized Anti-Cancer Drug Delivery. Presenter: Chaoliang He, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Prc Peoples Rep of China. Author(s): C. He, Y. Cheng, X. Chen. VIEW ABSTRACT

550  Injectable, Sustained-Release of BMP-2 by IonicThermosensitive Poly(organophosphazene) Hydrogel for Local BoneRegeneration. Presenter: Bo-Bae Seo, Division of Biomedical Research Institute, Korea Institute of Science & Technology, South Korea. Author(s): B. Seo, H. Choi, J. Koh, C. Chun, S. Song. VIEW ABSTRACT

551  Insights into the local inflammatory reaction induced by intramuscular injection of sustained-release drug microsuspensions. Presenter: Nicolas Darville, Drug Delivery and Disposition - University of Leuven, Belgium. Author(s): N. Darville, M. van Heerden, P. Sterkens, A. Vynckier, G. Van den Mooter. VIEW ABSTRACT

552  Intracellular Uptake Mechanism of Biodegradable and Injectable Poly(organophosphazene)-Docetaxel Conjugate Hydrogels. Presenter: Jung-Kyo Cho, Korea Institute of Science and Technology / University of Science and Technology, South Korea. Author(s): J. Cho, J. Hong, S. Song. VIEW ABSTRACT

553  LinkeRx™: A Versatile Platform for Designing Prodrugs for Extended Release after Intramuscular Administration. Presenter: Julius Remenar, Alkermes, plc, U.S.A. Author(s): J. F. Remenar, O. Almarsson, T. Zeidan, L. Blumberg, C. Sanrame, J. Waters. VIEW ABSTRACT

555  Liposomes and Polymers in Folate-Targeted Cancer Therapeutics: a Comparative Study. Presenter: Anna Scomparin, Tel Aviv University, Israel. Author(s): A. Scomparin, A. Eldar-Boock, S. Ferber, G. Tiram, H. Shmeeda, A. Gabizon, S. Salmaso, P. Caliceti, R. Satchi-Fainaro. VIEW ABSTRACT

556  Local Interstitial Delivery of Estradiol by Micellar Drug Release for Cardioprotection in vitro. Presenter: Hsia-Wei Liu, Fu Jen Catholic University, Taiwan. Author(s): H. Liu, H. Hua. VIEW ABSTRACT

557  Multiscale Drug Delivery System: Micelles Encapsulated in Hydrogels. Presenter: Mary Tang, University of Illinois at Chicago, U.S.A. Author(s): M. Y. Tang, L. Nwanah, Y. Zhang, M. Kollmer, R. A. Gemeinhart. VIEW ABSTRACT

558  Pathogen mimicking particles in an injectable synthetic-immune-priming center (sIPC) provide efficient immune cell activation and protection in murine tumor models. Presenter: Jardin Leleux, University of Texas, U.S.A. Author(s): J. Leleux, E. Dawson, P. Pradhan, I. Sakamaki, H. Qin, L. W. Kwak, K. Roy. VIEW ABSTRACT

559  Pharmacokinetics (PK) and Safety of a 120-day Implantable Risperidone Device in Rats. Presenter: Frank Martin, Delpor, Inc., U.S.A. Author(s): F. J. Martin, G. Watkins, P. Boulikas, W. Toomey. VIEW ABSTRACT

560  Polymer therapeutics: A combinational drug delivery approach for effective cancer treatment. Presenter: Mallaredy Vandana, Institute of life Sciences, India. Author(s): M. Vandana, S. K. Sahoo. VIEW ABSTRACT

561  Polyoxazoline is a suitable biopolymer for the extended release of irinotecan in rats and dogs. Presenter: Tacey Viegas, Serina Therapeutics, Inc., U.S.A. Author(s): T. X. Viegas, M. D. Bentley, K. Yoon, Z. Fang, B. Dizman, R. Weimer, J. Harris, R. W. Moreadith. VIEW ABSTRACT

562  Polysaccharide conjugates of Amphotericin B for improved efficacy and reduced toxicity. Presenter: Diana Ickowicz, Hebrew University Medical Center, Jerusalem, Israel. Author(s): D. E. Ickowicz, S. Kagan, S. Farber, I. Polacheck, A. J. Domb. VIEW ABSTRACT

563  Precision Particle Fabrication Microsphere Depot Sustains Tramadol Blood Levels with Minimal 'Burst'™. Presenter: David Dumbauld, Orbis Biosciences, Inc., U.S.A. Author(s): N. H. Dormer, M. Singh, D. W. Dumbauld, C. Berkland. VIEW ABSTRACT

564  Preparation and Evaluation of Self-assembled NanoparticlesBased on Low-Molecular-Weight Heparin and Stearylamine for Controlled Delivery of Docetaxel. Presenter: Dong Hwan Kim, College of Pharmacy, Seoul National University, Korea. Author(s): D. Kim, D. Kim. VIEW ABSTRACT

567  Redox Injectable Gel for Local Inflammation. Presenter: Yukio Nagasaki, University of Tsukuba, Japan. Author(s): M. Pua, Y. Nagasaki, T. Yoshitomi, P. Chonpathompikunlert, A. Hirayama. VIEW ABSTRACT

568  Self-Regenerative Nano Hybrid Materials for Long Term Controlled Drug Delivery Applications. Presenter: Martin Alm, BioModics, Denmark. Author(s): M. Alm. VIEW ABSTRACT

569  SER-201, a novel polyoxazoline conjugate of irinotecan with improved efficacy in five mouse xenograft models. Presenter: Tacey Viegas, Serina Therapeutics, Inc., U.S.A. Author(s): T. X. Viegas, M. D. Bentley, K. Yoon, Z. Fang, B. Dizman, R. Weimer, J. Harris, R. W. Moreadith. VIEW ABSTRACT

570  Short PEGylated Peptide-based Hydrogels as New Matrices for Slow Release. Presenter: Laurent Jeannin, PEPTISYNTHA SA, Belgium. Author(s): L. Jeannin, W. Moussa, M. Bousmanne, K. Vanvarenberg, A. JOLY, G. Nolleveaux, Y. Schneider, V. Preat. VIEW ABSTRACT

572  Surgical Suture Enabled with Controlled Drug Delivery for Anti-Scarring Functionality. Presenter: Sung Yoon Choi, Interdisiplinary Program in Bioengineering, College of Engineering, Seoul National University, Seoul, 110-799, Korea, Korea. Author(s): S. Choi, J. Lee, B. Kim, S. Park, M. Park, C. Heo, Y. Choy. VIEW ABSTRACT

573  Sustained Released Anti-angiogenic Thrombospondin Mimetic Peptide Induces an Angiogenesis-Dependent Dormant-Like Phenotype of Fast-Growing Glioblastomas. Presenter: Shiran Ferber, 1Department of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, 69978, Israel, Israel. Author(s): S. Ferber, N. Almog, J. Henkin, R. Satchi-Fainaro. VIEW ABSTRACT

574  The angiogenesis effect of a novel long-acting prostacyclin agonist loaded-PLGA microspheres prepared using different molecular weight in murine sponge model. Presenter: Mai Hazekawa, Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Mukogawa Women’s University, Japan. Author(s): M. Hazekawa, T. Haraguchi, M. Yoshida, T. Uchida. VIEW ABSTRACT

575  Twice and Once Monthly Risperidone Loaded Microparticle Formulations. Presenter: Darryl Love, Evonik Industries, U.S.A. Author(s): D. F. Love, J. M. Shaw, K. W. Burton. VIEW ABSTRACT

576  Use of Porosity to Impact the Erosional Release of a Drug from PLG Microparticles. Presenter: Kehley Miller, Scientist, U.S.A. Author(s): K. H. Miller, K. Burton. VIEW ABSTRACT

Peptide and Protein Delivery     [RETURN TO TOP]

579  A novel chemistry for the protein PEGylation. Presenter: Yutaka Ikeda, Department of Materials Science, Graduate School of Pure and Applied Sciences, University of Tsukuba, Japan. Author(s): Y. Ikeda, J. Katamachi, Y. Nagasaki. VIEW ABSTRACT

580  A novel NGF loaded electrospun fibrous membranes used for nerve conduit on peripheral nerve regeneration. Presenter: Fei Wu, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China, Prc Peoples Rep of China. Author(s): F. Wu, M. Qin, T. Jin. VIEW ABSTRACT

582  A Stealth and Biodegradable Polymeric Drug Carrier Composed of Amino Acid Modified Hyaluronic Acid. Presenter: Tomoko Kanei, Chugai Pharmaceutical Co.,Ltd., Japan. Author(s): T. Kanei, Y. Tampo, K. Yasugi, T. Shimoboji, M. Ishigai. VIEW ABSTRACT

583  A Titania Nanotube Membrane for Extended Zero-Order Macromolecule Delivery. Presenter: Kathleen Fischer, Nano Precision Medical, Inc, U.S.A. Author(s): K. E. Fischer, W. G. Fischer, K. H. Degenkolb, A. J. Monkowski, A. D. Mendelsohn. VIEW ABSTRACT

584  Affinity-driven Self-assembled Nanoparticles for the Controlled Delivery of Multiple Growth Factors. Presenter: Emil Ruvinov, Ben-Gurion University of the Negev, Israel. Author(s): E. Ruvinov, I. Freeman, S. Cohen. VIEW ABSTRACT

585  Assessment of Acceptable Subcutaneous Injection Volumes and Flow Rates. Presenter: William Lambert, MedImmune, U.S.A. Author(s): D. Doughty, C. Clawson, W. Lambert. VIEW ABSTRACT

586  Biomimetic hydrogels with dual function peptidesfor modulating angiogenesis and neurogenesis. Presenter: Jaeyeon Lee, Department of Biomedical Engineering, Medical College, Korea University, Korea. Author(s): J. Lee. VIEW ABSTRACT

587  Camouflaged and Thrombin-triggered delivery of tissue plasminogen activator for targeted thrombolysis. Presenter: Shahriar Absar, Texas Tech University Health Sciences Center, U.S.A. Author(s): S. Absar, Y. M. Kwon, F. Ahsan. VIEW ABSTRACT

588  Cell-Penetrating Peptide-Linked Polymers as Carriers for Mucosal Vaccine Delivery. Presenter: Kazuhiro Nishida, Setsunan Univercity, Japan. Author(s): K. Nishida, S. Sakuma, M. Suita, S. Inoue, Y. Marui, Y. Masaoka, M. Kataoka, S. Yamashita, K. Hiwatari, N. Morimoto, S. Koike, E. Tobita, T. Uto, M. Baba. VIEW ABSTRACT

589  Cell-Penetrating Peptides in Oral Delivery Systems for Insulin. Presenter: Ebbe Nielsen, Novo Nordisk A/S, Kobe Gakuin University, Denmark. Author(s): E. Nielsen, S. Yoshida, N. Kamei, U. L. Rahbek, B. L. Pedersen, K. Takayama, M. Takeda-Morishita. VIEW ABSTRACT

590  Cell-penetrating Peptides Targeting Intracellular Infections. Presenter: Jesper Bahnsen, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Author(s): J. S. Bahnsen. VIEW ABSTRACT

591  Controlled Release Mucoadhesive Films Containing Nanoparticles of Lysozyme. Presenter: Jason McConville, University of New Mexico, U.S.A. Author(s): J. O. Morales, J. T. McConville. VIEW ABSTRACT

592  Controlled-release of GDF-5 from fibrous scaffold for enhanced hASCs-based bone regeneration. Presenter: Jung Eun Shin, Ewha Womans University, South Korea. Author(s): J. Shin, I. Shim, H. Kyoung, D. Kim, H. Chung, S. Lee. VIEW ABSTRACT

594  Delivery of the latent tuberculosis antigen Hybrid56 in a liposome delivery system. Does liposome surface charge have an effect on immune response? Presenter: Yvonne Perrie, Aston University, United Kingdom. Author(s): Y. Perrie, A. Wilkinson, R. Kaur, D. Christensen, A. Mohammed. VIEW ABSTRACT

596  Development of A Novel Cell-penetrating Peptide for Intracellular Delivery of Proteins and Loposomes. Presenter: Toshinori Sato, Keio University, Japan. Author(s): T. Sato, R. Ohtani, T. Kimura, T. Matsubara. VIEW ABSTRACT

597  Development of Dendritic Cell-Targeted Peptide Vaccine Against Melanoma by Ligand-Modified Nanoparticles. Presenter: Joana Silva, Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty of Pharmacy, University of Lisbon, Portugal & LDRI - Louvain Drug Research Institute, Faculté de Pharmacie, Université Catholique de Louvain, Brussels, Belgium, Portugal. Author(s): J. M. Silva, G. Vandermeulen, V. Oliveira, S. Pinto, M. Videira, L. Graça, H. F. Florindo. VIEW ABSTRACT

598  Development of enzyme-loaded PICsomes for enzyme/prodrug therapy. Presenter: Yasutaka Anraku, Graduate School of Engineering, The University of Tokyo, Japan. Author(s): Y. Anraku, A. Kishimura, M. Kamiya, S. Tanaka, T. Nomoto, K. Tou, Y. Matsumoto, M. Kano, Y. Urano, N. Nishiyama, K. Kataoka. VIEW ABSTRACT

599  Development of multivalent pro-apoptotic peptide-based polymers for treatment of glioblastoma multiforme. Presenter: David Chu, University of Washington, U.S.A. Author(s): D. S. Chu, M. J. Bocek, R. C. Rostomily, S. H. Pun. VIEW ABSTRACT

601  Effect of Sec61 β gene on the tight junction barrier function in MDCK cells. Presenter: Makiko Washiyama, Showa Pharmaceutical University, Japan. Author(s): M. Washiyama, N. Koizumi, M. Fujii, Y. Watanabe. VIEW ABSTRACT

602  Efficacy and pharmacokinetics of insulin delivered to pigs by phase transition micro needle transdermal patch. Presenter: Tuo Jin, Shanghai Jiao Tong University, Prc Peoples Rep of China. Author(s): S. Yang, Y. Feng, X. Hong, W. Yuan, T. Jin. VIEW ABSTRACT

603  Efficient intracellular delivery of various proteins using silica nanoparticles possessing large pores. Presenter: Hee-Kyung Na, Korea Advanced Institute of Science and Technology, Korea. Author(s): H. Na. VIEW ABSTRACT

604  Electrostatic and Hydrophobic Dual-binding Interaction Inclusion Nano-complex for Controlled Release of Insulin from Poly(lactide-co-glycolide) Microsphere. Presenter: Kun Na, Department of Biotechnology, The Catholic University of Korea, South Korea. Author(s): W. Park, C. Kim, K. Na. VIEW ABSTRACT

605  Enhanced Antitumor Activity of Proteasome Inhibitor MG132-loaded Polymeric Micelle Drug Carriers. Presenter: Yoko Matsumoto, Department of Gynecology, The University of Tokyo Hospital, Japan. Author(s): Y. Matsumoto, Y. Miyamoto, K. Nagasaka, Y. Matsumoto, H. Cabral, H. Nishida, J. R. Christie, K. Kawana, T. Fujii, N. Nishiyama, K. Kataoka. VIEW ABSTRACT

606  Evaluation of a novel breast cancer-related protein, Eph receptor A10 for targeting therapy. Presenter: Kazuya Nagano, Laboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation, Japan. Author(s): K. Nagano, Y. Maeda, S. Kanasaki, T. Yamashita, M. Inoue, K. Higashisaka, Y. Yoshioka, Y. Abe, Y. Mukai, H. Kamada, Y. Tsutsumi, S. Tsunoda. VIEW ABSTRACT

609  Formulation and Evaluation of Hybrid Onconase Nanoparticles for treatment of Mesothelioma. Presenter: Rakesh Tekade, University of Hawaii, U.S.A. Author(s): R. K. Tekade, H. Yang, M. B. Chougule. VIEW ABSTRACT

610  Formulation and in vitro release characteristics of poly(D,L-lactide-co-glycolide) micro- and nanoparticles for intravitreal delivery of connexin43 mimetic peptide. Presenter: Ying-Shan (Erica) Chen, Department of Ophthalmology, The University of Auckland, New Zealand. Author(s): Y. Chen, C. R. Green, I. D. Rupenthal. VIEW ABSTRACT

611  Gelatin-Based Controlled Release System for Long-Term Delivery of Proteins. Presenter: Lucas Ahrens, University of Freiburg, Germany. Author(s): L. A. Ahrens, A. Runkle, J. H. Christensen, D. Vonwil, V. Shastri. VIEW ABSTRACT

612  Improvement of Transdermal Delivery of Insulin Using Novel Microneedle Arrays Fabricated from Hyaluronic acid. Presenter: Akira Yamamoto, Kyoto Pharmaceutical University, Japan. Author(s): A. Yamamoto, S. Liu, M. Jin, Y. Quan, F. Kamiyama, H. Katsumi, T. Sakane. VIEW ABSTRACT

613  In Vitro Studies on the Release of Lysozyme from Solid Lipid Microparticles in a Biorelevant Medium. Presenter: Huiling Mu, University of Copenhagen, Denmark. Author(s): P. C. Christophersen, H. M. Nielsen, M. Yang, A. Müllertz, H. Mu. VIEW ABSTRACT

614  In vivo assessment of Melanoma Peptide Vaccine Formulations. Presenter: Sarah Hook, School of Pharmacy, University of Otago, New Zealand. Author(s): S. Hook. VIEW ABSTRACT

615  Interaction of recombinant Human Growth Hormone with Albumin-coated Nanoparticles. Presenter: Snehal Atwe, University of the Sciences in Philadelphia, U.S.A. Author(s): S. Atwe, P. Gupta. VIEW ABSTRACT

616  Intracellular delivery of native proteins using polymeric nano-particulate carriers formed by phase-guided assembly. Presenter: Tuo Jin, Shanghai Jiaotong University, Prc Peoples Rep of China. Author(s): D. Xu, E. W. Yuan, F. Wu, T. Jin. VIEW ABSTRACT

617  Investigation of Vaccine Adjuvant Activity of Liposomes containing Phophatidylinositol Dimannosides and Analogues. Presenter: Sarah Hook, School of Pharmacy, University of Otago, New Zealand. Author(s): S. Hook. VIEW ABSTRACT

619  Liver cell specific targeting by PreS1 peptide-carrying nanocages. Presenter: Masaharu Murata, Innovation Center for Medical Redox Navigation, Kyushu University, Japan. Author(s): M. Murata, S. Narahara, R. Toita, J. Piao, M. Hashizume. VIEW ABSTRACT

620  Loading of an antimicrobial peptide into PLGA nanoparticles increases its efficacy against intracellular Staphylococcus aureus infection in the Calu-3 bronchial epithelial cell line. Presenter: Jorrit Water, University of Copenhagen, Denmark. Author(s): J. J. Water. VIEW ABSTRACT

621  Local antitumor effects of intratumoral delivery of rIL-2 by sustained-release PLGA/PLA microspheres. Presenter: Weien Yuan, School of Pharmacy, Shanghai Jiao Tong University, Prc Peoples Rep of China. Author(s): W. Yuan, T. Jin. VIEW ABSTRACT

623  Low Molecular Weight Methylcellulose-Based Injectable Hydrogel for Protein Drug Delivery. Presenter: Yong-Hee Kim, Hanyang Univ, Korea. Author(s): J. Kim, K. Lim, C. Yoo, J. Chae, S. Kim, Y. Kim. VIEW ABSTRACT

625  Migration of dendritic cells and induction of antigen-specific immunity by γ-PGA nanoparticles. Presenter: Takami Akagi, Osaka University, Japan. Author(s): T. Uto, M. Toyama, Y. Nishi, T. Akagi, F. Shima, M. Akashi, M. Baba. VIEW ABSTRACT

626  MK2 Inhibitory Peptide Delivery with Endosomolytic Nano-Polyplexes Prevents Vasoconstriction and Intimal Hyperplasia in Human Saphenous Vein Bypass Grafts. Presenter: Craig Duvall, Vanderbilt University, U.S.A. Author(s): B. C. Evans, K. M. Hocking, C. M. Brophy, C. L. Duvall. VIEW ABSTRACT

627  Modification of Macrophage Function through Pioglitazone Release with Biodegradable Hydrogels. Presenter: Yasuhiko Tabata, Department of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University, Japan. Author(s): Sato, T. Saito, Y. Tabata. VIEW ABSTRACT

628  Molecular Dynamics Study of 20 kDa PEG Reagents with Different Arquitectures. Presenter: Sheiliza Carmali, UCL School of Pharmacy, United Kingdom. Author(s): S. Carmali, T. S. Barata, A. Godwin, S. Brocchini, M. Zloh. VIEW ABSTRACT

630  Neovascularization and Control of Foreign Body Response via Programmed Delivery from A Microsphere/Hydrogel Composite. Presenter: Jie Shen, University of Connecticut, U.S.A. Author(s): J. Shen, F. Papadimitrakopoulos, D. J. Burgess. VIEW ABSTRACT

631  Neurotrophic Factor Gradient Delivery for Migration Guidance of Schwann Cells and Regenerating Axons. Presenter: Kellin Krick, Johns Hopkins University, U.S.A. Author(s): K. Krick, Y. Huang, P. Searson, A. Khademhosseini, A. Hoke, H. Mao. VIEW ABSTRACT

632  Novel Silicone Composite for Prolonged Release of Antimicrobial Peptides. Presenter: Søren Steffensen, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Author(s): S. L. Steffensen, E. H. Møller, M. G. Jensen, M. Alm, H. Franzyk, H. M. Nielsen. VIEW ABSTRACT

633  Oligoarginine-modified Biodegradable Nanoparticles: A Novel Delivery Carrier for Oral Administration of Insulin. Presenter: Gang Wei, Fudan University, Prc Peoples Rep of China. Author(s): G. Wei. VIEW ABSTRACT

634  One-pot Multiple Enzyme Reaction for the Glycosylation of Leu-Enkephalins; CNS Drug Delivery. Presenter: Pavla Simerska, The University of Queensland, School of Chemistry and Molecular Biosciences, St. Lucia 4072, Queensland, Australia, Australia. Author(s): P. Simerska, I. Toth. VIEW ABSTRACT

635  Optimization of a Glucose-Responsive Implant Microdevice for 'Smart'™ Insulin Therapy. Presenter: Michael Chu, University of Toronto, Canada. Author(s): M. K. Chu, C. R. Gordijo, A. Z. Abbasi, J. S. Li, X. Y. Wu. VIEW ABSTRACT

636  Optimization of Sustained-release Delivery of protein-dextran particle composite PLGA fibers bydifferent electrospinning methods. Presenter: Fei Wu, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China, Prc Peoples Rep of China. Author(s): F. Wu, Y. Liu, T. Jin. VIEW ABSTRACT

638  PLGA microspheres for sustained-release delivery of erythropoietin of native form to rhesus monkey, efficacy, pharmacokinetics, and immunogenicity. Presenter: Zhenhua Hu, Shanghai Jiao Tong University, Prc Peoples Rep of China. Author(s): Z. Hu, W. Yuan, F. Wu, T. Jin. VIEW ABSTRACT

639  Polymeric micelle functionality assessment using mPEG (2K)-DSPE for poorly soluble peptides. Presenter: Farooq Qureshi, Hoffmann-La Roche Inc., U.S.A. Author(s): F. Z. Qureshi, F. Aberg, A. Galasso, F. Macri, H. Michel, V. Roongta. VIEW ABSTRACT

640  Potential of Site-specific PEGylated Exendin-4 Modified with a High-molecular Weight Trimeric Polyethylene Glycol for Effective Type 2 Anti-diabetic Therapy. Presenter: Sung Mook Lim, SungKyunKwan University, Korea. Author(s): S. Lim, H. Eom, Y. Jang, H. Jiang, K. Lee. VIEW ABSTRACT

641  Potential Pharmaceutical Applications of Uniform-sized Chitosan Micro/Nanoparticles with Autofluorescent Property. Presenter: Wei Wei, National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Prc Peoples Rep of China. Author(s): W. Wei, P. Lv, G. Ma. VIEW ABSTRACT

644  Preparation of PEGylated Exendin-4-loaded PLGA Microspheres for Enhanced Stability and Anti-diabetic Activity. Presenter: Ha Na Eom, SungKyunKwan University, Korea. Author(s): H. Eom, H. Jiang, S. Lim, K. Lee. VIEW ABSTRACT

645  Preparation, characterization and in vitro studies of chitosan nanoparticles containing Androctonus Crassicauda scorpion venom. Presenter: Assal Sadeghi, Hakim Pharmaceutical Company, P.O. Box 11365-5465, Tehran, Iran, Iran. Author(s): A. M. M. Sadeghi, M. Avadi. VIEW ABSTRACT

646  Protein-excipient interaction hotspots - Fab case study. Presenter: Teresa Barata, ERSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies, UCL, United Kingdom. Author(s): T. S. Barata, P. Dalby, S. Brocchini, M. Zloh. VIEW ABSTRACT

647  Recombinant Human Hyaluronidase PH20 (rHuPH20) Facilitates Subcutaneous Dispersion and Systemic Absorption of Therapeutic Proteins in Non-Clinical Models. Presenter: David Kang, Halozyme Therapeutics, Inc., U.S.A. Author(s): D. W. Kang, T. A. Nekoroski, M. A. Printz, C. K. Hoh, D. R. Vera, J. F. Skipper, A. V. Radi, C. B. Thompson, M. L. Zepeda, D. C. Maneval. VIEW ABSTRACT

648  Safe and Efficacious Therapeutic Peptide Delivery Using Nano Emulsion. Presenter: Yashwant Pathak, University of South Florida, U.S.A. Author(s): Y. Pathak, R. Andruski, X. Lin, C. Cao. VIEW ABSTRACT

649  Screening of an injectable formulation of stapled peptide RO6836101 for oncology preclinical study. Presenter: Farooq Qureshi, Hoffmann-La Roche Inc., U.S.A. Author(s): F. Z. Qureshi, H. Michel, Q. Hu, F. Aberg, A. Galasso, K. Packman, P. Goelzer, H. Zeng, Z. Filipovic. VIEW ABSTRACT

651  Strategies for Protein Drug Encapsulation in Biodegradable Polymer: Size Control and Prevention of Protein Denaturation. Presenter: Guanghui Ma, State Key Laboratory of Bio-chemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Prc Peoples Rep of China. Author(s): G. Ma, Z. Su, Y. Wei, Y. Wang. VIEW ABSTRACT

652  Sustained Release of Protein Loaded in a Biodegradable Polymeric Scaffolds for Growth Plate Regeneration. Presenter: Amanda Clark, University of Kentucky , U.S.A. Author(s): A. Clark, T. Milbrandt, J. Hilt, D. Puleo. VIEW ABSTRACT

653  Synergistic Anti-tumor Effects of PEGylated TRAIL and Docetaxel Combination Therapy. Presenter: Yejin Jang, SungkyunKwan University, Korea. Author(s): Y. Jang, S. Lim, H. Jiang, K. Lee. VIEW ABSTRACT

654  Synthesis and Biological Activity of Self-adjuvanting Peptide-based Therapeutic Vaccin Against Cervical Cancer. Presenter: Tzu-Yu Liu, The University of Queensland, School of Chemistry and Molecular Biosciences, Australia. Author(s): T. Liu, W. M. Hussein, Z. Jia, S. Chandrudu, N. A. McMillan, M. J. Monteiro, I. Toth, M. Skwarczynski. VIEW ABSTRACT

655  Synthesis of Lipid LHRH Peptides for Targeted Drug Delivery. Presenter: Rachel Stephenson, The University of Queensland, Australia. Author(s): R. J. Stephenson, I. Toth. VIEW ABSTRACT

656  Synthetic nanofibrils mimicking proteoglycan. Presenter: Hye Sung Kim, Kangwon National University, South Korea. Author(s): H. Kim. VIEW ABSTRACT

657  The cell penetrating ability of the proapoptotic peptide, KLA fused to the N-terminal protein transduction domain of translationally controlled tumor protein (TCTP). Presenter: Hyo Young Kim, Ewha Womans University, Korea. Author(s): H. Kim. VIEW ABSTRACT

658  The Global Gene-Expression Profiles of U-937 Human Macrophages Treated with Tat Peptide and Tat-FITC Conjugate. Presenter: Jung-hua Kuo, Department of Pharmacy, Chia Nan University of Pharmacy and Science, Taiwan. Author(s): J. Kuo, M. Jan, C. Lin. VIEW ABSTRACT

659  The preparation of Multivesicular liposome formulation of deca-peptide(TKII-10) with sustained rellease characteristics. Presenter: Xiang Liu, School of Pharmacy, Zhejiang Univerisity, Prc Peoples Rep of China. Author(s): X. Liu. VIEW ABSTRACT

661  Thermoresponsive Self-Assembled Tropoelastin Nano/Micro-Particles for Protein Delivery. Presenter: Young Chan Choi, Hanyang University, South Korea. Author(s): Y. Choi, J. Kim, H. Yoon, E. Kim, J. Choi, Y. Cho. VIEW ABSTRACT

662  Tissue Engineering Fibers with Bead-like Junctions for Sustained Release of Proteins in Native Form. Presenter: Fei Wu, School of Pharmacy, Shanghai Jiao Tong University, Prc Peoples Rep of China. Author(s): F. Wu, T. Jin. VIEW ABSTRACT

663  Tunable hydrogels for differentiation of tissue progenitors using nanoparticles. Presenter: Edmund Carvalho, IITB Monash research academy, India. Author(s): E. J. Carvalho, P. Verma, K. Hourigan, R. Banerjee. VIEW ABSTRACT

664  VEGF-Fc delivery scaffold for promoting angiogenesis in biomaterials. Presenter: Jun Yang, The key laboratory of bioactive materials ministry of education, Nankai University, Prc Peoples Rep of China. Author(s): J. Yang. VIEW ABSTRACT

Personal and Home Care     [RETURN TO TOP]

665  Bioactive-based Polymers: Applications for Skin Care. Presenter: Kathryn Uhrich, Rutgers University, U.S.A. Author(s): K. E. Uhrich, M. A. Ouimet. VIEW ABSTRACT

666  Development of Novel Formulation Excipients for Oral Hygienic Products. Presenter: Hongjiang Yuan, University of Nebraska Medical Center, U.S.A. Author(s): F. Chen, H. Yuan, Z. Jia, K. C. Rice, R. A. Reinhardt, D. Wang. VIEW ABSTRACT

669  Preserved Argan oil-loaded NLC Concentrates for Industrial Production of NLC Cosmetics. Presenter: Cornelia Keck, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Free University, Kelchstr. 31,12169,Berlin, Germany, Germany. Author(s): X. Hu, C. Keck, R. Müller. VIEW ABSTRACT

672  The Effects of Treatment Conditions on Hair Wettability and Energetic Heterogeneity. Presenter: Daniel Burnett, Surface Measurement Systems, Ltd., U.S.A. Author(s): D. J. Burnett, A. R. Garcia, M. Acharya, M. Naderi. VIEW ABSTRACT

Processing Technology/Manufacturability     [RETURN TO TOP]

673  A Design of Experiment Study Applied to a New Nano Spray Drying Technic and Nanoprecipitation for Producing PLGA Drug Delivery Systems with Defined Sizes and Size Distributions. Presenter: Christina Draheim, Helmholtz-Institute for Pharm. Res. Saarland (HIPS), Helmholtz Ctr for Infection Research (HZI); Biopharmaceutics and Pharm Technology, Saarland University, 66123 Saarbruecken, Germany, Germany. Author(s): C. Draheim, F. de Crécy, S. Hansen, E. Collnot, C. Lehr. VIEW ABSTRACT

674  A novel, scalable, isothermal method for nano-emulsion formation. Presenter: Srikanth Kakumanu, Covaris Incoporated, U.S.A. Author(s): S. Kakumanu, M. Schmitt, X. He, C. Beckett, J. Laugharn. VIEW ABSTRACT

675  ARTcrystals® – Nanocrystal Production & Physical Long-TermStability. Presenter: Rainer Müller, Free University of Berlin, Germany. Author(s): R. H. Müller, R. Chen, C. M. Keck. VIEW ABSTRACT

676  Contact-free encapsulation of proteins in PLGA nanoparticles by focused ultrasound. Presenter: Claus-Michael Lehr, Helmholtz Institute for Pharmaceutical Research Saarland / Saarland University, Germany. Author(s): S. Schiller, A. Hanefeld, M. Schneider, M. Weigandt, C. Lehr. VIEW ABSTRACT

677  Controlled Synthesis of Limit Size cationic Lipid Nanoparticles by Microfluidic Mixing. Presenter: Yvonne Perrie, Aston University Birmingham, United Kingdom. Author(s): E. Kastner, R. Kaur, A. Wilkinson, Y. Perrie. VIEW ABSTRACT

678  Design, Development and Optimization of a Pilot Scale Multi-Source Clobetasol 17-Propionate (CP) Cream. Presenter: Roderick Walker, Rhodes University, Rep of South Africa. Author(s): R. B. Walker, A. F. Fauzee. VIEW ABSTRACT

679  Effect of Drug Concentration and Processing Temperature on Extrudability and Miscibility of Solid Dispersions by Hot Melt Extrusion. Presenter: Simerdeep Singh Gupta, St. John's University, NY, U.S.A. Author(s): S. Gupta, A. Serajuddin, T. Parikh, A. Meena. VIEW ABSTRACT

681  Impact of PLGA Conformational Behavior in the Feed Solution on the Drug Release Kinetics of Spray-dried Microparticles. Presenter: Feng Wan, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Author(s): F. Wan. VIEW ABSTRACT

682  Optimization of Platelet-Rich Plasma and Its Effects for the Recovery of Erectile Function after Bilateral Cavernous Nerve Injury in Rat Model. Presenter: Ming-Thau Sheu, Taipei Medical University, Taiwan. Author(s): M. Sheu, Y. Wu, C. Wu, Chiang, H. Ho. VIEW ABSTRACT

683  Preparation of Taste Mask MUPS (multiple unit particles system) ODT. Presenter: Naoya Yoshida, ASAHI KASEI CHEMICALS CORPORATION, Japan. Author(s): N. Yoshida. VIEW ABSTRACT

684  Process Optimization of A Level Sensor Controlled Vibratory Feeder to Manufacture below 1% Weight Variation Mini-Tabs. Presenter: Fei Cai, Prinston Pharmaceutical Inc, U.S.A. Author(s): F. Cai, D. Barbieri, J. Vaughn. VIEW ABSTRACT

687  Recrystallization of amorphous glibenclamide in tablets -- a multifactorial approach. Presenter: Marten Klukkert, Univ of Hamburg, Germany. Author(s): S. Rehder, T. Rades, C. S. Leopold, M. Klukkert. VIEW ABSTRACT

688  Simulation based coaxial electrohydrodynamic atomization process for production of polymeric double-walled microspheres. Presenter: Chi-Hwa Wang, National University of Singapore, Singapore. Author(s): Q. Xu, H. Qin, Z. Yin, D. W. Pack, C. Wang. VIEW ABSTRACT

689  Use of Surface Energy and Powder Flow Measurements to Investigate the Cohesive Nature of Surface Modified Mannitol. Presenter: Daniel Burnett, Surface Measurement Systems, Ltd., U.S.A. Author(s): D. J. Burnett, M. Naderi, M. Acharya, T. Freeman. VIEW ABSTRACT

Regional Delivery: Challenges in Ocular Delivery and Pulmonary Delivery     [RETURN TO TOP]

690  Aquasomes as Pulmonary Drug Delivery Systems. Presenter: Deborah Lowry, Aston University, United Kingdom. Author(s): F. A. Abdulrazzaq, D. Lowry, Y. Perrie. VIEW ABSTRACT

691  Characterization of Complexes of Two Fluorphores with Polymeric Micelles on Cornea Transport by Fluorescence Resonance Energy Transfer. Presenter: Jia-Horng Liaw, School of Pharmacy, Taipei Medical University, Taiwan. Author(s): F. Hsaio, J. Liaw. VIEW ABSTRACT

694  Intratracheal Gene Delivery into the Mouse Model of Cystic Fibrosis Using B-H Polyplex. Presenter: Mariko Harada-Shiba, National Cerebral and Cardiovascular Center Research Institute, Japan. Author(s): M. Harada-Shiba, E. Shibata, M. Shibata, M. Morimoto, S. Wada, F. Wada, K. Itaka, N. Nishiyama, K. Miyata, T. Ishii, K. Kataoka. VIEW ABSTRACT

695  Micron-sized Spherical Agglomerates of Pure Drug Nanoparticles for Improved Pulmonary Delivery. Presenter: Jun Hu, Institute of Chemical and Engineering Sciences, 1 Pesek Road, Jurong Island, 627833, Singapore, Singapore. Author(s): J. Hu, Y. Dong, G. Pastorin, W. Ng, R. Tan. VIEW ABSTRACT

696  Mucosal-Penetrating Particles Enable Topical Delivery to Posterior Segment of the Eye. Presenter: Elizabeth Enlow, Kala Pharmaceuticals, U.S.A. Author(s): A. Popov, E. Enlow, J. Bourassa, L. Schopf, H. Chen. VIEW ABSTRACT

697  Nanocarriers for Ocular Drug Delivery- the importance of drug loading. Presenter: Subbu Venkatraman, Nanyang Technological University, Singapore. Author(s): S. Venkatraman. VIEW ABSTRACT

698  NanoCluster Budesonide Combined with Novel Devices Optimize Drug Delivery in Mechanical Ventilation. Presenter: Warangkana Pornputtapitak, The University of Kansas, U.S.A. Author(s): W. Pornputtapitak, N. A. El-Gendy, C. Uyemura, C. J. Berkland. VIEW ABSTRACT

699  New HPLC method for quantification of 2-oxothiazolidine-4-carboxylic acid permeated through excised bovine sclera. Presenter: Ali Al-Kinani, School of Pharmacy and Chemistry, Kingston University London, United Kingdom. Author(s): A. A. Al-Kinani, G. Calabrese, D. P. Naughton, B. K. Pierscionek, A. Vangala, R. G. Alany. VIEW ABSTRACT

701  Novel PEG-PLA/PLGA microparticles having porous surfaces for pulmonary drug delivery. Presenter: Taku Takami, Tokyo University of Agriculture and Technology, Japan. Author(s): T. Takami, Y. Murakami. VIEW ABSTRACT

702  Optimized Solid Lipid Nanoparticles for Pulmonary Application. Presenter: Noha Nafee, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt, Egypt. Author(s): S. O. Makled, N. A. Nafee, N. A. Boraie. VIEW ABSTRACT

704  Prolonged drug release from in situ formulated inverted hexagonal type liquid chrystalline systems of selachyl alcohol: designing injectable drug carriers. Presenter: Mechthild Burmester, University of Helsinki, Centre for Drug Research, Division of Biopharmaceutics, Finland. Author(s): M. Burmester. VIEW ABSTRACT

705  Quo vadis dissolution testing for inhalation powders? Presenter: Sabine May, PharmBio Tec GmbH, Germany. Author(s): S. May, B. Jensen, C. Weiler, M. Wolkenhauer, M. Schneider, C. Lehr. VIEW ABSTRACT

707  Shifting Paradigms in Pulmonary Drug Delivery: From Aerosols to Biological Barriers. Presenter: Claus-Michael Lehr, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany. Author(s): C. Lehr, C. Ruge, J. Kirch, N. Daum, M. Schneider, U. F. Schäfer. VIEW ABSTRACT

708  Solid lipid nanoparticles improved the targeted delivery of phosphodiesterase 5 inhibitor for the treatment of pulmonary hypertension. Presenter: Noha Nafee, Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt, Egypt. Author(s): S. O. Makled, N. A. Nafee, N. A. Boraie. VIEW ABSTRACT

Rising Suns in Asia     [RETURN TO TOP]

710  Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles. Presenter: Yeu-Chun Kim, Korea Advanced Institute of Science and Technology (KAIST), South Korea. Author(s): Y. Kim, D. Yoo, R. Compans, S. Kang, M. Prausnitz. VIEW ABSTRACT

711  Preparation of a water soluble carbon monoxide donor, SMA-CORM2 micelles, and therapeutic potential for inflammatory bowel diseases. Presenter: Jun Fang, DDS Research Institute, Sojo University, Japan. Author(s): J. Fang, H. Qin, H. Yin, H. Nakamura, H. Maeda. VIEW ABSTRACT

RNAi and DNA Delivery     [RETURN TO TOP]

712  A neutral envelope-type nanoparticle containing pH-responsive and SS-cleavable lipid-like materials as a carrier for plasmid DNA. Presenter: Hidetaka Akita, Hokkaido University, Japan. Author(s): H. Akita, R. Ishiba, H. Hatakeyama, H. Tanaka, Y. Sato, K. Tange, M. Arai, K. Kubo, H. Harashima. VIEW ABSTRACT

713  A new approach for innovative nanomedicine of type 2 diabetes in combination with DNA microarray and in vivo siRNA delivery. Presenter: Erina Suemitsu, Hokkaido University, Japan. Author(s): E. Suemitsu, Y. Hayashi, K. Kajimoto, Y. Sato, A. Akhter, Y. Sakurai, H. Hatakeyama, M. Hyodo, H. Harashima. VIEW ABSTRACT

714  A Novel Targeted siRNA-Nanomedicine for Liver Fibrosis. Presenter: Fatima Khaja, University of Illinois at Chicago, U.S.A. Author(s): F. Khaja, A. Kuzmis, H. Onyuksel. VIEW ABSTRACT

715  Acid-Degradable Cationic Poly(ketal amidoamine) for Enhanced RNA Interference In Vitro and In Vivo. Presenter: Dongwon Lee, Chonbuk National University, South Korea. Author(s): J. Noh, S. Park, D. Joung, E. Ko, J. Kim, D. Lee. VIEW ABSTRACT

716  An Aircraft Carrier Model for Long-term Gene Therapy. Presenter: Young-Min Kim, Korea Institute of Science and Technology / University of Science and Technology , Korea. Author(s): Y. Kim, J. Kim, C. Chun, S. Song. VIEW ABSTRACT

717  An approach to mitochondrial genesilencing by the mitochondrial delivery of anti-sense RNA. Presenter: Yuma Yamada, Hokkaido University, Japan. Author(s): Y. Yamada, R. Furukawa, E. Kawamura, H. Harashima. VIEW ABSTRACT

718  Analysis of antitumor effect of human papillomavirus E6 siRNA-loaded polymeric micelles on human cervical cancer. Presenter: Haruka Nishida, The University of Tokyo, Department of Medicine, Gynecology, Japan. Author(s): H. Nishida, Y. Matsumoto, J. R. Christie, K. Kawana, K. Miyata, N. Nishiyama, T. Fujii, K. Kataoka. VIEW ABSTRACT

719  Analysis of PEI transfection by subcellular fractionation and radiolabeling reveals surprising differences between the intracellular trafficking of DNA and PEI. Presenter: Julie Shi, University of Washington, U.S.A. Author(s): J. Shi, B. Chou, J. L. Choi, A. L. Ta, S. H. Pun. VIEW ABSTRACT

721  Arginine-rich Cell Penetrating Peptide-microRNA Inhibitor Complexes Decrease Glioblastoma Migration Potential. Presenter: Yu Zhang, Department of Biopharmaceutical Sciences, University of Illinois at Chicago, U.S.A. Author(s): Y. Zhang, M. Köllmer, M. Tang, E. A. Ramirez, R. A. Gemeinhart. VIEW ABSTRACT

722  Biodegradable Polymer-SPION Nanocomplex for Gene Delivery and Magnetic Resonance Imaging. Presenter: Chien-Wen Chang, Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Taiwan. Author(s): C. Chang. VIEW ABSTRACT

723  Biodegradable Starch Derivatives as Carriers for pDNA. Presenter: Carolin Thiele, Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Germany. Author(s): C. Thiele, B. Loretz, C. Lehr. VIEW ABSTRACT

724  Bioreducible Poly (β-amino esters)/RNA Complex Nanoparticles Sensitize Drug Resistant Cells. Presenter: Qi Yin, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Prc Peoples Rep of China. Author(s): Q. Yin. VIEW ABSTRACT

725  Brain Specific Gene Delivery by Bubble Liposomes and Ultrasound. Presenter: Yusuke Oda, Faculty of Pharma-Sciences, Teikyo university, Japan. Author(s): Y. Oda, R. Suzuki, D. Omata, Y. Sawaguchi, Y. Negishi, K. Maruyama. VIEW ABSTRACT

726  Branched siRNA nanostructures for enhanced gene silencing. Presenter: Cheol Am Hong, College of Pharmacy, Ewha Womans University, South Korea. Author(s): C. Hong, H. Lee. VIEW ABSTRACT

727  Cationic Liposomes-Mediated Co-delivery of Plasmid DNA and siRNA for a Synergistic Gene Therapy. Presenter: Jeong-Sook Park, Chungnam National University, South Korea. Author(s): J. Park, E. Davaa, J. Kim. VIEW ABSTRACT

728  Cationic Polymethacrylate Nanoparticles downregulate Bfl-1/A1 Gene: Anew approach for intracellular infection. Presenter: Ratnesh Jain, Institute of Chemical Technology (ICT), Matunga, Mumbai 400019 India, India. Author(s): R. Jain, P. Dandekar Jain, Loretz, G. Wenz, C. Lehr. VIEW ABSTRACT

729  Cell Penetrable Nano-Polyplex Assembled Hydrogel for Effective Localized siRNA Delivery. Presenter: Young-Min Kim, Korea Institute of Science and Technology / University of Science and Technology, Korea. Author(s): Y. Kim, M. Park, C. Chun, S. Song. VIEW ABSTRACT

730  Controlled and sustained release of adeno-associated viral vectors from electrospun scaffolds. Presenter: Slgirim Lee, Department of Chemical and Bioengineering, Yonsei University, Korea. Author(s): S. Lee, J. Kim, H. Chu, J. Won, G. Kim, J. Jang. VIEW ABSTRACT

732   CpG delivery using antigen-presenting cell specific carrier polysaccharide for immunotherapy. Presenter: Noriko Miyamoto, The university of Kitakyushu, Japan. Author(s): S. Michizuki, N. Miyamoto, K. Sakurai. VIEW ABSTRACT

733  Cytoplasmic delivery of microRNA by using polycation liposomes. Presenter: Hidenori Ando, Department of Medical Biochemistry, University of Shizuoka Graduate School of Pharmaceutical Sciences , Japan. Author(s): H. Ando, A. Okamoto, M. Yokota, K. Shimizu, T. Asai, T. Dewa, N. Oku. VIEW ABSTRACT

735  Design and Evaluation of PEG-appended Lactosylated Dendrimer/Cyclodextrin Conjugate as a Novel Hepatocyte-selective siRNA Carrier for Familial Amyloidotic Polyneuropathy Therapy. Presenter: Yuya Hayashi, Kumamoto university, Japan. Author(s): Y. Hayashi. VIEW ABSTRACT

736  Development of a pH-sensitive multifunctional envelope-type nano device (MEND) as an efficient nucleic acids delivery system. Presenter: Hiroto Hatakeyama, Hokkaido University, Japan. Author(s): H. Hatakeyama, Y. Sato, Y. Sakurai, H. Harashima. VIEW ABSTRACT

737  Development of antigen presenting cell specific nucleic acid carrier using β-1,3-glucan. Presenter: Shinichi Mochizuki, The University of Kitakyushu, Japan. Author(s): S. Mochizuki, K. Sakurai. VIEW ABSTRACT

738  Development of biocompatible ultrasound-responsive gene delivery carrier, bubble lipopolyplex, for liver gene transfection. Presenter: Tomoaki Kurosaki, Graduate School of Pharmaceutical Sciences, Kyoto University, Japan. Author(s): T. Kurosaki, S. Kawakami, R. Suzuki, K. Maruyama, H. Sasaki, M. Hashida. VIEW ABSTRACT

739  Development of Cancer Gene Therapy with Nano-bubble Assisted Sonoporation. Presenter: Ryo Suzuki, Faculty of Pharma-Scineces, Teikyo University, Japan. Author(s): R. Suzuki, Y. Oda, D. Omata, Y. Sawaguchi, Y. Negishi, K. Maruyama. VIEW ABSTRACT

740  Development of cyanovinylcarbazole mediated photocrosslinking reaction toward for regulation of RNA functions in cell. Presenter: Atsuo Shigeno, Student, Japan. Author(s): A. Shigeno, O. Yuichi, T. Sakamoto, K. Fujimoto. VIEW ABSTRACT

741  Development of gelatin nanocarriers for the targeted delivery of STAT-6 siRNA. Presenter: Susanne Youngren, University of Hawaii at Hilo College of Pharmacy, U.S.A. Author(s): S. R. Youngren, R. K. Tekade, M. B. Chougule. VIEW ABSTRACT

742  Development of novel multifunctional pH-sensitive carrier for efficient siRNA delivery. Presenter: Maneesh Gujrati, Department of Biomedical Engineering, Case Western Reserve University , U.S.A. Author(s): M. Gujrati, A. Malamas, Z. Lu. VIEW ABSTRACT

743  Development of systemic anti-miRNA oligonucleotide (AMO) delivery system to liver. Presenter: Manami Murata, Hokkaido University, Japan. Author(s): M. Murata, H. Hatakeyama, Y. Sato, H. Harashima. VIEW ABSTRACT

744  Dexamethasone-Loaded Polymeric (PLGA)n-b-bPEI Micelles for Effective Gene Delivery. Presenter: Hana Cho, The Catholic University of Korea, Korea. Author(s): H. Cho, D. Mishra, H. Kang, Y. Bae. VIEW ABSTRACT

745  Differentiation of human dermal fibroblast cells transfectedwith genes coated onto PLGA nanoparticles. Presenter: Ji Sun Park, CHA University, Korea. Author(s): J. Park. VIEW ABSTRACT

746  Discovery of Polymers for Plasmid DNA Delivery using Combinatorial Synthesis and Cheminformatics Modeling. Presenter: Kaushal Rege, Arizona State University, U.S.A. Author(s): T. Potta, Z. Zhen, T. Grandhi, C. M. Breneman, K. Rege. VIEW ABSTRACT

747  DNA Nanotechnology for Molecularly Self-assembled Nanoparticles and Their Drug Delivery Applications. Presenter: Hyukjin Lee, Ewha Womans University, Korea. Author(s): H. Lee. VIEW ABSTRACT

748  Dual Specific Suicide Gene Expression Plasmid Delivery Using Bio-Reducible Polymer for Gene Therapy of Liver Cancer. Presenter: Hyun Ah Kim, University of Utah, U.S.A. Author(s): H. Kim, M. Lee, K. Nam, S. Kim. VIEW ABSTRACT

749  Dual therapy of anti-apoptotic siRNA and angiogenesis-inducible plasmid in a single carrier incorporating facially amphipathic cationic polymer for treatment of ischemic heart disease. Presenter: Dongkyu Kim, Korea Institute of Science and Technology, Korea. Author(s): D. Kim, D. Lee, D. Choi, S. Kim. VIEW ABSTRACT

750  Dual-function Polymeric CXCR4 Antagonist to Simultaneously Inhibit Cell Invasion and Deliver Gene Therapy. Presenter: Jing Li, University of Nebraska Medical Center, U.S.A. Author(s): J. Li, D. Oupicky. VIEW ABSTRACT

752  Effect of Supramolecular Structure of Cytocleavable Cationic Polyrotaxanes in Intracellular Uptake and Gene Silencing of siRNA. Presenter: Atsushi Tamura, Tokyo Medical and Dental University, Japan. Author(s): A. Tamura, N. Yui. VIEW ABSTRACT

753  Efficient cytoplasmic delivery of siRNA by tumoral pH sensitive nanoparticles via membrane fusion under tumor microenvironment. Presenter: Shoko Itakura, Department of Biophysucal Chemistry, Kyoto Pharmaceutical University, Japan. Author(s): S. Itakura, S. Hama, M. Nakai, K. Nakayama, S. Morimoto, H. Tsuchiya, K. Kogure. VIEW ABSTRACT

754  Enhanced Adenoviral Transduction and Ablation of Resistant Bladder Cancer Cells using novel Poly(aminoethers). Presenter: Kaushal Rege, Chemical Engineering, Arizona State University, Tempe, AZ 85287-6106, U.S.A. Author(s): H. Gosnell, L. Kasman, T. Potta, L. Vu, E. Garrett-Mayer, C. Voelkel-Johnson, K. Rege. VIEW ABSTRACT

755  Enhanced blood circulation of siRNA complexed with PEG-block-poly(L-lysine) for cancer treatment. Presenter: Sumiyo Watanabe, The University of Tokyo, Japan. Author(s): S. Watanabe, H. Chaya, K. Miyata, T. Nomoto, S. Fukushima, K. Toh, H. Takemoto, X. Liu, Y. Matsumoto, S. Uchida, M. Nangaku, K. Osada, N. Nishiyama, K. Kataoka. VIEW ABSTRACT

756  Enhanced local delivery of siRNA to the vaginal tract of mice using elongate microparticles. Presenter: Anthony Raphael, Dermatology Research Centre, School of Medicine, University of Queensland, Princess Alexandra Hospital, Translational Research Institute, Australia. Author(s): A. P. Raphael, E. Payne, H. Soyer, N. A. McMillan, T. W. Prow. VIEW ABSTRACT

757  Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery. Presenter: Haifa Shen, The Methodist Hospital Research Institute, U.S.A. Author(s): H. Shen. VIEW ABSTRACT

758  Evaluation of generations 0 and 1 dendrimer conjugated bio-reducible polymer (PAM-ABP) for efficient gene delivery. Presenter: Kihoon Nam, University of Utah, U.S.A. Author(s): K. Nam, S. Kim. VIEW ABSTRACT

760  Gene Delivery Using Lipid-like Material Composed of Fat Soluble Vitamin. Presenter: Hiroki Tanaka, Hokkaido University, Japan. Author(s): H. Tanaka, H. Akita, H. Hrashima. VIEW ABSTRACT

761  Graphene Oxide Mediated Delivery of DNAzyme for Simultaneous Detection and Knockdown of Viral Gene. Presenter: Seongchan Kim, Seoul National University, South Korea. Author(s): S. Kim. VIEW ABSTRACT

762  Histidine enhances transfection efficiency in vitro and ex vivo of poly(amidoamine)s polyplexes for intradermal DNA tattoo vaccination. Presenter: Iris van der Heijden, Department of Pharmacy & Pharmacology, Slotervaart Hospital, Netherlands. Author(s): I. van der Heijden, M. de Raad, W. E. Hennink, J. F. Engbersen, J. B. Haanen, J. H. Beijnen, B. Nuijen. VIEW ABSTRACT

763  Hybrid hydrogel/silica platform for intracellular delivery of small interfering RNA. Presenter: Ennio Tasciotti, The Methodist Hospital Research Institute, U.S.A. Author(s): A. Cevenini, A. Parodi, I. K. Yazdi, S. G. Haddix, S. Z. Khaled, E. Tasciotti. VIEW ABSTRACT

764  Hydrodynamic IGF-1 Gene Introduction Using Polyplex Nanomicelle for Treatment of Peripheral Nerve Injury. Presenter: Kazuya Nagata, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo, 113-0033, Japan, Japan. Author(s): K. Nagata, K. Itaka, T. Ishii, K. Kataoka. VIEW ABSTRACT

765  Hydrophobic grafting enhances low molecular polyethylenimine's delivery of plasmid DNA into mammalian cells. Presenter: Shan Liu, Chinese Academy of Medical Sciences & Peking Union Medical College, Prc Peoples Rep of China. Author(s): S. Liu, F. Yang, Q. Wang, W. Huang, M. Jin, Z. Gao. VIEW ABSTRACT

767  Improvement of mitochondrial targeting activity of MITO-Porter using functional peptides. Presenter: Eriko Kawamura, Faculty of Pharmaceutical Sciences, Hokkaido University, Japan. Author(s): E. Kawamura. VIEW ABSTRACT

768  In situ gelling formulation for localized and sustained delivery of siRNA. Presenter: Livia Borgheti-Cardoso, University of Sao Paulo, Brazil. Author(s): L. N. Borgheti-Cardoso, L. V. Depieri, F. T. Vicentini, M. C. Fantini, M. L. Bentley. VIEW ABSTRACT

769  In vitro Characterization of a Lipidic Delivery System for Anti-angiogenic siRNA. Presenter: Afrouz Yousefi, Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands, Netherlands. Author(s): A. Yousefi, N. Babae, J. van Beijnum, A. Griffioen, P. van Noort, R. Schaapveld, G. Storm, R. Schiffelers, E. Mastrobattista. VIEW ABSTRACT

770  Intracellularly triggered gene delivery system based on decationized polyplexes. Presenter: Luís Novo, Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Netherlands. Author(s): L. Novo, W. E. Hennink. VIEW ABSTRACT

771  Intranasal siRNA delivery into the brain combined with the cell-penetrating peptide-modified MPEG-PCL nanomicelles. Presenter: Takanori Kanazawa, Tokyo University of Pharmacy and Life Sciences, Japan. Author(s): T. Kanazawa, F. Akiyama, S. Kakizaki, Y. Takashima, Y. Seta. VIEW ABSTRACT

772  Loading Viral Vectors within Porous Microparticles for Improved Gene Delivery. Presenter: Rita Serda, Department of Nanomedicine, The Methodist Hospital Research Institute, U.S.A. Author(s): K. I. McConnell, J. Sakamoto, S. LaFrancesca, R. E. Serda. VIEW ABSTRACT

773  Mechanistic Insight into Statistical HPMA-oligolysine Copolymers for Gene Delivery. Presenter: Julie Shi, University of Washington, U.S.A. Author(s): J. Shi, B. Chou, J. G. Schellinger, R. N. Johnson, J. L. Choi, S. H. Pun. VIEW ABSTRACT

775  Methylated Poly(L-histidine) to Control the Stability of its siRNA Polyion Complexes for RNAi. Presenter: Shoichiro Asayama, Tokyo Metropolitan University, Japan. Author(s): S. Asayama. VIEW ABSTRACT

776  Multi-functional Dendrimer Based Nano-therapeutic System for Prostate Cancer. Presenter: Umesh Gupta, South Dakota State University, U.S.A. Author(s): U. Gupta, P. Sahdev, O. Perumal. VIEW ABSTRACT

777  Multifunctional Drug Delivery System for Combinatorial Treatment of Prostate Cancer. Presenter: Oleh Taratula, Oregon State University, U.S.A. Author(s): C. Schumann, R. K. Dani, O. Taratula, A. Wang, O. Taratula. VIEW ABSTRACT

779  Neutralized lipid envelope-type nanoparticle encapsulating pDNA as a liver-specific and long-lasting gene expression. Presenter: Masami Ukawa, Faculty of Pharmaceutical science, Hokkaido University, Japan. Author(s): M. Ukawa, H. Akita, Y. Hayashi, R. Ishiba, K. Tange, M. Arai, K. Kubo, Y. Higuchi, K. Shimizu, S. Konishi, M. Hashida, H. Harashima. VIEW ABSTRACT

780  Nylon-3 based poly-beta-peptides for siRNA delivery. Presenter: Venkatareddy Nadithe, WAYNE STATE UNIVERSITY, U.S.A. Author(s): V. Nadithe, O. M. Merkel. VIEW ABSTRACT

781  PEG Length and Linkage Dramatically Influence Polyacridine Peptide DNA Polyplex Gene Transfer Activity In Vivo. Presenter: Kevin Rice, University of Iowa College of Pharmacy, U.S.A. Author(s): K. Rice, S. Khangharia, K. Kizzire, M. Ericson, N. Baumhover. VIEW ABSTRACT

782  Peptide Polymer Nanoparticle Composites for Ocular Gene Delivery. Presenter: Arvind Jain, School of Pharmacy, Queen's University Belfast, United Kingdom. Author(s): A. K. Jain, H. Yusuf, H. O. McCarthy, D. M. McDonald, V. L. Kett. VIEW ABSTRACT

783  pH-sensitive Nano-crystals of Carbonate Apatite for Smart and Efficent Drug/ transgene Delivery. Presenter: Sharif Hossain, Tokyo Institute of Technology, Japan. Author(s): S. Hossain, T. Akaike. VIEW ABSTRACT

784  pH-Sensitive PEG-modification onto cell signal-responsive polyplex for improved colloidal stability and cell specificity in gene delivery. Presenter: Yoshiki Katayama, Kyushu University, Japan. Author(s): Y. Katayama, S. Kushio, A. Tsuchiya, T. Niidome, T. Mori. VIEW ABSTRACT

786  Polyion complex vesicles formed by a pair of PEG-catiomers and siRNAs for novel oligonucleotide delivery carriers. Presenter: Sayan Chuanoi, Graduate School of Engineering, University of Tokyo, Japan. Author(s): S. Chuanoi, A. Kishimura, K. Miyata, T. Suma, Y. Anraku, K. Kataoka. VIEW ABSTRACT

787  Polymeric Micelles Co-Loaded with Survivin siRNA and Paclitaxel: A Strategy to Overcome the Multidrug Resistance in Tumors. Presenter: Giuseppina Salzano, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, 360 Huntington Avenue, 140 The Fenway, Boston, Massachusetts, 02115, United States, U.S.A. Author(s): G. Salzano. VIEW ABSTRACT

789  Potential use of NF-kB Decoy Complex with Fucose-appended Dendrimer/α-cyclodextrin Conjugate for Treatment of Fulminant Hepatitis. Presenter: H. Arima, Kumamoto Univesity, Japan. Author(s): C. Akao, R. Onodera, R. Mitsuyasu, K. Motoyama, T. Higashi, H. Arima. VIEW ABSTRACT

790  Preparation and Evaluation of Folate-PEG-appended Dendrimer (G4) Conjugate with a-cyclodextrin as a Cancer Cell-selective siRNA Carrier. Presenter: Ayumu Ohyama, Kumamoto University, Japan. Author(s): A. Ohyama. VIEW ABSTRACT

791  Preparation of DNA hydrogel for radio-sensitive drug release. Presenter: Jun-ichiro Jo, National Institute of Radiological Sciences, Japan. Author(s): J. Jo, I. Aoki, T. Saga. VIEW ABSTRACT

793  RAFT Block Copolymers for siRNA Delivery to Inhibit Influenza Virus Replication. Presenter: Pathiraja Gunatillake, CSIRO Materials Science & Engineering, Australia. Author(s): P. A. Gunatillake, T. Hinton, S. Shi, A. CHallagulla, C. Stewart, S. Thang, C. Guerrero-Sanchez, F. Grusche, P. Monaghan. VIEW ABSTRACT

794  Reduction-Triggered siRNA Release Nanoconstruct for Targeted siRNA Delivery. Presenter: Won Jong Kim, POSTECH, Korea. Author(s): R. Namgung, W. Kim. VIEW ABSTRACT

795  Regulation of mRNA immunogenicity by nanomicelle encapsulation for in vivo mRNA delivery. Presenter: Satoshi Uchida, Graduate School of Medicine, the University of Tokyo, Japan. Author(s): S. Uchida, K. Itaka, H. Uchida, K. Hayakawa, T. Ogata, T. Ishii, S. Fukushima, K. Osada, K. Kataoka. VIEW ABSTRACT

796  Remarkable Enhancements of Cellular Membrane Uptake Ability and RNase H Activities of Arg Introduced Peptide Ribonucleic Acids (PRNA) and PRNA -- DNA Chimera for Cancer Cell Specific Oligonucleotide Therapeutics. Presenter: Takehiko Wada, IMRAM, Tohoku University, Japan. Author(s): T. Wada, R. Uematsu, Y. Araki, S. Sakamono. VIEW ABSTRACT

797  Reversible permeability enhancement of DNA-loaded chitosan oligosaccharide nanoparticle across Calu-3 epithelial cell model for airway gene delivery. Presenter: Yingying Xu, The University of Hong Kong, Prc Peoples Rep of China. Author(s): Y. Xu, Y. Ye, J. Lam. VIEW ABSTRACT

799  Self-immolative linker based BENSpm prodrug as dual drug/gene delivery system. Presenter: Yu Zhu, Wayne State University, U.S.A. Author(s): Y. Zhu, S. Hazeldine, D. Oupicky. VIEW ABSTRACT

800  siRNA Delivery by a Combination of Arginine-grafted Bioreducible Polymer, Ultrasound, and Microbubbles in an Ovarian Cancer Cell Line. Presenter: Stelios Florinas, Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, USA, U.S.A. Author(s): S. Florinas, S. Kim. VIEW ABSTRACT

801  Specific Targeting to Brain with Osmotic Polymannitol Gene Transporter Modified with Rabies Virus Glycoprotein for Alzheimer's Disease RNAi Interference Therapeutics. Presenter: Chong-Su Cho, Research Institute for Agriculture and Life Sciences, Seoul National University, Korea. Author(s): C. Cho, T. Park. VIEW ABSTRACT

802  Stabilization of Complex with PKCα-Specific LPEI-Peptide Conjugate via Hydrophobic Interaction. Presenter: Chan Woo Kim, Kyushu University, Japan. Author(s): C. Kim, T. Mori, Y. Katayama. VIEW ABSTRACT

803  Stem cell-derived vesicles as a gene delivery vehicle for cancer therapy. Presenter: Marcelle Machluf, The Technion, Israel. Author(s): L. Sertshuk, M. Machluf. VIEW ABSTRACT

804  Sticky Adeno-associated viral Vectors for Patterned Gene Delivery. Presenter: Eunmi Kim, Yonsei University, Korea. Author(s): E. Kim, I. Song, S. Lee, J. Kim, M. Park, G. Jin, H. Lee, J. Jang. VIEW ABSTRACT

805  Structure and Function Study of Nucleic Acid Nanoparticles For the Delivery of Peptide-siRNA Conjugates. Presenter: Jeong Hye, Ewha Womans University, Korea. Author(s): J. E. Hye. VIEW ABSTRACT

806  Structure Modification of CpG oligounucleotides and their antitumor activities by stimulating Innate Immunity. Presenter: Xiaofei Xiang, Shanghai Jiao Tong University, Prc Peoples Rep of China. Author(s): X. Xiang. VIEW ABSTRACT

807  Study of morphology and the surface topography of the complexes formed between cationic emulsions and an antimalarial oligonucleotide by atomic force microscopy. Presenter: Helder Teixeira, Universidade Federal do Rio Grande do Sul, Brazil. Author(s): F. Bruxel, M. Vilela, M. Andrade, M. Oliveira, H. Teixeira. VIEW ABSTRACT

808  Surface Membrane of Rationally Designed Block Copolymer Assembled around Polyplex Core for Intercellular Delivery of Nucleic Acids. Presenter: Xuemei Ge, Shanghai JiaoTong University, Prc Peoples Rep of China. Author(s): X. Ge, T. Jin. VIEW ABSTRACT

809  Synthesis and characterizations of cationic lipid molecules for siRNA delivery. Presenter: Jinping Zhang, School of pharmacy, Shanghai Jiao Tong University, Prc Peoples Rep of China. Author(s): J. Zhang. VIEW ABSTRACT

810  Targeted delivery of siRNA to tumors using antibody-modified lipid nanoparticle. Presenter: Ayaka Okamoto, Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Japan. Author(s): A. Okamoto, H. Ando, H. Kato, T. Tsuzuku, K. Shimizu, T. Asai, T. Minamino, E. Mekada, N. Oku. VIEW ABSTRACT

811  Targeted Gene Delivery in Liver by Bubble Liposomes and Ultrasound. Presenter: Daiki Omata, Laboratory of Drug and Gene Delivery System, Faculty of Pharma-sciences, Teikyo University, Japan. Author(s): D. Omata, R. Suzuki, Y. Oda, Y. Sawaguchi, Y. Negishi, K. Maruyama. VIEW ABSTRACT

812  Targeting Glioblastoma with an Anticancer MicroRNA. Presenter: Paula Ofek, Tel Aviv University, Israel. Author(s): P. Ofek, M. Calderon, W. Fischer, F. Sheikhi-Mehrabadi, R. Haag, R. Satchi-Fainaro. VIEW ABSTRACT

813  Tethering PEG density on polyplex micelles and stealthiness in blood circulation. Presenter: Kensuke Osada, The University of Tokyo, Japan. Author(s): K. Osada, T. A. Tockary, Q. Chen, A. Dirisala, K. Machitani, T. Nomoto, Y. Matsumoto, K. Kataoka. VIEW ABSTRACT

814  The effect of plasmid DNA sequence on gene expression and polycation complex formation. Presenter: Ryohei Togashi, Faculty of Pharmaceutical Sciences, Hokkaido University, Japan. Author(s): R. Togashi, H. Akita, H. Kamiya, H. Harashima. VIEW ABSTRACT

815  The Role of Caveolin-1 and Syndecan-4 in the Internalization of PEGylated PAMAM Dendrimer Polyplexes into Myoblast and Hepatic Cells. Presenter: Rong QI, Peking University Institute of Cardiovascular Sciences, Prc Peoples Rep of China. Author(s): R. QI, W. Shen, M. van Dongen, M. M. Banaszak Holl. VIEW ABSTRACT

816  The synthesis and activities of fatty acid-conjugated CpG oligodeoxynucleotide. Presenter: Caixing Wu, College of Pharmaceutical Science, Zhejiang University, Prc Peoples Rep of China. Author(s): C. Wu. VIEW ABSTRACT

817  Treatment of sensory nerve disorder by in vivo mRNA introduction using polyplex nanomicelle. Presenter: Keiji Itaka, University of Tokyo, Japan. Author(s): K. Itaka, M. Baba, T. Ishii, K. Kataoka. VIEW ABSTRACT

818  Tumor regression following intravenous administration of tumor-targeted dendriplexes. Presenter: Christine Dufes, University of Strathclyde, United Kingdom. Author(s): C. Dufes. VIEW ABSTRACT

820  Tunable and Sustained Scaffold-based Gene Silencing In Vivo. Presenter: Craig Duvall, Vanderbilt University, U.S.A. Author(s): C. E. Nelson, A. Kim, A. Hannah, E. J. Adolph, M. K. Gupta, F. Yu, J. M. Davidson, S. A. Guelcher, C. L. Duvall. VIEW ABSTRACT

821  Unraveling the Role of Serum on siRNA Delivery in Vitro. Presenter: Jian Liu, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Prc Peoples Rep of China. Author(s): J. Liu, W. Zhang, J. Meng, H. Xu. VIEW ABSTRACT

Solubilization Technology - A Key Enabler for the Delivery of Poorly Soluble Drugs     [RETURN TO TOP]

822  A Combination of a Coaxial Electrospray Deposition and a Post-Heating Process as a Technique That Improves Oral Bioavailability of Poorly Water-Soluble Drugs. Presenter: Narimoto Ishizuka, Setsunan University, Japan. Author(s): N. Ishizuka, S. Sakuma, M. Yamamoto, Y. Masaoka, M. Kataoka, S. Yamashita, S. Zhang, R. Chauhan, K. Kawakami. VIEW ABSTRACT

823  A High Drug-load, Solid Dispersion Formulation for A Poorly Soluble Drug Molecule. Presenter: Vivian Bi, Ashland Specialty Ingredients, U.S.A. Author(s): V. Bi, M. Rahman, J. Lester, T. Durig. VIEW ABSTRACT

824  A Miniaturized Method to Study Dissolution, Supersaturation and Precipitation of Amorphous Compounds. Presenter: Christel Bergström, Uppsala University, Department of Pharmacy, Sweden. Author(s): J. H. Fagerberg, C. Khalil, D. Mahlin, C. A. Bergström. VIEW ABSTRACT

826  Amino acids as amorphous stabilizers and dissolution enhancers for poorly water soluble drugs. Presenter: Korbinian Loebmann, University of Otago, New Zealand. Author(s): K. Loebmann, R. Laitinen, C. J. Strachan, H. Grohganz, T. Rades. VIEW ABSTRACT

827  Antioxidant Capacity of Tailor-made Quercetin Nanocrystals with KRLTest. Presenter: Cornelia Keck, University of Applied Sciences Kaiserslautern Campus Pirmasens, Germany. Author(s): R. Chen, M. Prost, L. Greiner, R. H. Müller, C. M. Keck. VIEW ABSTRACT

829  Application of a Novel Boron Carrier: Kojic Acid Appended Carborane/Hydroxypropyl-β-Cyclodextrin Complex for Boron Neutron Capture Thearapy. Presenter: Riku Kawasaki, Department of Applied Chemistry and Bioengineering, Graduate School of Engineering, Osaka City University, Japan. Author(s): R. Kawasaki, K. Ono, S. Masunaga, Y. Sakurai, M. Kirihata, T. Nagasaki. VIEW ABSTRACT

831  Assessing the phase behavior of digestible and non-digestible lipid based liquid crystalline oral drug delivery systems . Presenter: Tri-Hung Nguyen, Monash Institute of Pharmaceutical Science, Australia. Author(s): T. Nguyen, E. Murari, C. J. Porter, B. J. Boyd. VIEW ABSTRACT

833  CapsMorph: >4 Years Long-TermStability of Industrially Feasible Amorphous Drug Formulations. Presenter: Rainer Müller, Free University of Berlin, Germany. Author(s): R. H. Müller, Q. Wei, C. M. Keck. VIEW ABSTRACT

835  Comparative study of Pluronic® F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats. Presenter: Dengning Xia, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Prc Peoples Rep of China. Author(s): D. Xia, D. Chen, S. Guo, C. Zhu, Y. Gan. VIEW ABSTRACT

836  Controlled Digestion; Enhancing the Utility of Lipid Based Drug Delivery Systems. Presenter: Orlagh Feeney, Monash Institute of Pharmaceutical Sciences, Australia. Author(s): O. Feeney. VIEW ABSTRACT

837  Dispersity and bioavailability of highly drug-loaded PEG400 formulation is improved with micellar technology. Presenter: Kenichi Sakai, Chugai Pharmaceutical co., ltd., Japan. Author(s): K. Sakai, M. Shibata, R. Takano, M. Yoshikawa, H. Uchiyama, R. Kubota, A. Mizutani, Y. Sakai. VIEW ABSTRACT

838  Dissolution Rate Enhancement of Felodipine by Solid Dispersions using Novel Amphiphilic Polymer Soluplus®. Presenter: Murali Pandey, Birla Institute of Technology & Science, Pilani Campus, Pilani, India. Author(s): M. M. Pandey, J. A, A. Gajja, S. Y. Charde. VIEW ABSTRACT

839  Drug solubility in excipients of lipid based formulations. Presenter: Linda Persson, Uppsala University, Department of Pharmacy, Sweden. Author(s): L. C. Persson, C. J. Porter, W. N. Charman, C. A. Bergström. VIEW ABSTRACT

840  Esterase-Activatable β-Lapachone Prodrug Micelles for NQO1-Targeted Lung Cancer Therapy. Presenter: Xinpeng Ma, University of Texas Southwestern Medical Center, U.S.A. Author(s): X. Ma, X. Huang, G. Huang, Y. Wang, D. A. Boothman, J. Gao. VIEW ABSTRACT

841  Formulation and Pharmacokinetic Study of Oral Liposomal Docetaxel. Presenter: Dae-Hwan Shin, College of Pharmacy, Sookmyung Women’s University, Seoul, Korea, Korea. Author(s): D. Shin, J. Shin, N. Han, S. Xuan, S. Lee, J. Kim. VIEW ABSTRACT

842  Formulation of Solid Self-Microemulsifying Drug Delivery Systems using Inorganic Porous Adsorbents. Presenter: Katarina Bolko, Faculty of Pharmacy, University of Ljubljana, Slovenia. Author(s): K. Bolko, A. Zvonar, M. Gašperlin. VIEW ABSTRACT

844  Gastric Processing is a Critical Determinant of the Ability of Lipid-Based Formulations to Enhance the Oral Bioavailability of a Model Poorly Water-Soluble Drug. Presenter: Ben Boyd, Monash Institute of Pharmaceutical Sciences, Australia. Author(s): K. W. Lee, C. J. Porter, B. J. Boyd. VIEW ABSTRACT

845  Incorporation of Curcumin into polyvinylpyrrolidone fibers by electrospinning: Improving Curcumin water-solubility. Presenter: Priscilla Luz, Federal University of Espírito Santo, Brazil. Author(s): P. P. Luz, F. O. Ochanda, M. A. E. Silva, J. P. Hinestroza. VIEW ABSTRACT

846  Investigating the Surface Wettability of Poloxamers used for Solid Dispersions. Presenter: Daniel Burnett, Surface Measurement Systems, Ltd., U.S.A. Author(s): D. J. Burnett, A. R. Garcia, Y. Lan, S. Ali. VIEW ABSTRACT

847  Mechanism of Phospholipid complex and its SNEDDS enhancing the oral bioavailability of sylibin. Presenter: Jianxin Wang, Department of Pharmaceutics, School of Pharmacy, Fudan University, Prc Peoples Rep of China. Author(s): J. Wang. VIEW ABSTRACT

848  Metaxalone Nanoformulation Utilizing SoluMatrix Technology. Presenter: Jason Coleman, iCeutica, U.S.A. Author(s): J. Coleman, S. Dalton, P. Mididoddi, F. Meiser, M. Norret, A. Russell, B. Bosch. VIEW ABSTRACT

850  Micronized Benzodiazepines for Sublingual Applications Produced by Using Advanced Focused Ultrasound. Presenter: Srikanth Kakumanu, Covaris Inc, U.S.A. Author(s): A. Nivorozhkin, N. Landrau, T. Hao, S. Kakumanu, C. Beckett. VIEW ABSTRACT

852  Molecular interactions between drugs and amino acids in co-amorphous formulations. Presenter: Korbinian Loebmann, University of Otago, New Zealand. Author(s): K. Loebmann, R. Laitinen, C. J. Strachan, T. Rades, H. Grohganz. VIEW ABSTRACT

853  Nanoemulsified antioxidant formulations mitigates oxidative stress in chronic sleep fragmented Human apolipoprotein E4 targeted replacement mice. Presenter: Yashwant Pathak, University of South Florida, U.S.A. Author(s): Y. Pathak, R. Vijay, N. Kaushal, D. Nair, D. Gozal. VIEW ABSTRACT

854  Novel Thermosensitive Polymeric Micelles for Hydrophobic Chemotherapeutic Drugs: Enhanced Stability and Loading Capacity by Pi-Pi Stacking. Presenter: Yang Shi, Department of Pharmaceutics, Faculty of Sciences, Utrecht University , Netherlands. Author(s): Y. Shi, W. E. Hennink. VIEW ABSTRACT

855  Polymeric Micellar Carriers for a Hydrophobic Anti-cancer Drug. Presenter: Darren Svirskis, University of Auckland, New Zealand. Author(s): T. Wong, D. Svirskis, W. Wilson, B. Palmer, Z. Wu. VIEW ABSTRACT

856  Preparation and Characterization of Ternary Inclusion Complexes for solubility enhancement of paliperidone. Presenter: Atul Sherje, SPP School of Pharmacy & Technology Management, SVKM's NMIMS, Mumbai, India. Author(s): A. P. Sherje, V. Londhe. VIEW ABSTRACT

857  Preparation and evaluation of fenofibrate loaded mesoporous silica. Presenter: In-Ho Song, Yonsei University, Korea. Author(s): I. Song, J. Park, W. Cho, H. Kang, B. J. Lee, K. Cha, S. Hwang. VIEW ABSTRACT

858  Preparation and Evaluation of Self-Microemulsifying Drug Delivery System (SMEDDS) containing Atorvastatin and Ezetimibe. Presenter: Su-Hyeon Kim, Sungkyunkwan University, South Korea. Author(s): S. Kim, S. Park, J. Ha, J. Kim, K. Hwang, C. Park, Y. Rhee, S. Chi, E. Park. VIEW ABSTRACT

859  Preparation and Evaluation of Solid-Self Emulsifying Drug Delivery System for Enhancing Bioavailability and Lymphatic Delivery of Paclitaxel. Presenter: Yong-Bok Lee, College of Pharmacy and Institute of Bioequivalence and Bridging study, Chonnam National University, Korea. Author(s): H. Cho, J. Kang, Y. Lee. VIEW ABSTRACT

860  Self- microemulsifying drug delivery system for oral delivery of T1-11. Presenter: Ling-Yun Chang, Taipei Medical University, Taiwan. Author(s): L. Chang, T. Tsai. VIEW ABSTRACT

861  Small volume dissolution of poorly soluble drugs prepared as a solid dispersion. Presenter: Jon Mole, Sirius Analytical, U.S.A. Author(s): J. Mole, K. J. Box, J. Comer, R. Taylor, B. Stockton, D. Matthews. VIEW ABSTRACT

862  Solid Dispersion Formation of Poorly Soluble Compounds using OptiMelt Hot Melt Extrusion Technology. Presenter: Scott Lamb, Catalent Pharma Solutions, U.S.A. Author(s): N. Mahajan, I. Vitez, K. Crowley, S. Lamb, K. Nielsen. VIEW ABSTRACT

863  Solid state characterization of drug precipitation during digestion of super-SNEDDS lipid based drug delivery system using synchrotron SAXS/WAXS. Presenter: Stephanie Phan, Monash Institute of Pharmaceutical Sciences , Australia. Author(s): S. Phan, A. Hawley, X. Mulet, B. J. Boyd. VIEW ABSTRACT

864  Solid State Characterization of Felodipine-Soluplus® Solid Dispersions. Presenter: Michael Repka, Department of Pharmaceutics, School of Pharmacy, The University of Mississippi, University, MS 38677, U.S.A. Author(s): M. A. Repka, J. Lu, S. Shah, S. Jo, S. Majumdar, K. Kolter, N. A. Langley, H. Jun, D. Zhang. VIEW ABSTRACT

866  Solubility enhancement of mefenamic acid with eudragit® EPO using melt extrusion techniques. Presenter: Michael Repka, Department of Pharmaceutics, School of Pharmacy, The University of Mississippi, University, MS-38677, USA, U.S.A. Author(s): M. A. Repka, S. M. Alshehri, S. Shah, S. M. Alshahrani, B. K. Almutairy, J. Morott, S. N. Murthy, S. Majumdar. VIEW ABSTRACT

867  Solubility of drug compounds in the presence of an excipient used in lipid based formulations. Presenter: Jon Mole, Sirius Analytical, U.S.A. Author(s): J. Mole, K. Box, J. Comer, R. Taylor, R. Ruiz. VIEW ABSTRACT

868  Structural determinants of polymeric precipitation inhibitors for use with poorly water soluble drugs. Presenter: Dallas Warren, Monash Institute of Pharmacetutical Science, Monash University, Australia. Author(s): D. B. Warren, C. A. Bergström, M. U. Anby, H. Benameur, C. J. Porter, C. W. Pouton. VIEW ABSTRACT

869  Study on the nanoemulsion of poorly soluble drugs stabilized by Organic-Inorganic Nanocomposite. Presenter: Xinrui Ma, Shanghai Jiao Tong University, Prc Peoples Rep of China. Author(s): X. Ma, W. Sun, X. Wei, S. Qian, Y. Xu. VIEW ABSTRACT

870  Supersaturation and precipitation behavior of ionizable drugs in the presence of cellulose polymers. Presenter: Jon Mole, Sirius Analytical, U.S.A. Author(s): J. Mole, K. Box, J. Comer, R. Taylor, R. Ruiz. VIEW ABSTRACT

871  Using Hybrid Nanostructure to Improve the Performance of Oral Lipid Based Drug Delivery Systems. Presenter: Clive Prestidge, University of South Australia, Australia. Author(s): C. A. Prestidge, A. Tan. VIEW ABSTRACT

Topical/Transdermal Drug Delivery     [RETURN TO TOP]

872  A High Throughput Method for Determination of Hydrophobic Drugs in Surfacant-Containing Dissolution Media Used to Evaluate In-Vitro Release of Drug Eluting Stents (DES). Presenter: Marika Kamberi, Abbott Vascular, Inc., U.S.A. Author(s): M. Kamberi. VIEW ABSTRACT

873  A hyaluronic acid chip within a transdermal maltose microneedle. Presenter: Yoshikazu Tobinaga, Elegaphy, Inc., Japan. Author(s): Y. Tobinaga, T. Kitagawa. VIEW ABSTRACT

874  An investigation of cutaneous delivery of lipoic acid loaded in liquid crystalline nanodispersion. Presenter: Patricia Campos, School of Pharmaceutical Sciences of Ribeirao Preto - University of Sao Paulo, Brazil. Author(s): P. M. Campos, F. G. Praca, M. F. Otuki, M. L. Bentley. VIEW ABSTRACT

875  Assessment of Drug-Vehicle Interactions seen in Topical Drug Delivery using three PAMPA Artificial Membrane Systems. Presenter: Jim Riviere, Kansas State University, U.S.A. Author(s): J. E. Riviere. VIEW ABSTRACT

876  Catechol-Chitosan/Genipin Hydrogel as Mucoadhesive Buccal Drug Delivery System. Presenter: Jinke Xu, McGill University, Canada. Author(s): J. Xu, S. Strandman, J. Barralet, M. Cerruti. VIEW ABSTRACT

878  Characteristics of the Stability in Local Anesthetic Lipospheres. Presenter: Ae-June Wang, Andros Pharmaceuticals Co., Ltd., Taiwan. Author(s): A. Wang, J. Hu, W. Lee, R. Peng, C. Lee. VIEW ABSTRACT

880  Delivery of Ibuprofen Through Carbosil Membranes Using Finite Dose Technology. Presenter: Minja Gerber, North-West University, Private Bag X6001, Centre for Excellence in Pharmaceutical Sciences, Potchefstroom, North-West Province, 2531, South Africa, Rep of South Africa. Author(s): M. Gerber, J. Kilian, J. Hadgraft, M. Lane, J. Du. Plessis. VIEW ABSTRACT

882  Development and Evaluation of Estradiol-Loaded Microemulsion-Based Gel. Presenter: LI-TSE FU, School of pharmacy, Kaohsiung Medical University, Taiwan Rep of China. Author(s): L. FU. VIEW ABSTRACT

883  Development of a novel drug in adhesive transdermal analgesic patch: Formulation optimization and characterization. Presenter: Ranadheer Ravula, Mercer University, Atlanta , U.S.A. Author(s): R. Ravula, A. K. Herwadkar, M. J. Abla, J. P. Little, A. K. Banga. VIEW ABSTRACT

884  Development of matrix based transdermal delivery system for ketotifen. Presenter: Eun-Young Lee, Chosun University, Korea. Author(s): E. Lee, G. Lee, H. Choi. VIEW ABSTRACT

885  Development of Novel Arrayed Microjet Devices for Transdermal Drug Administration. Presenter: Huangpin Hsieh, PARC, A Xerox Company, U.S.A. Author(s): H. B. Hsieh, A. V. Pattekar, S. Uhland, A. R. Völkel, M. I. Recht, F. Linn, G. B. Anderson, E. M. Chow. VIEW ABSTRACT

886  Development of Novel Microneedle-based Systems for theMinimally Invasive Monitoring of Neonates. Presenter: Barbara Torrisi, Queen's University , United Kingdom. Author(s): B. M. Torrisi, E. Caffarel-Salvador, R. F. Donnelly. VIEW ABSTRACT

888  Effect of morphology and application modes of microneedles on permeability of ibuprofen against skin. Presenter: Jong-Suep Baek, Chungnam National University, South Korea. Author(s): J. Baek, M. Park, C. Lee, M. Han, M. Hong, B. Sul, C. Cho. VIEW ABSTRACT

889  Effect of Reverse Iontophoresis on Theophylline Uptake by Hydrogel-forming Microneedle Arrays. Presenter: Ester Caffarel-Salvador, Queen's University Belfast, United Kingdom. Author(s): E. Caffarel-Salvador, P. Gonzalez-Vazquez, R. F. Donnelly, D. S. Jones. VIEW ABSTRACT

891  Effects of hydroxypropyl-cellose (HPC) on the nasal drug absorption from powder formulations. Presenter: Akiko Tanaka, Department of Biopharmaceutics, Kyoto Pharmaceutical University, Japan. Author(s): A. Tanaka, K. Takano, A. Matsushita, T. Furubayashi, H. Katsumi, T. Sakane, A. Yamamoto. VIEW ABSTRACT

892  Elongate Microparticles Enhance Topical Drug Delivery in Pigs and Volunteers. Presenter: Tarl Prow, Dermatology Research Centre| School of Medicine| The University of Queensland , Australia. Author(s): T. W. Prow. VIEW ABSTRACT

893  Enhancement of nasal vaccination with adenoviral vectors by mucosal adhering and DC-targeting adjuvants. Presenter: Xun Sun, Sichuan University, Prc Peoples Rep of China. Author(s): X. Sun, Y. Jiang, Z. Zhang. VIEW ABSTRACT

894  Enhancing Permeability of Sodium Lauryl Sulfate and Dodecyl Maltoside Across The Dermal Tissue of L. Terrestris. Presenter: Jongbin Lee, Prafys Research Laboratory, U.S.A. Author(s): E. Kim, S. Lee, H. Jung, H. Kim, K. Jung, E. Kang, J. Choi, D. Kyung, J. Lee, A. J. Suh. VIEW ABSTRACT

895  Evaluation of alternative membrane models as a surrogate for buccal membrane permeation of nicotine. Presenter: Gaurav Bhatia, MERCER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES, ATLANTA, GA-30341, U.S.A. Author(s): G. Bhatia, M. Abla, G. Deshpande, A. K. Banga, A. Chaturvedula. VIEW ABSTRACT

899  High tolerance transdermal patches loaded with caffeine. Presenter: Cornelia Keck, University of applied sciences Kaiserslautern, Germany. Author(s): C. M. Keck, P. Gansen, B. Bohrer, R. H. Müller, M. Dittgen. VIEW ABSTRACT

900  Human In Vivo Study: Dermal Application of Rutin SmartCrystals® & Peptide-Loaded Liposomes to Decrease Skin Roughness. Presenter: Cornelia Keck, Freie Universität Berlin, Institute of Pharmacy, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Germany. Author(s): P. Sinambela, B. M. Löffler, E. Egorov, C. M. Keck, R. H. Müller. VIEW ABSTRACT

901  Immobilization of mEGF by Azidophenyl Chitosan for Medical Applications. Presenter: Tae Il Son, Department of Biotechnology, Chung-Ang University, South Korea. Author(s): T. Son. VIEW ABSTRACT

902  Intravenous Rutin Nanocrystals with Potential Use for Alzheimer Treatment. Presenter: Rainer Müller, Department of Pharmaceutics, Biopharmaceutics & NutriCosmetics, Free University of Berlin, Germany. Author(s): Y. Zhang, R. Chen, C. M. Keck, R. H. Müller. VIEW ABSTRACT

903  Lidocaine-Ibuprofen Ionic Liquid for Dermal Anesthesia. Presenter: Han Jung Park, Georgia Institute of Technology, U.S.A. Author(s): H. Park, M. R. Prausnitz. VIEW ABSTRACT

904  Light-activated antibacterial activity of nanoencapsulated hypericin against biofilm and planktonic cells of Methicillin-resistant Staphyllococcus aureus (MRSA) clinical isolates. Presenter: Noha Nafee, Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt, Egypt. Author(s): N. A. Nafee, A. A. Youssef, H. Asem, A. Abd. El-Fattah, L. K. El-Khordagui, S. Kandil. VIEW ABSTRACT

905  Local delivery of phenylephrine using hollow microneedle as a treatment of fecal incontinence. Presenter: Mee Ree Han, Chung-Ang Univesity, South Korea. Author(s): M. Han, J. Park, H. Jeon, J. Park. VIEW ABSTRACT

906  Low frequency sonophoresis: influence of solid lipid nanoparticles in skin LTRs distribution. Presenter: Tatiana Pereira, School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Brazil. Author(s): T. A. Pereira. VIEW ABSTRACT

907  Mechanical Properties of 'Super Swelling' Hydrogels. Presenter: Ester Caffarel-Salvador, Queen's University Belfast, United Kingdom. Author(s): E. Caffarel-Salvador, E. M. Vicente-Perez, P. Gonzalez-Vazquez, R. F. Donnelly, D. S. Jones. VIEW ABSTRACT

908  Microneedle-mediated Nanoparticle Vaccination. Presenter: Christopher Scott, Queen's University Belfast, United Kingdom. Author(s): R. F. Donnelly, A. Kissenpfennig, C. J. Scott, M. Zaric, U. Power. VIEW ABSTRACT

910  Nanostructured Lipid-Water Cubic Formulations for Dermal Drug Delivery. Presenter: Hanne Evenbratt, Chalmers University of Technology, Sweden. Author(s): H. Evenbratt, M. B. Ericson, S. Engström. VIEW ABSTRACT

911  Novel Core-Shell Zein Nanoparticles for Topical Delivery of Methotrexate. Presenter: Omathanu Perumal, South Dakota State University, U.S.A. Author(s): R. Averineni, O. Perumal. VIEW ABSTRACT

912  Optimization of dissolving microneedle delivery system through simplifying fabrication and investigating drug release. Presenter: Chuanbin Wu, School of Pharmaceutical Sciences, Sun Yat-sen University, Prc Peoples Rep of China. Author(s): Q. Wang, X. Pan, Y. Huang, C. Zhu, P. Liu, M. Huang, C. Wu. VIEW ABSTRACT

913  Pharmacokinetic evaluation of tolterodine hydrogels in rabbits. Presenter: Fengying Sun, Life Sciences building 352, Jilin University, Qianjin Street 2699, Changchun, Jilin Province, China, Prc Peoples Rep of China. Author(s): F. Sun. VIEW ABSTRACT

914  Porcine Mammary Papilla is a Suitable In-vitro Model to Study Transmammary Drug Delivery through Human Mammary Papilla. Presenter: Kaushalkumar Dave, Department of Pharmaceutical Sciences, South Dakota State University, U.S.A. Author(s): K. Dave, O. Perumal. VIEW ABSTRACT

915  Prediction of Percutaneous Absorption in Human of Nicotine from Marketed TTS using Three-dimensional Human Cultured Epidermis. Presenter: Tomohiro Hikima, Kyushu Institute of Technology, Japan. Author(s): T. Hikima, M. Komatsu, D. Mori, K. Tojo. VIEW ABSTRACT

916  Preparation and characterization of polymeric micelles for topical delivery of itraconazole. Presenter: Joonho Choi, 1 AMOREPACIFIC Co. R&D Center, 314-1 Bora-dong, Giheung-gu, Yongin-si, Gyeonggi-do 446-729, Republic of Korea; 2 College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, South Korea, South Korea. Author(s): J. Choi, S. Chung, C. Shim, D. Kim. VIEW ABSTRACT

917  Preparation and Evaluation of Triamcinolone Acetonide-loaded Hydrogel using an Electron Beam. Presenter: Jeong-Sook Park, Chungnam National University, South Korea. Author(s): J. Park, K. Huh, J. Kim. VIEW ABSTRACT

918  Quantification of nanoparticle uptake into hair follicles - in vitro in vivo correlation. Presenter: Ankit Mittal, Saarland University, Biopharmaceutics and Pharmaceutical Technology, Germany. Author(s): A. S. Raber, A. Mittal, J. Schaefer, U. Bakowsky, U. F. Schaefer, C. Lehr, S. Hansen. VIEW ABSTRACT

919  Rapidly Dissolvable Microneedles for Transdermal Delivery via a Highly Reproducible Soft Lithography Approach. Presenter: Katherine Moga, UNC Chapel Hill, U.S.A. Author(s): K. A. Moga, L. R. Bickford, R. D. Geil, S. S. Dunn, A. A. Pandya, Y. Wang, J. H. Fain, C. F. Archuleta, A. T. O'Neill, J. M. DeSimone. VIEW ABSTRACT

920  Smart Transdermal Vaccine Delivery Systems Using Hyaluronic Acid Derivatives. Presenter: Hyemin Kim, Department of Material Science and Engineering, POSTECH, South Korea. Author(s): H. Kim, K. Kim, S. Yun, S. Hahn. VIEW ABSTRACT

922  Strategies for electrospinning carrageenan-based nanofibers. Presenter: Deep Hathi, University of Washington, U.S.A. Author(s): D. K. Hathi, C. Ball, K. Woodrow. VIEW ABSTRACT

923  Synthesis and Topical Delivery of Ester and Carbonate Co-Drugs Derived from Tocopherol and Lipoic Acid. Presenter: Martha Hass, Albany College of Pharmacy and Health Sciences, U.S.A. Author(s): M. A. Hass, S. Thomas, M. McCall, L. B. Lopes. VIEW ABSTRACT

924  The effect of nanoemulsions on the transdermal delivery of citalopram. Presenter: Pao-chu Wu, school of pharmacy, Kaohsiung medical university, Taiwan. Author(s): P. Wu, C. Huang. VIEW ABSTRACT

925  The finest concentration and preparing condition of new Nanostructured Lipid Carriers (NLC). Presenter: Cornelia Keck, Applied Pharmacy Division, University of Applied Sciences Kaiserslautern, Germany. Author(s): T. Junmahasathien, R. H. Müller, C. M. Keck. VIEW ABSTRACT

926  The Penetration Enhancement Effect of Single and Binary Phase Combinations of Hydrophilic and Lipophilic Vehicles, Using Ibuprofen as a Model Drug. Presenter: Jeanetta Du Plessis, North-West University, Private Bag X6001, Centre for Excellence in Pharmaceutical Sciences, Potchefstroom, North-West Province, 2531, South Africa, Rep of South Africa. Author(s): J. Du. Plessis, J. Kilian, J. Hadgraft, M. Lane, M. Gerber. VIEW ABSTRACT

927  Transcutaneous Immunization using Iontophoresis - In vivo Preliminary Studies. Presenter: Daniela Bernardi, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Brazil. Author(s): D. S. Bernardi, C. Bitencourt, D. S. Silveira, E. L. Cruz, L. H. Faccioli, R. F. Lopez. VIEW ABSTRACT

928  Transdermal Administration of Serotonin-Dopamine Antagonist. Presenter: Hiroo Maeda, Dainippon Sumitomo Pharma, Japan. Author(s): H. Maeda. VIEW ABSTRACT

929  Transdermal delivery of fluoxetine. Presenter: Eunjae Jung, Seoul National University, Korea. Author(s): E. Jung, D. Kim, J. Kim. VIEW ABSTRACT

933  UV Imaging Studies on Pluronic F127-based Hydrogel Formulations of Ibuprofen. Presenter: Alexander Chapman, Paraytec Ltd, United Kingdom. Author(s): A. Chapman, K. Dodou. VIEW ABSTRACT

© Copyright Controlled Release Society  | Contact Us - Report a Bad Link